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ABSTRACT 
CHARACTERIZATION OF THE RCF1 Q-X3-R-X-R-X3-Q MOTIF AND ITS ROLE 
IN SUPPORTING OXIDATIVE PHOSPHORYLATION ENZYME COMPLEXES 
 
 
Joshua Garlich 
 
Marquette University, 2016 
 
 
 
 Mitochondrial respiratory complexes are critical components of cellular energy 
production that require tight regulation to ensure optimal function. Rcf1 and Rcf2 are 
mitochondrial proteins that can physically associate with the yeast respiratory complexes 
III and IV, and the higher-ordered III-IV respiratory supercomplex that also contains the 
ADP/ATP translocase, AAC. Rcf1 can physically associate with both complex III and IV 
independently, and can be chemically crosslinked to AAC, indicating a close physical 
proximity to a predominant regulator of energy flux within the cell. It was therefore 
hypothesized that Rcf1, through its physical association with complexes III and IV, and 
its close proximity to AAC, may possess the capacity to communicate with multiple 
components of supercomplexes, a feature which may be important for coordinated 
regulation of the respiratory enzymes. 
   
 The goal of this dissertation was to characterize the importance of an 
evolutionarily conserved motif, referred to here as the Q-X3-R-X-R-X3-Q (QRRQ) 
motif, within Rcf1 that defines it as a member of the Hypoxia-induced gene 1 (Hig1) 
protein family. To investigate the functional significance of the QRRQ motif, His-tagged 
Rcf1 proteins harboring mutations in the QRRQ motif were generated and expressed 
these in a yeast strain devoid of Hig1 proteins (Δrcf1Δrcf2). The importance of the 
QRRQ motif for the function of yeast Rcf1 was explored. I was found that mutations in 
conserved residues of the QRRQ motif affect the organization of the III-IV supercomplex 
and lead to the assembly of a novel Rcf1-complex IV subpopulation that displays altered 
enzymatic properties. The QRRQ motif impacts the ability of Rcf1 to associate with 
assembled complex IV and newly-synthesized unassembled Cox3, a core subunit of 
complex IV. Additionally, it was determined that Rcf1 exists in close physical proximity 
to Cox2, a catalytically important subunit of complex IV. It was found that the QRRQ 
motif influences the molecular environment of Rcf1 including its relationship to AAC 
proteins and possibly the cardiolipin-remodeling enzyme TAZ. Based on these findings, a 
model of the Rcf1-complex IV binding site is proposed and it is speculated that Rcf1 
functions to modulate the complex IV enzyme activity and supercomplex organization.  
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CHAPTER 1: INTRODUCTION 
1.1  Chapter Overview 
 Cytochrome c oxidase (complex IV) is the terminal enzyme complex of the 
mitochondrial electron transport chain and couples the reduction of oxygen to water to 
the pumping of protons across the inner mitochondrial membrane. In yeast, as in many 
eukaryotic taxa, cytochrome c oxidase can assemble into higher ordered structures termed 
supercomplexes with other respiratory enzymes. Respiratory supercomplex factor 1 
(Rcf1) was recently described as an integral inner mitochondrial membrane protein that 
influences the activity of complex IV, the assembly state of complex IV-containing 
respiratory supercomplexes, and the mitigation of mitochondrial oxidative damage. Rcf1 
is a member of a highly conserved sub-set of homologous proteins that contain a 
hypoxia-induced protein conserved region (Hig1) domain, and are functionally related in 
their regulation of complex IV activity and supercomplex organization. However, the 
molecular basis underlying the conserved functions of Hig1 proteins is not understood. 
To gain insight into the molecular underpinnings of Hig1 proteins, the conserved Hig1 
domain region and the molecular environment of Rcf1 were characterized in this 
dissertation. Conserved regions of Rcf1 were analyzed to determine their contribution to 
Rcf1 interactions and function. Additionally, the relationship between Rcf1 and the 
mitochondrial ADP/ATP carrier protein was explored in this study. To that end, this 
chapter will provide background information regarding complex IV and complex IV -
containing supercomplexes, as well as a short review on the Rcf1 protein and the larger 
Hig1 domain protein family in order to aid in understanding this dissertation study.  
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1.2 Origin and Function of Mitochondria  
 Mitochondria are essential eukaryotic organelles that are enclosed by a double 
membrane system. The inner membrane separates the center of the mitochondria, referred 
to as the matrix, from the intermembrane space that lies between the inner and outer 
membranes (Figure 1). As most cellular organelles contain a single-layered membrane, 
the double-membrane compartmental architecture is a unique feature of mitochondria and 
is directly related to its most well known function, the aerobic production of cellular 
energy through respiration.  
 It is generally accepted that mitochondria arose from an alpha-proteobacterium 
engulfed by an ancestral eukaryotic precursor cell during a critical time period when the 
earth was becoming increasingly oxygenated (Lane and Martin, 2010). It is proposed that 
this atmospheric transitional period for earth was uniquely optimal for the transformation 
of endosymbiotic bacteria, going from an oxygen “scavenging” partner to a permanent 
cellular organelle that functions as an oxygen-utilizing specialist in energy production. 
During evolution, much of the bacterial genome was transferred to the nucleus of the 
eukaryotic cell, but mitochondria have retained a small circular genome of 
deoxyribonucleic acid (mtDNA) that encodes for a small, but critical subset of OXPHOS 
complex subunits. 
 Mitochondria perform a diversity of functions that include steps in the catalytic 
pathways of heme biosynthesis, urea cycle, Krebs cycle, fatty acid metabolism and the 
biosynthesis of phospholipids, amino acids and nucleotides (Nunnari and Suomalainen, 
2012; Saraste, 1999; Scheffler, 2001). Moreover, mitochondria have been shown to play 
an important role in ageing, apoptosis, cancer, cellular Ca2+ flux, ROS homeostasis, and 
	 3	
the assembly of iron-sulfer clusters (Cui et al., 2012; Demaurex et al., 2009; Lill and 
Mühlenhoff, 2008; Wallace, 2005). However, these functions are often eclipsed by 
mitochondria’s most prominent role as the primary means of aerobic energy production 
by a process known as oxidative phosphorylation.    
1.3  Oxidative Phosphorylation 
 Oxidative phosphorylation (OXPHOS) couples the establishment of an 
electrochemical proton gradient to the generation of adenosine triphosphate (ATP). The 
mechanistic underpinnings of this critical cellular process were first proposed through the 
chemiosmotic coupling theory, in a series of seminal papers by Peter Mitchell (Mitchell, 
1961, 1966, 1968). The chemiosmotic theory posits that enzymes of the electron transfer 
chain facilitate the unidirectional movement of protons across a membrane, establishing 
an electrochemical gradient (ΔpH +ΔΨ) that drives the synthesis of ATP from adenosine 
diphosphate (ADP) and inorganic phosphate (Pi) by ATP-synthase (Mitchell, 1966). The 
enzymes involved in this cellular energy pathway, referred to as complexes I-IV, include: 
NADH-ubiquinoe oxidoreductase (complex I), succinate dehydrogenase (complex II), 
cytochrome bc1 reductase (complex III); and cytochrome c oxidase (complex IV).  Yeast, 
the model organism of this study, does not contain the traditional complex I, but rather, 
has alternative internal and external NADH dehydrogenases. Respiratory enzyme 
complexes are embedded within the inner mitochondrial membrane and facilitate the 
oxidation of reducing equivalents Nicotinamide Adenine Dinucleotide, reduced (NADH) 
and Flavin adenine dinucleotide, reduced (FADH2)(Figure 2). In the final steps of this  
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A.
B.
Figure 1. Overview of the Mitochondrial structure. (A) Transmission 
electron microscopy image of a mitochondrion, highlighting the ultrastructure 
and measurmements of unique features of the double-membrane system. 
(Nicholls and Ferguson, Bioenergetics, Academic Press, 4th Edition, 2013). 
(B) Mitochondria are double membraned organelles and the architecture of 
the inner membrane divideds the mitochondrion into separate compartments 
of the intermembrane space and matrix (Modified from Nicholls and Fergu-
son, Bioenergetics, Academic Press, 4th Edition, 2013). 
	 5	
process, the soluble iron-containing electron carrier, cytochrome c, mediates the transfer 
of electrons from complex III to complex IV, which donates electrons to molecular 
oxygen (O2) forming water (Fontanesi et al., 2008; Mick et al., 2011; Schägger, 2002; 
Tsukihara et al., 1996) Complex III and complex IV (in addition to the traditional 
complex I enzyme) couple electron transfer to the translocation of protons across the 
inner mitochondrial membrane from the mitochondrial matrix to the intermembrane 
space (IMS), resulting in an electrochemical gradient within the IMS (Brandt , 1994; 
Hatefi, 1985; Wikstrom, 1977). The proton gradient is utilized by the F1FO -ATP 
synthase, and provides the energy necessary to generate ATP from ADP and inorganic 
phosphate (Pi) (Saraste, 1999).  
 Mitochondrial OXPHOS is the preeminent source of ATP for the vast majority of 
cellular processes. Not surprisingly, mitochondrial O2 dysregulation and oxidative stress 
are distinct features of diverse pathologies including cancer, aging, ischaemic heart 
disease and diabetes (Fernyhough et al., 2010; Jarrett et al., 2010; Ren et al., 2010; Sas et 
al., 2010; Wallace, 2005). Additionally, mitochondrial dysfunction and reduced 
bioenergetic capacity underlie numerous muscular and neurological diseases (Ferreira et 
al., 2010; Kawamata and Manfredi, 2010; Kones, 2010; Waldbaum and Patel, 2010). 
Therefore, understanding how mitochondria regulate OXPHOS is paramount to 
understanding health and disease at the cellular level.  
 
 
	 6	
 
FO
F1
AACII III2IV IV
Ndi
Nde
IMS
Matrix
O2
H2O
ATP
ADP
ATP
ADP + Pi
H+ H+H+
H+ H+H+
H+ H+H+
H+
H+
H+
H+
H+
H+ H+
H+ H+
Figure 2. The mitochondrial oxidative phosphorylation enzyme com-
plexes. Respiratory enzyme complexes embedded in the inner mitochondri-
al membrane establish an electrochemical proton gradient by coupling the 
oxidation of reducing equivalents to the pumping of protons across the inner 
membrane into the inner membrane space (IMS). The F1FO ATP synthase 
couples the energy of the electrochemical gradient to the production of ATP 
in the process of oxidative phosphorylation. Enzyme complex structures 
generated from structures deposited in the protein data base (PDB) 4G9K 
(Ndi,Nde), 1NEK (II), 1KYO (III), 1OCC (IV), 4C9G (Aac), 1E79 (F1), 1C17 
(FO). 
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1.4  Complex IV 
1.4.1  Complex IV Overview 
 Complex IV is an oligomeric enzyme complex that couples the reduction of 
molecular oxygen to the translocation of protons across the bacterial membrane or the 
inner mitochondrial membrane (Figure 3). As the terminal enzyme in the mitochondrial 
electron transport chain, complex IV is a pivotal component of cellular respiration. 
Therefore, characterizing the mechanistic underpinnings of complex IV has been the 
focus of substantial effort in the fields of biochemistry and bioenergetics. Underlying the 
mechanism of complex IV reactions are fundamental chemical reactions, termed 
reduction and oxidation (redox) reactions. These reactions are characterized by the 
transfer of negatively charged subatomic particles known as electrons between different 
molecules, and in cytochrome c oxidase these are carried out by four redox active metal 
sites, CuA, heme a, heme a3 and CuB, within the enzyme.  
 Deficiency in complex IV accounts for the majority of human OXPHOS defects, 
and defects in the assembly or function of complex IV underlie multiple diseases 
associated with mitochondrial dysfunction (Barrientos et al., 2002; Bratton et al., 2003). 
Therefore, characterizing the factors that regulate complex IV assembly and function is 
paramount to understanding the molecular underpinnings of diseases associated with 
mitochondrial dysfunction.   
1.4.2 Complex IV Polypeptide Composition  
 Knowledge of complex IV has benefited greatly from the crystal structure, first 
described in bacterial and bovine complex IV (Iwata et al., 1995; Tsukihara et al., 1995).  
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Figure 3. Cytochrome c oxidase (Complex IV) is a multi-subunit 
enzyme complex. Complex IV is embedded in the inner mitochondrial 
membrane (IMM) where it couples the oxidation of cytochrome c and the 
reduction of oxygen to the translocation of protons across the IMM and into 
the inner membrane space (IMS). Depicted is bovine complex IV PDB 
2DYR (Shinazawa-Itoh et al., 2007). Individual mammalian (m-prefix) poly-
peptide subunits and their yeast homologs in parenthesis are; mCox1 
(Cox1) yellow, mCox2 (Cox2) forrest green, mCox3 (Cox3) slate blue, 
mCox4-1 (Cox5a) teal, mCOX5a (Cox6) salmon,  mCOX5b (Cox4) purple, 
mCOX6a (Cox13) red, mCOX6b (Cox12) orange, mCOX6c (Cox9) light 
blue, mCOX7a (Cox7) pink, mCOX7b (no yeast homolog identified) dark 
grey, mCOX7c (Cox8) light grey, mCOX8 (no yeast homolog identified) 
maroon.
IMS
Matrix
IMM
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The reduction of oxygen is coupled to the translocation of protons, and the enzymatic 
mechanisms involved are highly conserved features of complex IV. However, the number 
of individual polypeptide subunits varies between different organisms, ranging from 3 to 
5 in the aa3-type complex IV in bacteria, to at least 12 and 13 subunits in yeast and 
humans, respectively (Lucas et al., 2011; Mick et al., 2011). The yeast Saccharomyces 
cerevisiae (S. cerevisiae) contains a 12- subunit complex IV enzyme that is genetically 
mosaic in origin. Three large, highly hydrophobic transmembrane proteins, Cox1, Cox2, 
and Cox3, form the catalytic core of the enzyme, are encoded by mtDNA, and are 
homologous to the three subunits that comprise bacterial complex IV (Das et al., 2004; 
Fontanesi et al., 2008; Tsukihara et al., 1996). The mtDNA-encoded core subunits are 
synthesized by mitochondrial ribosomes, and inserted into the inner mitochondrial 
membrane. While specific assembly chaperones have been identified for Cox1 and Cox2 
proteins, no assembly partner for Cox3 has yet been identified (Fontanesi et al., 2008; 
Mick et al., 2011; Tsukihara et al., 1996). The remaining 9 nuclear-encoded subunits are 
synthesized by ribosomes in the cytosol, imported into the mitochondria by the 
translocase of the outer membrane (TOM) and translocase of the inner membrane (TIM), 
and assembled in a coordinated multistep manner with Cox1, Cox2 and Cox3 (Das et al., 
2004; Fontanesi et al., 2008; 2011; Fornuskova et al., 2010; Mick et al., 2011; 2007). 
Nuclear–encoded subunits, while not enzymatically active, are necessary for the 
assembly and stability of the holo-enzyme, as well as its predicted dimerization 
(Fontanesi et al., 2008). Additionally, non-catalytic subunits of complex IV can modulate 
catalytic activity of the enzyme in response to external cues. In S. cerevisiae, Cox5a and 
Cox5b are isoforms expressed alternately in response to oxygen levels, with the 
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expression of Cox5b resulting in complex IV that is capable of functioning under low 
oxygen conditions. Additionally, the peripheral Cox13 subunit has been suggested to be 
important to protect respiratory enzyme complexes from dysfunction and the generation 
of reactive oxygen species (ROS) under hypoxic conditions (Vukotic et al., 2012).  
1.4.3 Heme and Copper Reactive Centers of Complex IV 
 Mitochondrial complex IV contains 4 redox active functional heme and copper 
groups that serve as the reactive centers, and catalyze the transfer of electrons from 
cytochrome c to molecular oxygen. Both hemes, heme a and heme a3, are located within 
the Cox1 (bacterial subunit 1) protein moiety. The low-spin heme a facilitates the transfer 
of electrons from the soluble electron carrier cytochrome c to the high-spin heme a3. 
Heme a3, together with a copper atom (CuB) form a binuclear reactive center that 
functions as the site of molecular O2 reduction. A second copper center (CuA) consisting 
of two copper atoms is located within the protein moiety of Cox2 (bacterial subunit II). 
CuA is believed to be the primary acceptor of electrons from the soluble electron carrier, 
cytochrome c (Lucas et al., 2011). 
 Biosynthesis of heme A occurs within the mitochondrial inner membrane and 
involves successive farnesylation and oxidation steps that are catalyzed by the enzymes 
Cox10 and Cox15, respectively (Barrientos et al., 2002; Barros et al., 2001; Saiki et al., 
1993; Tzagoloff et al., 1993). Heme A is unique in that it is present only in cytochrome c 
oxidase (Barrientos et al., 2002). Copper that is destined for assembly into cytochrome c 
oxidase enters S. cerevisiae through a combination of high affinity (Ctr1/3) or low 
affinity (Fet4/Smf1) permeases, and the high affinity metalloreductase Fre1. Following 
copper translocation into the mitochondria, the metallation of cytochrome c oxidase is 
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facilitated by a number of accessory factors and is required for the maturation of Cox1 
and Cox2. The insertion of copper into nascent Cox1 and Cox2 proteins is believed to 
occur within the intermembrane space (IMS) and is dependent upon the soluble, IMS-
localized donor molecule Cox17, together with the co-metallochaperones Cox11 and 
Sco1, both located in the inner membrane and containing a globular domain that projects 
into the IMS (Cobine et al., 2006). The insertion of copper is required for the maturation 
of Cox1 and Cox2 
 The formation of the CuB site is believed to occur in parallel to the assembly of 
heme a3 in Cox1, and that the formation of the heme a3 - CuB reactive center occurs via a 
co-translational process with nascent Cox1, prior to its assembly with Cox2 (Cobine et 
al., 2006). Similarly, the transfer of copper to Cox2 occurs prior to the assembly of Cox2 
into complex IV.   
1.4.4 Complex IV Assembly  
 The translation of mitochondrial- encoded complex IV protein subunits is tightly 
regulated and requires specific regulators for the translation and maturation of 
mitochondrial- encoded Cox1 Cox2 and Cox3.  
 Cox1 translation is dependent upon the translational regulators Mss51 and Pet309. 
Together with an assembly-regulating Cox14-Coa1-Coa3 complex, Cox1 translational 
regulators control Cox1 synthesis, thereby regulating the assembly of the complex IV 
holo-enzyme (Barrientos et al., 2004; Soto et al., 2012). It has been suggested that the 
Cox1 protein serves as a core platform for complex IV assembly, whereby a regulatory 
feedback loop would connect the translation of Cox1 to the assembly of complex IV 
(Barrientos et al., 2004). 
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 The translation of Cox2 is regulated by Pet111 and results in a Cox2 precursor 
(pCox2) that contains an amino-terminal 15 amino acid extension (Mulero and Fox, 
1993; Poutre and Fox, 1987). The subsequent insertion of Cox2 into the membrane is 
thought to occur co-translationally in a process that involves the assembly factors Oxa1, 
Cox18 and Mss2 (Fiumera et al., 2007; Herrmann and Funes, 2005; Mick et al., 2011). 
Following Cox2 membrane insertion, the Cox2 specific chaperone Cox20 facilitates the 
cleavage of the 15 amino acid leader sequence by the mitochondrial inner membrane 
peptidase subunit 1 (Imp1) protease and maintains Cox2 in an assembly-competent state 
(Hell et al., 2000; Jan et al., 2000; Nunnari et al., 1993). 
 Three translational activators are required for the synthesis of Cox3 in S. 
cerevisiae, Pet54, Pet122, and Pet494 (Costanzo et al., 1986; Kloeckener-Gruissem and 
McEwen, 1988).  Interestingly, it was shown that one of the factors regulating Cox3 
translation, Pet54, is also required for the synthesis of Cox1, suggesting an additional 
level of co-translational regulation between the catalytic core subunits of complex IV 
(Shingú-Vázquez et al., 2010).  
 The mechanistic underpinnings that define how the highly hydrophobic Cox3 
protein is inserted into the inner mitochondrial membrane, as well as its integration into 
complex IV assembly intermediates and the identification of Cox3 specific chaperones 
remain unknown. Along with Cox1 and Cox2, the Cox3 protein completes the catalytic 
core of complex IV. However, unlike Cox1 and Cox2, Cox3 does not contain a redox 
reactive prosthetic group. Yet the Cox3 protein is a highly conserved core subunit of 
complex IV and the conserved sequence identity of Cox3 between the bacteria 
Rhodobacter sphaeroides and Homo sapiens is as high as that of Cox1 in the same 
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species (Varanasi et al., 2006). It is thought that Cox3 functions, in part, to stabilize the 
core, as the absence of Cox3 results in the loss of detectable Cox1 and Cox2 proteins in 
the mitochondrial membrane (Barrientos et al., 2004).   
 Mitochondrial encoded subunits of complex IV are assembled together with 
nuclear-encoded subunits in a tightly regulated process. The study of yeast deletion 
mutants has aided the identification of complex IV assembly intermediates, and has shed 
light on the assembly process (Barrientos et al., 2009; Mick et al., 2011). Following the 
synthesis of Cox1, Cox2 and Cox3 in the mitochondria, Cox1 associates with nuclear 
encoded subunits Cox5 and Cox6 (Fontanesi et al., 2008; Horan et al., 2005; Stiburek et 
al., 2005). It is unclear whether the assembly of Cox2 and Cox3 into the Cox1-Cox5-
Cox6 intermediate occurs independently or concurrently. However, Cox2 or Cox3 
containing intermediates have been identified in Cox3 or Cox2 mutants, respectively 
(Horan et al., 2005; Tiranti et al., 2000). The subsequent steps of complex IV assembly 
see the integration of Cox7, Cox8 and Cox9 along with the peripheral, non-essential 
subunits Cox12 and Cox13. However, little is know about the assembly of these subunits. 
1.4.5 General Functions of Complex IV 
A.  Oxidation/Reduction Reactions of complex IV 
 Complex IV couples the complete reduction of molecular oxygen to water with 
the translocation of 4 protons into the IMS (Wikstrom, 1977). The heme a3-CuB O2 
reduction site sequentially receives electrons from cytochrome c. Following the 
electrostatic binding of reduced cytochrome c to the Cox2 subunit, electrons are 
transferred from CuA and heme a metal centers to the heme a3-CuB O2 reduction site. The 
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O2 -binding heme a3-CuB center is located in the Cox1 protein moiety and lies within the 
interior of the complex IV enzyme (Bloch et al., 2004; Yoshikawa et al., 2011).  
B.  Proton Pumping by complex IV 
 Subsequently, substrate protons that are used to generate water molecules are 
pumped into the interior-located heme a3-CuB O2 reduction site from the mitochondrial 
matrix through two proton-pumping pathways, referred to as the K- and D-pathways 
(Yoshikawa et al., 2011). Mutational analyses of key residues within the K and D 
channels suggest that these pathways are involved in both the channeling of substrate 
protons used in the catalytic cycle as well as the coupled translocation of protons from 
the mitochondrial matrix to the IMS. An additional proton –translocation pathway, 
referred to as the H-pathway, has been proposed to exist in bovine complex IV 
(Yoshikawa et al., 2011). The proton pumping pathways of complex IV are comprised of 
a hydrogen bond network within the Cox1 subunit that facilitates the channeling of 4 
protons per catalytic cycle through the tightly-assembled complex IV holo-enzyme. The 
energy necessary to drive the active, gated, translocation of protons from the 
mitochondrial matrix to the IMS is driven by the exergonic reduction of O2 enzyme (Rich 
and Marechal, 2013). Therefore, the ability of mitochondria to generate ATP through the 
proton motive force, is dependent upon the translocation of protons by complex IV and is 
functionally connected to the ability of complex IV to channel O2 and substrate protons to 
the heme a3-CuB binuclear center. 
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1.5 The Complex III–Complex IV Supercomplex 
1.5.1 Respiratory Supercomplex Overview 
 The structural organization of respiratory enzyme complexes within the 
mitochondrial electron transport chain represents a widely debated point of contention 
within the field of mitochondrial biology. For more than 20 years, two predominant and 
opposing models of respiratory enzyme complex organization, referred to as the ‘solid’ 
and ‘fluid’ models, divided the field. The ‘solid model’ predicted that respiratory enzyme 
complexes are rigidly bound together in a framework that represents a functional unit 
capable of carrying out efficient electron transfer and OXPHOS (Chance et al., 1963; 
Keilin and Hartree, 1937). Two important findings preceded the subsequent proposed 
alternative to the solid state model. The first was Mitchell’s chemiosmotic theory that 
proposed the electrochemical gradient drives the synthesis of ATP by ATP-synthase, in a 
system that does not require the physical interaction between complex V and the other 
mitochondrial respiratory enzyme complexes (Mitchell, 1961). The second was the 
isolation and reconstitution of enzymatically functional forms of mitochondrial 
respiratory enzyme complexes I-IV (Hatefi et al., 1962). Based partly on these findings, it 
was proposed that electron transfer between mitochondrial respiratory enzyme complexes 
occurs through the dual modes of intracomplex electron transfer between solid state 
components and intercomplex electron transfer mediated by the diffusion of co-substrates 
such as the electron carriers coenzyme Q (CoQ) and cytochrome c (Green and Tzagoloff, 
1966). These findings led to the proposal of a new model termed the random collision 
model often referred to as the ‘fluid model’ (Hackenbrock et al., 1977, Hackenbrock et 
al., 1986). While its predecessor, the ‘solid model, suggested mitochondrial respiratory 
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enzyme complexes were physically associated in an architecture that ensures high 
catalytic activity, the fluid model posited that the mitochondrial respiratory enzyme 
complexes are arranged as independent complexes positioned in close proximity to one 
another within the inner mitochondrial membrane (IMM) and that electron transfer 
occurs laterally through long-range diffusion (Hackenbrock et al., 1986). The first 
demonstration of the existence of higher ordered organization of OXPHOS complexes 
came from the characterization of the dimeric F1FO ATP-synthase, where it was proposed 
that function of so-called ‘supracomplex’ formation was to optimize the activity of the 
enzymes and enhance their stability (Arnold et al., 1998). Two studies that further 
challenged the then widely-accepted fluid model were published in 2000 when Cruciat et 
al. reported the isolation of a III-IV ‘supracomplex’ from yeast mitochondria and 
proposed that supracomplex assembly was a critical regulatory or enhancement feature of 
the OXPHOS system (Cruciat et al., 2000). At the same time, Schägger and Pfeiffer 
described the BN-PAGE isolation of supramolecular structures of respiratory enzyme 
complexes that included the III-IV ‘supercomplex’ in yeast, and the mammalian I-III-IV 
assembly that, together, informed a higher-ordered ‘respirasome’ model of respiratory 
chain complex organization (Schägger and Pfeiffer, 2000).  In isolating higher-ordered 
assemblies of eukaryotic respiratory enzyme complexes, these two seminal papers were 
the first to demonstrate that different OXPHOS complexes organize into supramolecular 
structures, thereby challenging the fluid model paradigm. Subsequently, it was shown 
that the higher-ordered organization of OXPHOS complexes is interdependent, and the 
organizational state of one complex can influence the assembly of a separate enzyme into 
supercomplexes. Specifically, the stoichiometry of III-IV supercomplex formation was 
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altered and despite normal levels of complex IV, its activity was reduced when the ability 
of F1FO ATP-synthase to assemble as a dimer was inhibited (Saddar et al., 2008). 
Additionally, the assembly of dimeric F1FO ATP-synthase was shown to influence the 
biogenesis of the IMM, where the IMM cristae structure was adversely affected in the 
absence of ATP-synthase dimerization-dependent subunits (Paumard et al., 2002). These 
findings highlighted an additional layer of complexity in the organizational state of 
OXPHOS enzyme complexes into oligomeric supercomplexes.  
 Despite initial opposition to the existence of supercomplexes, an overwhelming 
amount of experimental evidence has confirmed the presence of catalytically functional 
respiratory supercomplexes across diverse eukaryotic taxa. Respiratory supercomplexes 
have been detected by BN-PAGE in mitochondria from plants (Eubel et al., 2003; Krause 
et al., 2004; Pineau et al., 2013); fungi (including yeast) (Arnold et al., 1998; Brandner et 
al., 2005; Cruciat et al., 2000; Nübel et al., 2009; Schägger and Pfeiffer, 2000); 
invertebrates (Suthammarak et al., 2009) and vertebrates (Acín-Pérez et al., 2008; 
D'Aurelio et al., 2006; McKenzie et al., 2006; Schägger and Pfeiffer, 2000). Remarkably, 
the compositional organization of these complexes was found to be similar across 
different species, suggesting an evolutionarily conserved mechanism for the formation of 
supercomplexes with defined stoichiometric composition (Enríquez, 2016). Despite 
skepticism suggesting that supercomplexes might represent an artifact of detergent 
solubilization, respiratory supercomplexes were also found to be stable in the absence of 
detergent (Althoff et al., 2011). The structural characterization of purified respiratory 
supercomplexes by transmission electron microscopy and single-particle tomography has 
yielded important information regarding the conformation of the I1III2 supercomplex 
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from Arabidopsis thaliana (Dudkina et al., 2005) and Bos taurus (Schäfer et al., 2006), 
the I1III2IV1 from B taurus (Althoff et al., 2011; Dudkina et al., 2011; Schäfer et al., 
2006) and the III2IV2 supercomplex from S. cerevisiae (Mileykovskaya et al., 2012).   
 Respiratory supercomplexes are stabilized by both AAC and the signature 
mitochondrial phospholipid cardiolipin (CL), with the loss of either affecting the stability 
of supercomplexes (Dienhart and Stuart, 2008; Zhang et al., 2002). Aac itself contains 3 
cardiolipin molecules that have been shown to be required for transport in reconstituted 
vesicles (Klingenberg, 2009). The importance of cardiolipin for the stability of 
supercomplexes is a function that is conserved from yeast to humans (Mileykovskaya and 
Dowhan, 2014; Pfeiffer et al., 2003). Yeast strains deficient in CL (Δcrd1) have a 
reduction in assembled complex IV, lack stably assembled III-IV supercomplexes and 
have a concomitant reduction in respiratory growth. (Jiang et al., 2000; Mileykovskaya et 
al., 2005; Pfeiffer et al., 2003; Zhang et al., 2002; 2005). In model systems and tissue 
from patients with Barth Syndrome, an X-linked mutation in the CL remodeling 
acyltransferase gene TAZ associated with cardioskeletal myopathy, there is a reduction in 
the organization of respiratory complexes into higher ordered supercomplexes. (reviewed 
by (Mileykovskaya and Dowhan, 2014).  
 Since the initial reports of respiratory supercomplexes in the literature, a number 
of reviews have been written on the topic of supercomplexes (Barrientos and Ugalde, 
2013; Boekema and Braun, 2007; Enríquez, 2016; Lenaz and Genova, 2009; Schägger 
and Pfeiffer, 2000; Stuart, 2008).  
In the yeast S. cerevisiae, respiratory supercomplex factors 1 and 2 (Rcf1 and 
Rcf2) are nonessential components of complex IV and impact the stability of complex 
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IV, and therefore, the stoichiometry of III-IV supercomplexes. The following section will 
provide an in-depth review of the known functions and molecular interactions of Rcf1 
and Rcf1-homologs.   
1.6 Respiratory Supercomplex Factor 1 (Rcf1) Characterization 
1.6.1 Rcf1 Protein Overview 
 Rcf1 was originally identified as an 18 kilodalton (kDa) mitochondrial protein of 
unknown function in a number of large-scale, computationally driven studies with broad 
and diverse goals (Helbig et al., 2009; Hess et al., 2009; Reinders et al., 2006; Sickmann 
et al., 2003).  Nearly a decade after its identification, Rcf1 was characterized and its role 
in OXPHOS supercomplex function and complex IV function was described in three 
independent publications in 2012, (Chen et al., 2012; Strogolova et al., 2012; Vukotic et 
al., 2012).  
 The Rcf1 protein was first identified in a large-scale tandem mass spectrometry 
analysis to identify the S. cerevisiae mitochondrial proteome (Sickmann et al., 2003). 
Rcf1 was subsequently discovered in a screen designed to identify gene products that 
alter mitochondrial biogenesis and inheritance in S. cerevisiae, and thus, was originally 
named Aim31 for altered inheritance of mitochondria (Hess et al., 2009). Concurrently, 
in an approach that combined 1-D blue native polyacrylamide electrophoresis (BN-
PAGE) with quantitative mass spectrometry, it was discovered that Rcf1 (then Aim31) 
co-migrated with complex IV and was thus identified as a putative novel complex IV 
interacting partner (Helbig et al., 2009). In 2012, three papers described S. cerevisiae 
Rcf1 as a member of the conserved hypoxia-induced gene (Hig1) protein family and an 
integral inner mitochondrial membrane protein that stably associates with complex IV 
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and complex III, is required for the efficient assembly of complex IV and III-IV 
supercomplexes, and plays an important role in hypoxic growth. The deletion of Rcf1 led 
to altered complex III- complex IV supercomplex assembly, a reduction in complex IV 
activity, impaired respiration, and elevated oxidative stress (Chen et al., 2012; Strogolova 
et al., 2012; Vukotic et al., 2012). Rcf1 was found to display a strong association with the 
Cox3 protein and was characterized as being in close proximity to AAC. Additionally, it 
was shown that Rcf1 contains overlapping function with a second Hig1 protein in S. 
cerevisiae, Rcf2. The absence of Rcf1 and Rcf2 results in a respiration-based growth 
deficiency that is not observed when only one Hig1 protein, Rcf1 or Rcf2, is absent 
(Strogolova et al., 2012). Rcf1 contains homologs in varied and diverse eukaryotic taxa, 
including humans. In contrast, although Rcf2 shares limited sequence homology to Rcf1 
and Hig1 proteins, it contains no homologs outside of fungal species. The following 
sections will provide a detailed description of current Rcf1 findings that preceded and 
were published during this dissertation. 
1.6.2 Identification of Saccharomyces cerevisiae Rcf1 as a Respiratory 
 Supercomplex-associated Protein 
 
The initial functional characterization of Rcf1 and its role in supporting III-IV 
assembly was reported in three independent publications (Chen et al., 2012; Strogolova et 
al., 2012; Vukotic et al., 2012). Analysis of the complex III-Complex IV (III-IV) 
respiratory supercomplex by BN-PAGE and affinity chromatography identified a novel 
protein, 18 kDa in size that co-purified with the supercomplex (Strogolova et al., 2012; 
Vukotic et al., 2012). Mass spectrometry analysis indicated that this protein was Aim31, 
encoded by the nuclear gene YML030w in S. cerevisiae. Aim31 was subsequently 
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renamed respiratory supercomplex factor 1 (Rcf1), to reflect its characterization as a 
supercomplex -associated protein.  
1.6.3  Characterization of Rcf1 membrane topology  
Statistical modeling programs indicate the presence of two predicted 
transmembrane segments within the Rcf1 protein. Using protease accessibility and 
alkaline extraction assays, it was proposed that Rcf1 was an integral IMM protein with an 
Nout-Cout orientation (Chen et al., 2012; Strogolova et al., 2012; Vukotic et al., 2012) 
(Figure 4).  
1.6.4 Hypoxia-induced gene family domain of Rcf1 
 Sequence analysis indicated that Rcf1 is a member of the conserved “hypoxia 
induced gene 1 (Hig1)” family of proteins, conserved from bacteria to diverse eukaryotic 
taxa.  The conserved region, referred to as the hypoxia induced protein conserved region 
(Pfam PF04588: HIG_1_N), encompasses Rcf1 amino acids 28-81 and spans from the N- 
terminal intermembrane space region through the first transmembrane segment (TM1), 
the matrix loop and the majority of the second transmembrane  segment (TM2). While 
preliminary data indicate that Hig1 proteins may be involved in stress response, the 
function of these proteins remains largely unknown. Hig1 family members are divided 
into two similar, but distinct, groups based on sequence. Hig1-type 1 proteins were 
identified in several screens designed to identify genes whose expression was enhanced 
during a number of cellular stresses including, but not limited to, hypoxia, low glucose, 
and oxidative stress (Bedo et al., 2005; Denko et al., 2000; Gracey et al., 2001; Shen et 
al., 2005; Wang et al., 2006).  Hig1-type 2 proteins were identified primarily through  
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Figure 4. Respiratory supercomplex factor 1 (Rcf1) is an integral inner 
mitochondrial membrane protein. The predicted Rcf1 structure contains 
two putative transmembrane segments and is predicted to adopt an Nout-Cout 
orientation within the inner mitochondrial membrane. Labeled amino acids 
represent residues that were targeted for alanine mutagenesis in this study.
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their high degree of sequence homology with Hig1-type 1 proteins and potentially 
represent constitutively expressed members of the Hig1 family. A number of Hig1-type 2 
proteins from different species, including S. cerevisiae Rcf1, represent a highly conserved 
sub-set of homologous proteins that contain a Hig1 domain and are functionally related in 
their regulation of complex IV activity and respiratory supercomplex organization. 
 
1.6.5 Yeast Hig1 homologs Rcf1 and Rcf2 contain overlapping function 
 
A.  Identification of Rcf2 
 
 
 In addition to Rcf1, a blastp database search indicated that S. cerevisiae contains a 
second Hig1 protein, Rcf2, that bears limited sequence similarity with Rcf1 and Hig1-
type 2 proteins (Strogolova et al., 2012). Rcf1 and Rcf2 each contain a Hig1 domain and 
are functionally related in their regulation of complex IV activity and supercomplex 
organization. While Rcf1 is evolutionarily conserved and contains homologs in alpha-
proteobacteria, plants, nematodes and mammals, Rcf2 is a fungal-specific protein. 
 In the same S. cerevisiae altered mitochondrial inheritance screen that identified 
Rcf1, Rcf2, formerly Aim38 (Hess et al., 2009) was also identified. Additionally, both 
Rcf1/Aim31 and Rcf2/Aim38 were identified as putative novel complex IV interacting 
partners through a combination of BN-PAGE and quantitative mass spectrometry (Helbig 
et al., 2009). Rcf2 is a 25 kDa mitochondrial protein that is predicted to contain 2 
transmembrane segments. 
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B.  The absence of S. cerevisiae Hig1-type 2 proteins Rcf1 and Rcf2 results in a 
 respiration-based growth deficiency 
 
 In S. cerevisiae, Rcf1 and Rcf2 cooperatively play a critical role in respiration -
based growth and the activity of complex IV (Strogolova et al., 2012). The deletion of 
either the RCF1 or RCF2 gene individually, results in a modest decrease in respiration-
based growth on non-fermentable carbon sources (Chen et al., 2012; Strogolova et al., 
2012; Vukotic et al., 2012). In contrast, a pronounced growth defect is observed in yeast 
in which both Rcf1 and Rcf2 are absent (Δrcf1;Δrcf2) and the expression of his-tagged 
forms of either Rcf1 (Rcf1His) or Rcf2 (Rcf2His) complement this growth defect 
(Strogolova et al., 2012). However, the underlying defect(s) that results in the growth 
deficiency of the Δrcf1;Δrcf2 mutant strain remains unknown.  
C.  Rcf1 and Rcf2 cooperatively influence the activity of complex IV, and their 
 absence results in an aerobic growth deficiency that cannot be explained by 
 complex IV impairment alone   
  
 The deletion of RCF1 or RCF2 alone does not appear to result in a reduction of 
the protein levels of complex IV, yet partially compromises complex IV enzymatic 
activity (measured spectrally by the oxidation of cytochrome c) (Strogolova et al., 2012; 
Vukotic et al., 2012). In contrast, the protein levels and enzyme activity of complex IV 
are reduced in the Δrcf1;Δrcf2 mutant, and both are approximately 50% of the wild type 
levels. Comparatively, the levels of the NADH dehydrogenase, and complexes II and III 
were not reduced in Δrcf1;Δrcf2 mutant mitochondria, suggesting that deficiencies in 
complex IV activity in the absence of Rcf1 and Rcf2 could underlie the growth 
deficiency of the double mutant. However, a number of independent studies, including 
those from our lab, indicate that complex IV enzyme levels do not become limiting to 
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supporting respiration-based growth until they dip below a threshold of 20-30% of wild 
type levels. Thus, the respiration-based growth deficiency of the Δrcf1;Δrcf2 mutant 
cannot be explained solely by the reduction in complex IV. Therefore, additional factors 
that might contribute to the respiration-based growth deficiency, including defects in 
other OXPHOS enzymes, must be considered.  
 
D. Mitochondria from the Δrcf1;Δrcf2 strain appear to contain hyperactive O2 
 consumption rates despite a reduction in complex IV protein  
  
 Respiration can be evaluated in intact mitochondria by measuring O2 consumption 
in response to the presence of oxidizable substrates (NADH or succinate). Upon the 
addition of substrate alone, a low level of O2 consumption can be measured that is 
referred to as state 4 respiration. The electron transport chain (ETC) is regulated through 
a feed back mechanism by the proton gradient that it generates.  State 4 respiration has 
been proposed to reflect the level of ‘basal’ activity that is necessary to compensate for 
proton leak across the IMM, thereby maintaining a sufficient level of proton motive 
force. It has been reported that up to 2/3 of basal proton leak can be attributed to intrinsic 
uncoupling activity of AAC proteins. When ADP is added in the presence of substrate 
(i.e. NADH or succinate + ADP), the H+ transport activity of the F1FO -ATP synthase is 
induced, resulting in the dissipation of the Δp gradient and subsequent stimulation of 
ETC activity referred to as state 3 respiration. The O2 consumption rate is elevated during 
state 3 respiration, compared to state 4 respiration, and the ratio of state 3 to state 4 O2 
consumption rates (state 3/ state 4) - referred to as respiratory control ratio (RCR)- is a 
value that is commonly used to determine the level of coupling in evaluating 
mitochondrial defects. Furthermore, the isolated complex IV activity can also be 
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determined by measuring the O2 consumption rate in the presence of the exogenously 
added electron donor ascorbate/TMPD. Mediated by TMPD, ascorbate donates electrons 
directly to cytochrome c that are subsequently passed to complex IV, thus bypassing 
other enzymes of the ETC and providing a method to evaluate the bio-energetically 
isolated complex IV O2 consumption rate. When the O2 consumption rate by 
ascorbate/TMPD is measured in the presence of the protonophore CCCP, which 
dissipates the Δp resulting in a compensatory increase in complex IV enzyme activity, the 
maximum complex IV O2 consumption capacity can be measured. 
 Using a Clark electrode, O2 consumption rates were measured in wild type and 
Rcf mutant mitochondria Δrcf1 and Δrcf1;Δrcf2. Interestingly, when the state 4 O2 
consumption rate was measured in Δrcf1;Δrcf2 mitochondria (measured using NADH as 
substrate), the rates were found to be similar to those measured in wild type 
mitochondria. However, when the maximum complex IV O2 consumption capacity (i.e. 
ascorbate/TMPD in the presence of CCCP) was measured in Δrcf1;Δrcf2 mitochondria, it 
was found to be approximately 50% of wild type mitochondria. These results suggest that 
in Δrcf1;Δrcf2 mitochondria, where the abundance of complex IV is substantially 
reduced, the OXPHOS system is working twice as hard as that of the wild type, in order 
to achieve similar state 4 O2 consumption rates. These results together, could potentially 
be explained by the thermodynamics of H+ pumping, whereby when complex IV is 
limiting (as in Δrcf1;Δrcf2 mitochondria) an increased effort is required to maintain Δp 
under state 4 conditions. Alternatively, the degree of H+ leak across the IMM might be 
elevated in the absence of Rcf1 and Rcf2.  
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 When the Δrcf1 single mutant was analyzed in parallel to the Δrcf1;Δrcf2 double 
mutant, the state 4 respiration and maximum complex IV O2 consumption rates were 
found to be similar between the single and double null mutant mitochondria. However, 
unlike the Δrcf1;Δrcf2 double null mutant, the Δrcf1 single null strain retains the ability 
to support aerobic growth, adding further evidence that complex IV activity alone, cannot 
completely explain the aerobic growth deficiency of the Δrcf1;Δrcf2 double mutant 
strain.  
 Analysis of state 3 respiration (addition of ADP in the presence of NADH) was 
carried out in parallel in Δrcf1 single and Δrcf1;Δrcf2 double null mutant mitochondria 
and indicates that, compared to wild type mitochondria, the Δrcf1;Δrcf2 double null 
mutant but not the single mutant (Δrcf1) may contain impaired adenine nucleotide 
transport or ATP synthesis. The respiratory control ratio (RCR, state 3 rate/state 4 rate) is 
a determinant of the ‘coupled’ state of the mitochondria, and a reduced RCR can indicate 
an underlying impairment of ADP/ATP transport, ATP synthesis and/or excessive H+ 
leak. The RCR of Δrcf1;Δrcf2 mitochondria was reduced compared to both wild type 
mitochondria and the Δrcf1 single null mutant, suggesting that in the absence of Rcf1 and 
Rcf2 additional mitochondrial defects could contribute to the aerobic growth deficiency 
of the Δrcf1;Δrcf2 strain.  
E.  Rcf1 Associates with complex IV and complex III independently likely 
 through an association with newly-synthesized Cox3 
 
 Rcf1 co-purifies with the III-IV supercomplex and partitions with complex IV. 
Rcf1 (both a newly imported radiolabeled species as well as endogenous Rcf1) was found 
to co-fractionate with the III-IV supercomplex, as revealed by mass spectrometry analysis 
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of the III-IV supercomplex (Strogolova et al., 2012). Likewise, using tagged Rcf1 and 
Rcf2 proteins combined with affinity purification under digitonin solubilization 
conditions, subunits of the III-IV supercomplex were found to independently co-purify 
with Rcf1 and Rcf2 (Chen et al., 2012; Strogolova et al., 2012; Vukotic et al., 2012). 
However, Rcf1 did not co-purify Rcf2, and vice-versa, suggesting that Rcf1 and Rcf2 are 
not found together in the same III-IV, but rather, independently associate with III-IV 
supercomplexes (Strogolova et al., 2012). It was found that the peripheral subunits Cox12 
and Cox13 do not appear to be present at the same level as they are in a Cox5aHis-purified 
III-IV supercomplex, suggesting that the III-IV associating with Rcf1 could be a late-
stage III-IV assembly intermediate, where the assembly of peripheral subunits Cox12 and 
Cox13 is not yet complete. 
 When Rcf1 and Rcf2 were purified following Triton X-100 or n-dodecyl β-D-
maltoside (DDM) mitochondrial solubilization - detergent conditions that disrupt III-IV 
arrangement – Rcf1 was found to co-purify with complex IV, whereas Rcf2 did not co-
purify with complex IV (or complex III). Thus, Rcf2’s association with complex III 
and/or IV appears to be labile to Triton X-100 (and DDM) detergent, and therefore it 
cannot be determined whether Rcf2 partitions with one complex or the other. When a 
C.elegans Hig1 protein is expressed in the Δrcf1;Δrcf2 yeast strain, an increased 
association of Cox12 with the complex IV that co-purified with C.elegans Hig1 was 
observed, highlighting the conserved capacity of Hig1 proteins to associate with complex 
IV and a potential role in the assembly or stability of Cox12.  
 Additionally, Rcf1 was found to directly interact with the newly-synthesized 
mitochondrial-encoded Cox3 protein prior to its assembly into complex IV (Strogolova et 
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al., 2012). Thus it was concluded that Rcf1 displays a higher affinity to the complex IV 
aspect of the III-IV supercomplex, presumably through its high affinity to the Cox3 
protein.  
 Finally, evidence was also presented to indicate that Rcf1 displays the capacity to 
independently associate with complex III.  When Rcf1 was purified from mutants 
deficient in the assembly of complex IV under the mild detergent conditions of digitonin, 
the co-purification complex III protein subunits was also observed (Chen et al., 2012; 
Strogolova et al., 2012).  
F.  The assembly of complex IV and its association with complex III is altered in 
 the absence of Rcf1 and Rcf2 
 
 Rcf1 and Rcf2 display overlapping function in their ability to support the correct 
assembly of complex IV and its association with complex III. In the current assembly 
model of complex IV, the core protein subunits (Cox1, Cox2, and Cox3) together with 
Cox5 and Cox6, form the early structural framework for the assembly of the complete 
complex IV holoenzyme (Mick et al., 2011). If complex IV assembly is hindered, the 
core complex IV protein subunits are highly susceptible to proteolytic turnover. 
Therefore, the assembly state of complex IV can be determined by examining the steady-
state protein levels of complex IV subunits. In Δrcf1 mitochondria, the steady-state levels 
of complex IV subunits are reduced to approximately 50% of wild type levels, and a 
similar level of reduction was observed in the Δrcf1;Δrcf2 double mutant. In contrast, the 
levels of other OXPHOS enzyme subunits were unaffected by the presence of Rcf1 or 
Rcf2 (Strogolova et al., 2012). These results indicated that the presence of Rcf1 is 
required to stabilize the core complex IV subunits. Additionally, the association of 
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conserved structural complex IV subunits, Cox12 and Cox13, is specifically impaired in 
the absence of Rcf1 and Rcf2. The Δrcf1;Δrcf2 double mutant displays a strong reduction 
in the association of Cox12 and Cox13 with complex IV, in contrast to wild type 
mitochondria and single mutants (Δrcf1 or Δrcf2), where there does not appear to be a 
significant impairment in Cox13 assembly, and a only a modest decrease in Cox12 
association is observed in the Δrcf1 single null mutant (Strogolova et al., 2012).  
 The importance of Rcf1 and Rcf2 for the association of Cox12 and Cox13 with 
complex IV, together with the enhanced association of Cox12 with complex IV observed 
in the presence of the C. elegans Hig1 homolog, suggests that Rcf1/Hig1 proteins may 
regulate a dynamic association of Cox12 with complex IV, and that the cycling off of 
Cox12 from complex IV may be impaired when C. elegans Hig1 is present in yeast. 
 In wild type mitochondria, nearly all of complex IV is associated with complex III 
in III2-IV2 and to a lesser extent III2-IV supercomplex forms. In the absence of Rcf1 and 
Rcf2, respiratory complexes III and IV can still associate, however the levels of III2-IV2 
and III2-IV are reduced and an additional accumulation of free III2 is observed 
(Strogolova et al., 2012). However, the reduction in supercomplexes is likely due to 
lowered levels of complex IV in the absence of Rcf1 and Rcf2, where complex IV levels 
are limiting for III2-IV(1-2) formation. 
 Together, these results indicate that Rcf1 and Rcf2 cooperatively influence the 
assembly state of complex IV, thereby influencing the organization of respiratory 
supercomplexes.  
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G.  Rcf1 associates with AAC proteins, and Rcf1 and AAC exhibit a close 
 physical relationship 
 
 Rcf1 was found to associate with AAC, and these proteins exist in close physical 
proximity within the mitochondrial inner membrane. The purification of a His-tagged 
AAC derivative under digitonin solubilization conditions resulted in the co-purification 
of Rcf1 (Strogolova et al., 2012). Likewise, the reciprocal purification of tagged Rcf1 
was reported to co-purify AAC, as determined by mass spectrometry  (Chen et al., 2012).  
 Wild type Rcf1 and his-tagged derivatives were shown to crosslink to all isoforms 
of AAC via MBS, an amine-sulfhydryl cross-linker with a 7.3 Å spacer length 
(Strogolova et al., 2012). Moreover, when crosslinking was performed in mitochondria 
isolated from mtDNA deficient yeast strains (rho0), crosslinking between Rcf1 and AAC 
was enhanced, suggesting that the interaction between Rcf1 and AAC occurs independent 
of assembled complexes III or IV.  
 Furthermore, a genetic interaction has been reported to exist between Rcf1 and 
AAC, where a double null Δrcf1;Δaac2 mutant strain displayed a survival defect during 
stationary phase that was not observed in either single mutant strain (Δrcf1 or Δaac2) 
(Chen et al., 2012).  
 Together, these results suggest that Rcf1 and AAC co-exist in close proximity and 
that the interaction between Rcf1 and AAC occurs independent of assembled complexes 
III or IV.  
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H.  Rcf1 and Rcf2 have been reported to function in cellular mediation of 
 oxidative stress   
 
 
 The mediation of oxidative stress is a conserved feature among Hig1 proteins, 
including Rcf1 and Rcf2 (Ameri et al., 2015; Chen et al., 2012; Fischer et al., 2016; 
Vukotic et al., 2012). In the Rcf1 null yeast strain (Δrcf1), a hypoxic (1% O2) growth 
deficiency was reported on both fermentable and non-fermentable (respiration) carbon 
sources (Vukotic et al., 2012). Furthermore, it was reported that yeast lacking Rcf1 or 
Rcf2 (Δrcf1 or Δrcf2 strains) contain an elevated level of mitochondrial dysfunction that 
results in the increased production or accumulation of reactive oxygen species (ROS), 
oxidative damage and an elevated susceptibility to exogenous oxidative stress (Chen et 
al., 2012; Vukotic et al., 2012). These results suggest that one potential role of Rcf1 (and 
Rcf2) might be to modulate respiration through regulation of complex IV thereby 
mediating mitochondrial dysfunction. 
 Recent studies have demonstrated that Rcf1 homologs (from a number of 
different fungal, nematode and mammalian species) contain evolutionarily conserved 
functions, including the ability to: associate with complex IV, support respiration-based 
growth and complex IV activity, influence the assembled state of complex IV and 
complex IV-containing supercomplexes, and mitigate ROS production or damage (Ameri 
et al., 2015; Chen et al., 2012; Fischer et al., 2016; Hayashi et al., 2015; Strogolova et al., 
2012; Vukotic et al., 2012). However, a unifying molecular basis for the conserved 
functions of Hig1 domain proteins remains unknown. 
 Notably, it has been reported that the physical binding of isolated Higd1A to 
purified complex IV induces structural changes that increase the enzymatic activity of 
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complex IV (Hayashi et al., 2015). The authors of this study propose a model in which 
the binding of Higd1a induces structural changes that increase the activity of complex IV 
through modulation of the proton-pumping pathway (Hayashi et al., 2015). Importantly, 
the aforementioned study provides evidence that a Hig1 domain protein can induce 
structural changes within complex IV that modulate activity. However, a common 
molecular underpinning by which Hig1 proteins modulate complex IV activity remains 
unknown.  
1.7 Yeast as a Model System 
 The research detailed in this dissertation is focused on understanding the role of 
Rcf1 in the function of the mitochondrial respiratory chain complexes and 
supercomplexes. The process of OXPHOS and the components involved have been 
shown to be highly conserved throughout eukaryotic evolution, from single cell 
organisms such as yeast, to more complex organisms such as humans. I have adopted a 
variety of genetic and biochemical approaches to address the role of the Rcf1/Hig1 
protein in the function of complex IV. To do so, I have studied OXPHOS function and 
molecular interactions in the yeast S. cerevisiae as a eukaryotic model system. In addition 
to performing aerobic respiration, yeast can live by fermentation, which enables the 
propagation and analysis of mutants, deficient areas of aerobic metabolism, thus making 
yeast an ideal model organism to study mitochondrial function. Furthermore, yeast cells 
are relatively easy to genetically manipulate and the entire genome has been sequenced 
now for a number of years, which simplified many aspects of this research. Isolation of 
large quantities of mitochondria from wild type and mutant yeast cells is very 
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straightforward and thus enabled me to perform detailed biochemistry on the 
mitochondrial OXPHOS complexes and their individual protein components. 
1.8 Dissertation Study Aims  
 The goal of this dissertation study is to characterize the role of Rcf1/Hig1 proteins 
in cellular energy production by oxidative phosphorylation. Chapter 3 is focused on 
characterizing the role of the conserved Rcf1/Hig1 QRRQ motif in the interaction 
between Rcf1 and Cox3/complex IV, and the importance of this motif for Rcf1’s role in 
supporting complex IV stability, activity and association with complex III in the III-IV 
supercomplex. Included in this analysis is the analysis of the molecular environment of 
the Rcf1 QRRQ motif. Additionally, potential functional differences between Hig1-type1 
and Hig1-type2 proteins were investigated. The aim of Chapter 4 is the characterization 
of the Rcf1-AAC interaction, and includes an investigation into the functional 
relationship between Rcf1 and AAC by identifying the molecular and bio-energetic 
conditions that promote or obstruct their interaction. 
 
 
 
 
 
 
 
 
 
	 35	
CHAPTER 2: MATERIALS AND METHODS 
 
2.1 Introduction 
 This chapter is divided into two sections and provides a detailed description of the 
molecular and cellular biology, protein chemistry and physiology methods that were used 
in this dissertation work to study the function and molecular interactions of the Rcf1 and 
Hig1 proteins. The first section is comprised of the molecular and cellular techniques that 
were used to make point mutations in the Rcf1 protein, express the Rcf1 mutant 
derivatives and Human Hig1 isoforms in yeast, and the isolation of the mitochondria 
from the resulting strains. The second section includes the protein chemistry and 
physiological methods that were used to analyze the function of the Rcf1 and Hig1 
proteins and to characterize the Rcf1 mutant derivatives. 
 
2.2  Molecular and Cellular Biology Methods 
 
2.2.1  Polymerase Chain Reaction (PCR) and PCR-mutagenesis 
 Point mutations in Rcf1 (YML030W gene) were generated in the wild type yeast 
YML030W gene encoding the Rcf1 Open Reading Frame (ORF) that has been previously 
isolated from the wild type (W303-1A) yeast strain, PCR amplified to encode a 
histidine12 epitope, and cloned into the Yip351 plasmid down-stream of the galactose-
inducible GAL-10 promoter (Figure 5) (Strogolova et al., 2012). In this study, mutations 
were made in the predicted matrix loop/TM2 region and within the N-terminal/TM1 
region of the Rcf1 protein using a two-step PCR mutagenesis strategy and incorporating 
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the mutated sequence into forward and reverse primers (TABLE 1). To generate the 
Q61A/Q71A mutant derivative, residues Gln-61 and Gln-71 were mutated to Ala at the  
 
TABLE 1 
Sequence of PCR Primers Used in This Study 
Primer # Name Sequence of PCR Primer 5’ to 3’ 
ST746 YipSeq For 5’ GGTGGTAATGCCATGTAATATG 3’ 
ST757 YipSeq Rev 5’ GACGTTGTAAACGACGGCCAGTG 3’ 
2ST093 Rcf1 C28A For 5’ 
GGCGAAAGGATTATATACCATGCGAAGAAACAG 
CCATTGGTACCCATTGGG 3’ 
2ST094 Rcf1 C28A Rev 5’ 
CCCAATGGGTACCAATGGCTGTTTCTTCGCATG 
GTATATAATCCTTTCGCC 3’ 
2ST221 Rcf1 P32A For 5’ 
GGATTATATACCATTGTAAGAAACAGGCTTTGGT 
ACCCATTGGGTGCTTGC 3’ 
 
2ST222 Rcf1 P32A Rev 5’ 
GCAAGCACCCAATGGGTACCAAAGCCTGTTTCTT 
ACAATGGTATATAATCC 3’ 
 
2ST225 Rcf1 P35A For 5’ 
CCATTGTAAGAAACAGCCATTGGTAGCTATTGG
G 
TGCTTGCTGACTACAGG 3’ 
 
2ST226 Rcf1 P35A Rev 5’ 
CCTGTAGTCAGCAAGCACCCAATAGCTACCAAT
G 
GCTGTTTCTTACAATGG 3’ 
 
2ST095 Rcf1 C38A For 5’ 
GCCATTGGTACCCATTGGGGCGTTGCTGACTACA 
GGAGCTGTCATTCTGGC 3’ 
2ST096 Rcf1 C38A Rev 5’ 
GCCAGAATGACAGCTCCTGTAGTCAGCAACGCC 
CCAATGGGTACCAATGGC 3’ 
2ST181 Rcf1 W58C For 5’ 
GCTCAAAATGTTCGTCTTGGTAATAAATGTAAAG
C 
	 37	
TCAGTACTACTTCCGT 3’ 
 
2ST182 Rcf1 W58C Rev 5’ 
ACGGAAGTAGTACTGAGCTTTACATTTATTACCA
A 
GACGAACATTTTGAGC 3’ 
 
2ST183 Rcf1 A60C For 5’ 
CGTCTTGGTAATAAATGGAAATGTCAGTACTACT
T 
CCGTTGGCG 3’ 
 
2ST184 Rcf1 A60C Rev 5’ 
CGCCAACGGAAGTAGTACTGACATTTCCATTTAT 
TACCAAGACG 3’ 
 
ST836 Rcf1 Q61A For 5’ 
CGTCTTGGTAATAAATGGAAAGCTGCGTACTACT 
TCCG 3’ 
ST837 Rcf1 Q61A Rev 5’ 
CGGAAGTAGTACGCAGCTTTCCATTTATTACCAA 
GACG 3’ 
2ST243 Rcf1 Q61A For2 5’ 
CGTCTTGGTAATAAATGGAAAGCTGCGTACTACT 
TCGC 3’ 
 
2ST244 Rcf1 Q61A 
Rev2 
5’ 
GCGAAGTAGTACGCAGCTTTCCATTTATTACCAA 
GACG 3’ 
 
ST875 Rcf1 R65A For 5’ 
GCTCAGTACTACTTCGCTTGGCGTGTGGGTCTA 
CAAGCG 3’ 
 
ST876 Rcf1 R65A Rev 5’ 
CGCTTGTAGACCCACACGCCAAGCGAAGTAGTA 
CTGAGC 3’ 
 
ST877 Rcf1 R67A For 5’ 
GCTCAGTACTACTTCCGTTGGGCTGTGGGTCTA 
CAAGCGGCC 3’ 
 
ST878 Rcf1 R67A Rev 5’ 
GGCCGCTTGTAGACCCACAGCCCAACGGAAGTA 
GTACTGAGC 3’ 
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2ST189 Rcf1 R67Q For 5’ 
GCTCAGTACTACTTCCGTTGGCAAGTGGGTCTA 
CAAGCGGCC 3’ 
 
2ST190 Rcf1 R67Q Rev 5’ 
GGCCGCTTGTAGACCCACTTGCCAACGGAAGTA 
GTACTGAGC 3’ 
 
2ST191 Rcf1 R67E For 5’ 
GCTCAGTACTACTTCCGTTGGGAAGTGGGTCTA 
CAAGCGGCC 3’ 
 
2ST192 Rcf1 R67E Rev 5’ 
GGCCGCTTGTAGACCCACTTCCCAACGGAAGTA 
GTACTGAGC 
 
2ST193 Rcf1 R67K For 5’ 
GCTCAGTACTACTTCCGTTGGAAGGTGGGTCTA 
CAAGCGGCC 3’ 
 
2ST194 Rcf1 R67K Rev 5’ 
GGCCGCTTGTAGACCCACCTTCCAACGGAAGTA 
GTACTGAGC 3’ 
 
2ST195 Rcf1 R67H For 5’ 
GCTCAGTACTACTTCCGTTGGCATGTGGGTCTA 
CAAGCGGCC 3’ 
 
2ST196 Rcf1 R67H Rev 5’ 
GGCCGCTTGTAGACCCACATGCCAACGGAAGTA 
GTACTGAGC 3’ 
 
2ST185 Rcf1 V68C For 5’ 
GCTCAGTACTACTTCCGTTGGCGTTGTGGTCTAC 
AAGCGGCCACACTAGTCGC 3’ 
 
2ST186 Rcf1 V68C Rev 5’ 
GCGACTAGTGTGGCCGCTTGTAGACCACAACGC 
CAACGGAAGTAGTACTGAGC 3’ 
 
2ST187 Rcf1 G69C For 5’ 
GCTCAGTACTACTTCCGTTGGCGTGTGTGTCTAC 
AAGCGGCCACACTAGTCGC 3’ 
 
2ST188 Rcf1 G69C Rev 5’ 
GCGACTAGTGTGGCCGCTTGTAGACACACACGC 
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CAACGGAAGTAGTACTGAGC 3’ 
 
 
ST838 
 
Rcf1 Q71A For 
 
5’ GCGTGTGGGTCTAGCAGCGGCCACACTAGTCG 
CACTAGTCGC 3’ 
ST839 Rcf1 Q71A Rev 5’ 
GCGACTAGTGCGACTAGTGTGGCCGCTGCTAGA 
CCCACACGC 3’ 
2ST245 Rcf1 Q71A For2 5’ GGCTGTGGGTCTAGCAGCGGCCACACTAGTCG 
CACTAGTCGC 3’ 
 
2ST246 Rcf1 Q71A 
Rev2 
5’ 
GCGACTAGTGCGACTAGTGTGGCCGCTGCTAGA 
CCCACAGCC 3’ 
 
2ST189 HsHig1-1A For 5’ 
GGGTCTAGAATGTCAACAGACACAGGTGTTTCC
C 3’ 
2ST005 HsHig1-1A 
Rev2 
5’ 
GGGCTGCAGTTAGTGGTGATGATGGTGGTGATG 
ATGGTGGTGATGATGAGGCTTAGGTTTTGCCCA 
3’ 
ST885 HsHig1-2A For 5’ GGGTCTAGAATGGCGACTCCCGGCCCTGTG 3’ 
ST886 HsHig1-2A Rev 5’ 
GGGCTGCAGTTAGTGGTGATGATGGTGGTGATG 
ATGGTGGTGATGATGGGGTCGAGACTTCATAGC 
3’ 
 
For = Forward primer (binds to 5’ region of ORF) 
Rev = Reverse primer (binds to 3’ region of ORF) 
same time. Rcf1 P32A, P35A, C38A, R65A and R67A (Q/H/K/E) derivatives were made 
by mutating Pro-32, Pro-35, Cys-38, Arg-65 or Arg-67 individually. The Rcf1 Q/R pair 
mutants (Q61A/R65A and R67A/Q71A) were made using the R65A and R67A mutant 
derivatives as the template to mutate Gln-61 or Gln-71, respectively. Likewise, the 
C28A/C38A mutant was made by using the C38A mutant as the template to mutate Cys-
28 to Ala. The reaction mixture for the PCR was prepared according to standard 
protocols and contained; template DNA [100 ng], forward (or reverse) primer [0.25 µM], 
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1x Pfu Buffer, dNTP mix [200 µM], Pfu DNA polymerase (1.25 units). Forward and 
reverse priming reactions were performed separately, an in parallel to a control reaction 
that did not contain DNA polymerase. Following a hot start that was performed at 95°C 
for 50 s, three cycles of denaturation (95°C for 50 s), annealing (55°C for 50 s) and 
extension (68°C for 15 m) were performed. Corresponding forward and reverse reactions 
were then combined into a single tube and an additional 1.25 units of Pfu DNA 
polymerase was added. This was followed by a hot start performed at 95°C for 50 s, and 
24 cycles of denaturation (95°C for 50 s), annealing (55°C for 50 s) and extension (68°C 
for 15 m). Amplified DNA was subsequently analyzed by agarose gel electrophoresis 
(Sambrook et al. 1989).  Following PCR amplification, DpnI restriction digestion of 
template DNA was performed using 1 unit of the Dpn1 restriction endonuclease (New 
England BioLabs). The reaction mixture was incubated at 37°C for 3 hours. Following 
heat inactivation of the enzyme at 80°C for 20 min. 1 µl of the reaction was transformed 
into the E. coli cells as described in section 2.1. Positive E.coli  transformants, which 
harbored the plasmid containing the ampicillin resistant gene, were selected based on 
their ability to grow on LB media containing ampicillin. The plasmid DNA of successful 
transformants was purified (as decribed in section 2.1.3) and subjected to DNA 
sequencing to verify the incorporation of the correct mutation.   
2.2.2  Restriction Digestion and Transformation into E. coli   
Plasmid DNA (e.g. the DpnI digested product described in section 2.1.1)(1 µl) 
was transferred to a 0.1 cm electroporation cuvette and transformed into 40 µl of TOP10 
chemically competent E. coli. by electroporation using a Biorad Gene MiroPulser (3 kV, 
400 Ω, 25 µF). Following the pulse, 1 ml of LB (Luria-Bertani) medium was immediately 
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added to the cuvette and the mixture was incubated at 37°C for 1 hour shaking at 225 
rpm. Cells were recovered by a short (~1 min) centrifugation and plated on selective 
medium (LB-Amp) for 16 hours at 37°C. 
2.2.3  Isolation of Plasmid DNA  
Positive bacterial transformant colonies were manually isolated from the initial 
selection (LB-AMP) plate and inoculated in 5 ml LB-Amp medium overnight at 37°C. 
Plasmid DNA was isolated from selected colonies using a plasmid isolation kit according 
to the manufacturers specifications (Qiagen). Following isolation, DNA was eluted in 
H2O and stored at 4°C. DNA was then subjected to sequencing to verify the incorporation 
of the correct mutation. 
2.2.4  Plasmid DNA Linearization and Transformation into Competent Yeast Cells 
 Plasmid DNA of yeast integrating plasmids (e.g. Yip351-based palsmids) was 
linearized using the restriction endonuclease BstEII (New England BioLabs) and the 
reaction was performed in the recommended buffer supplied by the manufacturer (New 
England BioLabs). BstEII cuts at a unique position in the LEU2 gene of the Yip351 
plasmid. Purified plasmid DNA (15 µl, concentration varied) was digested using 10 units 
of BstEII at 60°C for 2 hours during which the mixture was vortexed every 20 min. 
Approximately 1 hour into the incubation, an additional 10 units of enzyme was added. 
Following incubation in restriction enzyme, 3M NaAc (pH6.0) and Ethanol (p.a.) were 
added to the digested (linearized) product and the mixture was stored at -20°C overnight.  
 Following linearization, recombinant plasmids were integrated into the yeast 
genome at the leu2 gene locus. To prepare DNA for transformation into yeast, linearized 
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DNA was pelleted by centrifugation at 15,000 rpm for 15 min at 4°C, washed in 70% 
Ethanol and pelleted again prior to drying using a SpeedVac vacuum concentrator. To the 
dried pellet, 15 µl of H2O was added and DNA was stored at -20°C. Approximately 5 µl 
of linearized DNA was mixed with 50 µl of yeast competent cells (W303-1A) by gentle 
pipetting up and down. Cold PEG (300 µl)(100 mM LiAc, 10 mM Tris-HCl (pH 8.8), 1 
mM EDTA/NaOH, 40% PEG 3350) was added to the mixture and gently mixed by 
pipetting up and down prior to incubation at 30°C for 30 min under constant shaking. 
Following incubation, DMSO (40 µl) was added and the mixture was incubated at 42°C 
for 10 min. The yeast competent cells were pelleted by centrifugation at 2,000 rpm for 3 
min, and washed once in H2O prior to being pelleted again in a final volume of 200 µl 
H2O. Approximately 100 µl of yeast cells were plated onto selective medium (SD-Leu) 
and grown for approximately 3 days at 30°C. Leucine-positive transformants were 
isolated and grown overnight in 5 ml of YP-lactate containing galactose (2%) prior to 
isolation of the mitochondria by the Quick Preparation Procedure described in section 
2.1.6. for further characterization by SDS-PAGE (section 2.2.2), western blotting (section 
2.2.3), and immune-decoration (section 2.2.4) with an anti-His antibody.    
2.2.5  Cloning of Human Hig1-1A and Hig1-2A  
 Clones of human Hig1 isoforms, Hig1-1A (NP_054775) and Hig1-2A 
(NP_620175), were purchased from a manufacturer (ATCC, Manassas, VA) and 
individual clones were provided in respective cloning vectors (pDNR-LIB-Hig1-1A 
(pOTB7- Hig1-2A) that had been transformed into E. coli (Figure 6, Figure 7).  
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PCR amplification of Hig1-1A/2A ORF  
 Bacterial clones were grown overnight at 37°C in selective medium (LB-
chloramphenicol). Following overnight growth, plasmid DNA was isolated as described 
above in section 2.1.3. PCR amplification of the human Hig1 DNA was performed using 
primers (TABLE 1) that were designed to amplify the Hig1 ORFs as Xba1-Pst1 
fragments, and included 12 histidine residues prior to the stop codon. The PCR-amplified 
DNA was purified using a DNA isolation kit according to the manufacturers 
specifications (GeneJET®, Fermentas) and excess ethanol was evaporated from the 
purified plasmid DNA using a SpeedVac vacuum concentrator.  
Restriction Digest and Gel purification of Hig1-1A/2A DNA fragments 
 The insert (Hig1-1A or Hig1-2A) was excised by restriction digestion, performed 
in the recommended buffer supplied by the manufacturer (New England BioLabs) and 1 
unit of each endonuclease (Xba1 and Pst1). The reaction mixture, containing 25 µl of 
purified DNA, was incubated at 37°C for 2 hours. Following heat inactivation of the 
enzyme at 80°C for 20 min, the digested product was loaded onto a 1% agarose gel and 
electrophoresis was performed for 1 hour at 50 V. DNA fragments were visualized using 
a UV illuminator and identified by their respective sizes (Hig1-1A, approximately 350 
kDa and Hig1-2A, approximately 400 kDa). The purified DNA fragments were excised 
from the gel using a sterile razor blade and kit purified according to the manufacturers 
specifications (QIAquick®, Qiagen).  
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Figure 5. The Yip351 plasmid featuring a single BstEII site and 
LEU2 gene. Image source: SnapGene
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Figure 6. The pDNR-LIB plasmid featuring single Xba1 and 
Pst1 sites. Image source: SnapGene
	 46	
 
Figure 7. The pOTB7 plasmid featuring single Xba1 and Pst1 
sites. Image source: SnapGene
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Ligation of Hig1-1A/2A into Yip351-GAL10/LEU2 expression vector 
 The purified DNA fragments were ligated into Yip351/LEU2 plasmid 
downstream of the GAL10 promoter for expression of the human Hig1 proteins (Figure 
5). The Yip351/LEU2 plasmid was pre-cut with Xba/Pst1 and treated with calf intestinal 
phosphatase (CIP) in preparation for the ligation reaction. The ligation reactions of 
purified Hig1-1A/2A DNA fragments into the Yip351 vector were performed overnight 
at 16°C using a 1:1 (vector:insert) ratio and 1 unit of T4 DNA ligase in appropriate buffer 
supplied by the manufacturer (New England Biolabs).  
 
Transformation into E. Coli, colony PCR, analytical digestion and Yeast transformation   
 Ligated Yip351-Hig1-1A/2A plasmids were transformed into MH1 E. coli as 
described above in section (2.1.2), and grown overnight on plates containing selection 
medium (LB-Amp). Ampicillin-positive colonies were isolated by gentle removal from 
the plate using a sterile pipet tip, and colony PCR was performed to identify bacterial 
transformants that contained Yip351-Hig1-1A/2A plasmids. The reaction mixture for the 
PCR was prepared according to standard protocols and contained; template DNA, 
forward (Yip351) and reverse (Hig1-1A or Hig1-1A) primers [0.4 µM], 1x Pfu Buffer, 
dNTP mix [200 µM], Pfu DNA polymerase (1.25 units). The colony PCR products were 
run on a 1%agarose gel and successful transformants were selected for plasmid 
purification as described above. Analytical digestion was performed on the purified 
plasmid DNA in a reaction mixture containing 5 µl of purified plasmid DNA 
(approximately 2 µg of DNA), 1 unit of Xba1 and Pst1, and appropriate buffers provided 
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by the manufacturer (New England Biolabs). Following digestion at 37°C for 2 hours, the 
enzymes were heat inactivated by incubation at 80°C for 20 min. Successful 
transformants were verified by sequencing as described above, and following the 
linearization by BstEII, recombinant plasmid was transformed into the Δrcf1;Δrcf2 yeast 
strain. 
2.2.6  Isolation of mitochondria: Long, and Quick-Long, and Quick Preparation 
 Mitochondria were isolated from wild type and mutant strains to characterize the 
Rcf1 and Hig1 proteins by various biochemical and physiological analyses. Three 
different procedures were used to isolate mitochondria, with the specific method selected 
according to the level of mitochondrial function that is required for the biochemical 
analyses to be performed. The long preparation yields large quantities of intact 
mitochondria that are of sufficient quality for the majority of the biochemical and 
physiological analysis performed in our lab. The Quick-long and Quick preparations were 
adapted to expedite the isolation of mitochondria from yeast strains for routine analysis 
of protein content. While the Quick-long preparation yields large amounts of 
mitochondria, the use of glass beads to physically break the cell wall of the yeast can 
result in damage to the mitochondria, a hazard that is circumvented in the Long 
preparation by using zymolyase to digest the cell wall of yeast. The Quick preparation is 
primarily used as a rapid method of isolating mitochondria to test whether a protein of 
interest is expressed in the mitochondria in a stable manner.  
Long Preparation Procedure.  
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 Yeast strains were pre-inoculated at 30°C for 3 days prior to mitochondrial 
isolation in successively larger volumes (50-400 ml) of YP (yeast extract and peptone)-
medium containing 0.5% lactate and 2% galactose. Mitochondria were isolated from a 
given yeast culture that was grown in 4L of medium, and harvested when the yeast were 
in mid-logarithmic phase. Mitochondria were isolated from yeast cells according to the 
method described in (Daum et al., 1982) with specific modifications (Herrmann et al., 
1994). Following isolation, mitochondria were re-suspended in SEM buffer (250 mM 
sucrose, 2 mM EDTA, 10 mM MOPS-KOH pH7.2) and aliquoted at a protein 
concentration of 10 mg/ml into 25 µl aliquots, flash-frozen in liquid nitrogen and stored 
at -80°C.  
Quick-long Preparation Procedure 
 Mitochondria were isolated according to the method described by (Arnold et al., 
1998), and modified to isolate mitochondria from 500 ml cultures. Yeast strains were pre-
inoculated at 30°C overnight in (50-100 ml) of YP (yeast extract and peptone)-Lactate 
containing 2% galactose, which was used to inoculate 500 ml of medium at an optical 
density (O.D.) of 0.2 A580nm. Yeast cells were harvested by centrifugation at 4,000 rpm 
for 5 min when they reached an O.D. of 2.0 A580nm and washed in H2O. The weight of the 
cell pellet was measured and glass beads (0.5 mM) and SEM buffer were added 
accordingly (1g cells=1 ml SEM and 1ml glass beads). Yeast cells were vortexed at 30 s 
intervals for 10 min. Lysed cells were transferred to new tubes and centrifuged at 4,000 
rpm for 5 min to separate mitochondria from the glass beads and cell debris. The 
supernatant, containing isolated mitochondria, was transferred to a new tube and 
centrifuged at 10,000 rpm for 12 min at 4°C. The pelleted mitochondria were re-
	 50	
suspended in 10 ml of cold SEM buffer and centrifuged at 4,000 rpm for 5 min at 4°C to 
remove residual cell debris. The supernatant was transferred to a new tube and 
centrifuged at 12,000 rpm for 12 min at 4°C to pellet the isolated mitochondria.  
Protein concentration was determined and 10 mg/ml aliquots were flash-frozen in liquid 
nitrogen and stored at -80°C. 
Quick Preparation Procedure 
 Mitochondria were isolated from 5 ml of yeast cells grown overnight in YP-
lactate (2% galactose) at 30°C. Yeast cells were harvested by centrifugation at 2200 rpm 
for 3 min at room temperature (RT) and resuspended in 0.6 ml of cold SH (0.6 M 
sorbitiol, 20 mM -KOH pH 7.2) buffer containing 1mM PMSF. The cell suspension was 
divided equally between two microcentrifuge tubes and glass beads were added 
(approximately 100 µl). Cell suspension was vortexed 5-6 times for 30 s intervals and 
kept on ice for ≥ 30 s prior to next vortexing. Following centrifugation of the cell 
suspension at 3000 rpm for 3 min at 4°C, 500 ml of supernatant was removed and 
transferred to a new tube (supernatants were pooled from identical samples). Isolated 
mitochondria were pelleted by centrifugation at 12,000 rpm for 15 min at 4°C and 
resuspended in 20 µl of 1X Laemmli buffer containing β-mercaptoethanol (BME) prior to 
freezing at -80°C. 
2.2.7  Serial Dilution Growth Analysis 
 Yeast strains to be tested were streaked from glycerol stocks onto a fresh YPAD 
plate and incubated at 30°C for 3 days prior to serial dilution. A small amount of yeast 
cells were extracted from the YPAD growth plate using a sterile pipet tip and transferred 
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to a microcentrifuge tube containing 900 µl of H2O. The cell suspension was vortexed 
and 800 µl were transferred to a spectrophotometer cuvette prior to measurement of the 
O.D. at A580 nm. Based on the starting O.D., the remaining cell suspension (100 µl) was 
diluted to make a stock solution of O.D. 0.1 A580 nm. From the stock cell suspension, ten-
fold dilutions were prepared in separate tubes. The serial dilutions were pipetted (4 µl)  
onto a new plate and incubated at 25°C, 30°C, or 37°C for 3-5 days. Images of the plate 
were scanned every 24 hours.     
 
2.3  Protein Biochemistry and Physiology Methods 
 
2.3.1  Protein determination (Bradford Method)   
 Mitochondrial protein concentration was determined using the Bradford method, a 
colorimetric-based detection assay for measuring the concentration of proteins in solution 
(Bradford, 1976). Bovine gamma globulin IgG (Bio-Rad) was used to generate protein 
standards for the assay by the resuspension of bovine gamma globulin IgG in 100 µl 
(total) H2O in increasing concentrations (0, 0.04, 0.07, 0.15, 0.3, 0.6 mg/ml). 
Mitochondrial protein samples to be tested were diluted in H2O (1:10) and 10 µl of the 
diluted sample was used for protein determination. Protein Assay Dye Reagent (Bio-Rad) 
was diluted (1:5) and 1 ml of reagent was added to samples and standards and mixed by 
inversion (6-10 times). The A595 nm of each standard was measured using a 
spectrophotometer (Beckman Coulter) and plotted against the protein concentration. 
Mitochondrial samples were then measured and their protein concentration was 
calculated based on the standard curve. 
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2.3.2  SDS-PAGE 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gels 
were prepared according to Laemmli (1970) as 9 cm x 15 cm separating layer and 1 cm x 
15 cm stacking layer. For this study, 17.5% acrylamide, 0.2% bisacrylamide SDS-PAGE 
gels were used (Laemmli, 1970). Separation of proteins was performed by 
electrophoresis in 1X electrophoresis running buffer (2 M glycine, 0.1% SDS, 50 mM 
Tris-Cl pH 8.9). Samples were prepared with 1X Laemmli buffer and loaded into gel 
lanes using a Hamilton 50 µl syringe. A molecular weight marker (Thermo) was loaded 
onto the SDS-PAGE gel for estimation of molecular weight. Electrophoresis was 
performed at a constant voltage (25 mA) for approximately 2 hours.   
2.3.3  Western Blotting: Transfer of SDS-PAGE Gel to Nitrocellulose Membrane  
 Following electrophoresis, the SDS-PAGE gel was transferred onto a 
nitrocellulose membrane (Whatman) for immuno-decoration. In this dissertation study, 
the transferring of proteins on an SDS-PAGE gel to nitrocellulose and the subsequent 
analysis by immuno-decoration is collectively referred to as western blotting. The semi-
dry blotting method described by Kyshe-Anderson (1984) was used to transfer proteins 
from the SDS-PAGE gel to nitrocellulose, with modifications. A layered preparation 
consisting of: 3 Whatman filter papers (3mm), a nitrocellulose membrane (0.2 µm), an 
SDS-PAGE gel, and 2 Whatman filter papers (3mm) was assembled on a western blot 
apparatus (SCIE-PLAS) (each component was pre-soaked in transfer buffer. The western 
blot layered preparation was subjected to electrophoresis (250 mA) for 1.5 hours. 
Following electrophoresis, the nitrocellulose membrane was washed in H2O and stained 
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with Ponceau S solution (Sigma) to visualize proteins. The position of the molecular 
weight marker was recorded on the nitrocellulose membrane using a permanent marker 
prior to removal of ponceau by washing the membrane in H2O.   
2.3.4  Western Blotting: Immuno-decoration of Nitrocellulose Membrane  
 The nitrocellulose membrane was prepared for immune-decoration by blocking in 
5% non-fat milk powder solution prepared in 1X TBS (10 mM Tris-Cl pH7.5, 150 mM 
NaCl) for 1 hour at RT. Primary antibody solution was prepared in 5% non-fat milk 
powder solution at a dilution recommended by the producer (typically 1:1,000). The 
membrane was incubated in primary antibody solution for 1 hour at RT or overnight at 
4°C with continuous rocking. Following primary antibody incubation, the membrane was 
washed in 3 consecutive 10-15 minute steps: 1X TBS, 1X TBS with 0.05% (w/v) Triton 
X-100, and 1X TBS. The membrane was incubated in appropriate horseradish peroxidase 
–conjugated secondary antibody that was prepared in milk powder solution (1:5000 
dilution) for 1 hour at RT.  
 Following secondary antibody incubation, the membrane was washed according 
to the 3-step procedure described above. The horseradish-peroxidase signal was detected 
by enzymatic chemiluminescence (ECL) (Roswell and White, 1978). Two separate ECL 
solutions were prepared accordingly: solution I (9.2 ml H2O, 530 µl 1.875 M Tris-Cl pH 
8.8, and 6 µl H2O2) and solution II (9.2 ml H2O, 530 µl 1.875 M Tris-Cl pH 8.8, 44 µl 
Coumeric acid (15 mg/ml in DMSO), and 100 µl Luminol (44 mg/ml in DMSO)). The 
two solutions were mixed (1:1) in the dark room and the membrane was incubated for 1 
min at RT in the ECL solution mixture with gentle rocking. The membrane was exposed 
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to X-ray film for appropriate time intervals and films were developed using an AGFA 
CP1000 automated developer. 
2.3.5  BN-PAGE and 1D BN-PAGE/2D SDS-PAGE 
 For the resolution of protein complexes, Blue Native-PAGE was performed using 
the Novex® NativePAGE™ Bis-Tris gel system (Invitrogen/Thermo Fisher Scientific). 
For this study, pre-cast polyacrylamide 3-12% Bis-Tris mini-gels (8 cm x 8 cm, 1.0 mm 
thickness) were used. Separation of protein complexes was performed by electrophoresis 
at 150 V for 4.5-5.5 hours using a Novex® NativePAGE™ electrophoresis apparatus 
containing cold anode buffer (1X NativePAGE electrophoresis running buffer (50 mM 
Bis-Tris, 50 mM tricine pH 6.8)) in the outer chamber, and cold 1X blue cathode buffer 
(1X NativePAGE electrophoresis running buffer, 0.02-0.002% G250 Coomassie) in the 
inner chamber. Electrophoresis was performed first with 1X dark blue cathode buffer 
(0.02 % G250 Coomassie) in the inner chamber for 45 minutes, at which time the current 
was stopped and dark blue cathode buffer was replaced with light blue cathode buffer 
(0.002 % G250 Coomassie) in the inner chamber prior to resuming electrophoresis.  
Preparation of Samples 
 Mitochondria (30 µg) were thawed on ice and pelleted by centrifugation at 13,000 
rpm for 10 min at 4°C. Pelleted mitochondria were solubilized in buffer containing 1% 
digitonin or 0.6% n-Dodecyl-β-D-Maltoside (DDM) and Invitrogen pink sample buffer 
(50 mM Bis-Tris, 6 N HCl, 50 mM NaCl, 10% w/v glycerol, 0.001% Ponceau S, pH 7.2) 
for 20 min on ice. Following solubilization of the mitochondria, a clarifying spin was 
performed on the mitochondrial lysate by centrifugation at 15,000 rpm for 10 min at 4°C. 
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The supernatant was transferred to a new microcentrifuge tube and 0.35 µl of 5% G250 
Coomassie was added and mixed with the supernatant by gently flicking the tube. 
Samples were loaded onto the BN-PAGE gel using a Hamilton syringe, and a 
NativeMARK™ unstained protein standard (Invitrogen/Thermo Fischer) was loaded onto 
the BN-PAGE gel for the estimation of molecular weight.  
2nd Dimension SDS-PAGE 
 After the separation of protein complexes by BN-PAGE, individual lanes of the 
native gel were excised as a 60 mm rectangle for separation on a denaturing NuPAGE™ 
4-12% Bis-Tris Gel. Selected lanes were excised using a razorblade and carefully 
transferred by spatula to a 15 ml conical tube. Gel strips were prepared for 2D SDS-
PAGE by a series of 3 incubations in LDS (lithium dodecyl sulfate) solutions (4X LDS: 
106 mM Tris HCl, 141 mM Tris Base, 2% LDS, 10% glycerol, 0.51 mM EDTA, 0.22 
mM G250 Coomassie, 0.175 phenol red, pH 8.5): LDS-DTT (dithiothreitol) reducing 
solution (50 mM DTT, 1X LDS) for 30 min at RT, LDS-DMA (N,N-
dimethylacrylamide) alkylating solution (50 mM DMA in 1X LDS) for 30 min at RT, 
and LDS-Ethanol-DTT quenching solution (5 mM DTT, 20% ethanol, 1X LDS) for 15 
min at RT. Following incubations, gel strips were transferred to the 2nd dimension SDS-
PAGE gel using a spatula, and the low molecular weight end of the gel strip was 
positioned directly adjacent to the 2nd dimension SDS-PAGE gel lane containing the 
molecular weight marker. Electrophoresis was performed at 100 V for 1.5-2 hours.      
Semi-dry Transfer of 1D BN-PAGE and 1D BN-PAGE / 2D SDS-PAGE 
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 BN-PAGE and 2nd dimension SDS-PAGE gels were transferred to a nitrocellulose 
as previously described (section 2.2.3), with the modification of a 1 hour transfer time.  
2.3.6 Steady state analysis of mitochondrial proteins   
 Mitochondria were prepared for steady state analysis by resuspending 100-200 µg 
of mitochondria (10 mg/ml in SEM buffer pH 7.2) in an equal volume of 2X Laemmli 
buffer (4% SDS, 20% glycerol, 20 mM Tris, 0.02% bromophenol blue, 5% β-
mercaptoethanol) followed by further dilution in 1X Laemmli buffer (final concentration 
of 2.5 mg/ml). Samples were mixed by pipetting up and down and stored at -20°C prior 
to analysis by SDS-PAGE, western blotting and immune-decoration with appropriate 
anti-serum. 
 
2.3.7 Ni-NTA Affinity purification of His-tagged proteins.  
 The affinity purification of His-tagged proteins was performed using Ni-NTA 
agarose beads (Qiagen), as previously described (Jia et al., 2007).  
Preparation of beads 
 The Ni-NTA agarose beads were equilibrated prior to the addition of 
mitochondrial lysate. Microcentrifuge tubes containing 30 µl of beads were prepared for 
each sample of mitochondria. Following a brief spin at 13,000 rpm for 2 min at RT, the 
beads were equilibrated by 3 iterations of addition of buffer (0.1 M KCl, 0.02 M Hepes-
KOH pH 7.2, 0.001 M PMSF, 0.03 M imidazole 0.1% detergent, as indicated), followed 
by centrifugation at 13,000 rpm for 2 min at RT. After the last centrifugation and removal 
of supernatant, 9 µl of 1 M imidazole was added and the beads were stored on ice. 
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Affinity Purification of His-tagged protein on Ni-NTA beads 
 Mitochondria (200 µg) were solubilized in lysis buffer (100 mM KCl, 20 mM 
HEPES-KOH, 10 mM MgCl2, 0.5 mM pheylmethylsulfonyl fluoride (PMSF), pH 7.4), 
containing either 0.25% Triton X-100, 0.6% n-Dodecyl-β-D-Maltoside (DDM) or 1% 
digitonin for 30 minutes on ice. Mitochondrial lysate was centrifuged at 10,000 rpm for 
10 minutes at 4°C. Following centrifugation of the mitochondrial lysate, an aliquot (5% 
of total supernatant) of the supernatant was transferred to a separate tube and prepared for 
gel electrophoresis by the addition of 2X Laemmli buffer containing βME, and stored at -
20°C. The remaining supernatant was added to the equilibrated beads, and after a quick 
vortex, the mixture was incubated with continuous agitation for 1 hour at 4°C. Following 
incubation, the Ni-NTA beads containing bound His-tagged protein were pelleted by 
centrifugation at 13,000 rpm for 2 minutes at 4°C. The beads were washed 3 times with 
buffer, as described in the Preparation of the Beads. After the final centrifugation the 
supernatant was removed completely using a syringe and 1X Laemmli buffer containing 
βME and 500 mM imidazole was added and vortexed hard for 1 min. Samples were 
stored at -20°C. 
2.3.8 Chemical cross-linking  
 Chemical cross-linking was performed to identify proteins within the molecular 
environment of Rcf1 in the mitochondria and was performed as previously described by 
Jia, et al. ((Jia et al., 2009) with modifications. Cross-linking was carried out in vivo, and 
thus, provides the advantage of studying the native molecular environment of Rcf1 in the 
absence of solubilizing the outer mitochondrial membrane. Mitochondria (100 µg) were 
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resuspended in SH buffer pH7.2 (0.6 M sorbitol, 20 mM Hepes) at a final concentration 
of 0.5 mg/ml, and cross-linking was performed on ice for 30 min in the presence of cross-
linker or DMSO control (all cross-linkers were dissolved in DMSO, and thus, DMSO 
served as the control condition). Cross-linking reactions were quenched with 10 mM 
glycine (for amino-based cross-linking) or N-ethylmaleimide (for sulfhydryl-based cross-
linking) for 15 min on ice, followed by a clarifying centrifugation at 15,000 rpm for 15 
min at 4°C. Pelleted mitochondria were then washed in SH Buffer and centrifuged again 
at 15,000 rpm for 15 min at 4°C. Mitochondria were resuspended in 1X Laemmli buffer 
containing βME and were stored at -20°C for analysis by SDS-PAGE and western 
blotting.  
 
Chemical cross-linking under various mitochondrial bio-energetic states  
 Chemical cross-linking was performed under a number of mitochondrial bio-
energetic states to determine whether the molecular environment of Rcf1 and partner 
proteins is influenced by the mitochondrial bio-energetic status. For bio-energetic cross-
linking experiments, mitochondria were resuspended in isosmotic buffer (10 mM KPi, 20 
mM Hepes-KOH, 2 mM MgCl2, 1 mM EDTA, 1 mg/ml BSA, 0.6 M Mannitol; pH 7.2) 
in place of SH-buffer. State 4 respiration was achieved by the addition of the substrate 
NADH (0.5 mM final concentration) and proceeded for a duration of 2 min prior to the 
addition of cross-linking reagent (for state 4 cross-linking) or the subsequent addition of 
ADP (0.2 mM) to achieve state 3 respiration. State 3 respiration proceeded for 2 min, at 
which point cross-linking reagent was added (for state 3 cross-linking) or the 
protonophore CCCP (20 mM) was added to achieve an elevated level of respiration 
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where the translocation of protons is uncoupled from the phosphorylation of ADP. The 
uncoupled respiration induced by the addition of CCCP proceeded for 1 min, at which 
point cross-linking reagent was added. Following the pre-conditioning of mitochondria to 
achieve a specific bio-energetic status, cross-linking reactions proceeded as described 
above. 
Chemical cross-linking in the presence of inhibitors  
 Chemical cross-linking was performed in the presence of specific inhibitors of 
AAC (atractyloside/AT, bongkrekic acid/B.A.) to determine whether the conformation of 
AAC influences the formation of the Rcf1-AAC cross-link adduct. Prior to the addition 
of cross-linking reagent, inhibitor was added to the resuspended mitochondria at a final 
concentration of 10 µM. The addition of inhibitor to the resuspended mitochondria was 
followed immediately by the addition of cross-linking reagent and the reaction proceeded 
as described above.  
2.3.9 Mitochondrial In organello labeling of mitochondrial translation products 
 In organello [35S] methionine labeling of mitochondrial translation products was 
performed according to Hell et al., ((Hell et al., 2001). Isolated mitochondria (200 µg) 
were incubated in translation buffer (0.6 M sorbitol, 150 mM KCl 15 mMKH2PO4, 13 
mM MgSO4, 0.15 mg/ml all amino acids (minus methionine), 3 mg/ml fatty-acid free 
bovine serum albumin, 4 mM ATP, 0.5 mM GTP, 5 mM α-ketoglutarate, 5 mM 
phosphoenolpyruvate, and 20 mM Tris-Cl, pH7.4) containing 0.6 units of pyruvate kinase 
and 2 mM NADH prior to the addition of 1 µl (10-15 µCi) of [35S] methionine. Samples 
were incubated in buffer containing [35S] methionine for 20 min at 30°C before being 
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stopped by the addition of puromycin (42 µg/ µL) and 10 mM unlabeled methionine. The 
samples were incubated an additional 5 min at 30°C to completely stop synthesis, and 
isolated by centrifugation at 10,000 rpm for 10 min at 4°C. Pelleted mitochondria were 
washed once in SH-buffer, pelleted again by centrifugation at 10,000 rpm for 10 min at 
4°C. Following further analysis (i.e. Ni-NTA affinity chromatography, SDS-PAGE (or 
1D BN-PAGE/2D SDS-PAGE) and western blotting, radiolabeled translation products 
were visualized by autoradiography for various time intervals. 
2.3.10 Silver staining of SDS-PAGE Gels 
 SDS-PAGE gels were silver stained to visualize mitochondrial proteins for further 
analysis (i.e. extraction for LC-MS/MS or to directly compare protein composition and 
abundance between samples). Immediately following SDS-PAGE, the gel was washed 
briefly in H2O, and fixed by incubation for 30 min at RT in a methanol (45% final 
concentration)- acetic acid (7% final concentration) solution. The gel was washed 3 X 5 
min in H2O prior to incubation in 1mM sodium thiosulfate penthydrate (Sigma) solution 
for 1.5 min. Following incubation, the gel was washed 3 X 0.5 min and stained in 10 mM 
silver nitrate (Sigma) solution for 25 min at RT. The silver stained gel was then washed 3 
X 1 min in H2O prior to incubation in developing solution (0.6 M sodium carbonate 
(Sigma), 0.02 mM sodium thiosulfate penthydrate, and 0.02% formaldehyde) for 5-10 
min. Developing was stopped by incubating the gel in methanol - acetic acid solution for 
10 min.  
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2.3.11 Cytochrome c oxidase ‘In Gel’ activity assay  
 The specific activity of complex IV was determined by performing an ‘in-gel’ 
activity assay following the separation of protein complexes by BN-PAGE (0.6% DDM). 
BN-PAGE was performed as described above with the following modifications. 
Mitochondrial protein (200 µg) was solubilized in buffer (80 µl) containing 0.6% DDM 
for 30 minutes at 4°C. Solubilized mitochondria were subjected to clarifying 
centrifugation for 10 minutes at 15,000 rpm at 4°C. Following centrifugation, the 
supernatant was removed and split between 2 microcentrifuge tubes. 0.7 µl of G250 
coomassie was added to each sample and samples (duplicates) were loaded into one 3-
12% BIS-TRIS Invitrogen NuPAGE 10-well gel. Electrophoresis was performed at 150 
V for 5 hours and 30 min, and the gel was cut in two; one half of the gel (containing one 
set of samples) was prepared for western blotting and the second half of the gel 
(containing a set of identical samples) was used for the cytochrome c oxidase in gel 
activity assay detailed below. 
 Prior to incubation in Activity Assay Buffer, the gel was placed on a glass plate 
and scanned (SCAN1). The gel was then incubated for 90 minutes at room temperature in 
Activity Assay Buffer (50 mM phosphate buffer pH 7.4, 1 mg/ml 3,3’ diaminobenzidine 
(DAB), 1 nM catalase, 1mg/ml cytochrome c, 75 mg/ml sucrose). Immediately following 
the incubation, the gel was washed well for 1 min in several washes of distilled water to 
remove excess DAB and then scanned (SCAN2). The reaction was stopped by fixing the 
gel in 45% Methanol / 10% Acetic acid solution for 1 hour at RT. Following the 
methanol/acetic acid fixation, the gel was again scanned (SCAN3), and then de-stained in 
10% Methanol / 10% Acetic acid solution overnight to remove residual coomassie from 
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the BN-PAGE gel. Following overnight de-staining the gel was scanned (SCAN4) one 
last time.  
2.3.12 Oxygen consumption rates (OCR)  
 The oxygen consumption rate (OCR) of isolated mitochondria was calculated 
from the decrease in oxygenation of media within the chamber of a Clark-type oxygen 
electrode (Rank Brothers, Digital Model 10) using isolated mitochondria (80 µg) in an 
isosmotic buffer (10 mM KPi, 20 mM Hepes-KOH, 2 mM MgCl2, 1 mM EDTA, 1 
mg/ml BSA, 0.6 M Mannitol; pH 7.2) at room temperature. State 4 respiration was 
achieved by the addition of substrate, NADH (0.5 mM), and measured for 3 min. State 3 
was achieved by the subsequent addition of ADP (0.2 mM) and the measurement of O2 
consumption for an additional 5 min. Bioenergetically isolated complex IV OCR was 
attained by the addition of TMPD/ascorbate (0.4 mM/1.6 mM) to directly reduce 
cytochrome c. Maximal bioenergetically isolated complex IV activity was achieved by 
the subsequent addition of a protonophore (CCCP, 0.2 mM). The DCCD inhibition of 
bioenergetically isolated complex IV was measured as described above following a 90-
minute, 25°C incubation of mitochondria in MES-TRIS buffer pH 7.3, containing 0.2% 
DDM and 0.6 or 1.2 mM DCCD (in methanol) or control (methanol alone). 
2.4 Miscellaneous 
2.4.1 Yeast strains and growth conditions.  
 The S. cerevisiae strains used in this study are the wild type (WT; W303-1A mata 
leu2 trp1 ura3 his3 ade2), an RCF1::HIS3 RCF2::KAN (Δrcf1 Δrcf2) strain (W303-1A 
mata leu2 trp1 ura3 ade2), the AAC2::KAN (Δaac2) strain (Chen, 2004)., an 
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MMP37::KANMX (Δtam41, aka Δmmp37) strain (Gallas et al., 2006), and the (Δcrd1) 
strain, constructed in our lab by disruption of the CRD1 gene using a KAN marker. The 
creation of the Δrcf1;Δrcf2 double mutant, the Δaac2 mutant, and the Δtam41 mutant 
have been previously described in (Strogolova et al., 2012), (Chen, 2004) and (Gallas et 
al., 2006), respectively. Yeast strains were maintained and cultured at 30°C on YP 
medium supplemented with 2% glucose and 20 mg/liter adenine hemisulfate (YPAD) 
under standard protocols. Mitochondria were harvested from cultures grown in YP 
medium containing 0.5% lactate and supplemented with 2% galactose. A complete list of 
the yeast strains that were used in this study is provided (Table 2). 
 
 
TABLE 2 
Yeast Strains Used in This Study 
 
Yeast Strain Genotype Source 
WT W303-1A mata, leu2, trp1, ura3, his3, ade2 Tzagoloff A. 
WT+Rcf1His W303-1A, Plasmid YIP351GAL10-Rcf1His/LEU2  Strogolova et 
al. 2012 
WT+Rcf1His ρ0 W303-1A ρ0, Plasmid YIP351GAL10-Rcf1His/LEU2 Strogolova et 
al. 2012 
Δrcf1 W303-1A, mata,leu2,trp1,ura3, ade2, RCF1::HIS3 Strogolova et 
al. 2012 
Δrcf2 W303-1B, matα,leu2,trp1,ura3, his3, ade2, RCF2::KAN Strogolova et 
al. 2012 
Δrcf1;Δrcf2 W303-1A, mata,leu2,trp1,ura3,ade2 
RCF1::HIS3,RCF2::KAN 
Strogolova et 
al. 2012 
Rcf1His Δrcf1;Δrcf2, Plasmid YIP351GAL10- Rcf1His /LEU2 Strogolova et 
al. 2012 
rcf1HisC28A,C38A Δrcf1;Δrcf2, Plasmid YIP351GAL10- rcf1HisC28A,C38A /LEU2 This study 
rcf1HisP32A Δrcf1;Δrcf2, Plasmid YIP351GAL10- rcf1HisP32A /LEU2 This study 
rcf1HisP35A Δrcf1;Δrcf2, Plasmid YIP351GAL10- rcf1HisP35A /LEU2 This study 
rcf1HisW58C Δrcf1;Δrcf2, Plasmid YIP351GAL10- rcf1HisW58C /LEU2 This study 
rcf1HisA60C Δrcf1;Δrcf2, Plasmid YIP351GAL10- rcf1HisA60C /LEU2 This study 
rcf1HisQ61A,Q71A Δrcf1;Δrcf2, Plasmid YIP351GAL10- rcf1HisQ61A,Q71A /LEU2 This study 
rcf1HisQ61A,R65A Δrcf1;Δrcf2, Plasmid YIP351GAL10- rcf1HisQ61A,R65A /LEU2 This study 
rcf1HisR65A Δrcf1;Δrcf2, Plasmid YIP351GAL10- rcf1HisR65A /LEU2 This study 
rcf1HisR67A Δrcf1;Δrcf2, Plasmid YIP351GAL10- rcf1HisR67A /LEU2 This study 
rcf1HisR67Q Δrcf1;Δrcf2, Plasmid YIP351GAL10- rcf1HisR67Q /LEU2 This study 
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rcf1HisR67E Δrcf1;Δrcf2, Plasmid YIP351GAL10- rcf1HisR67E /LEU2 This study 
rcf1HisR67K Δrcf1;Δrcf2, Plasmid YIP351GAL10- rcf1HisR67K /LEU2 This study 
rcf1HisR67H Δrcf1;Δrcf2, Plasmid YIP351GAL10- rcf1HisR67H /LEU2 This study 
rcf1HisR67A,Q71A Δrcf1;Δrcf2, Plasmid YIP351GAL10- rcf1HisQ61A,R65A /LEU2 This study 
rcf1HisV68C Δrcf1;Δrcf2, Plasmid YIP351GAL10- rcf1HisV68C /LEU2 This study 
rcf1HisG69C Δrcf1;Δrcf2, Plasmid YIP351GAL10- rcf1HisG69C /LEU2 This study 
HsHig1-1AHis Δrcf1;Δrcf2, Plasmid YIP351GAL10- HsHig1-1AHis /LEU2 This study 
HsHig1-2AHis Δrcf1;Δrcf2, Plasmid YIP351GAL10- HsHig1-2AHis /LEU2 This study 
Δaac2/ 
CS282/1 
W303-1B, mata, leu2-3, 112 his3-11- 15 ura3-1 ade2-1 trp1-1 
can1-100 SAL1, AAC2::KAN 
Chen X.J. 
Δtam41/ 
YLM2814b 
W303-1A, mata, ura3, leu2-3,112, his3-11, trp1-1, ade2-1, 
ho, can1-100, mmp37Δ::KAN  
Gallas M.R. 
Δcrd1 W303-1A,CRD1::KAN Stuart R.A. 
 
 
2.4.2 Preparation of yeast and bacterial competent cells 
 The MH1 E coli. bacterial strain was inoculated in 5 ml of medium (LB-Amp) 
and grown at 37°C overnight. From this culture, 500 ml of fresh LB-Amp was inoculated 
and grown at 37°C until an O.D. at A580 nm of 0.5 was reached. The bacterial cells were 
then harvested by centrifugation at 5,000 rpm for 15 min at 4°C and resuspended in cold, 
sterile 10% (w/v) glycerol and washed 3 X with progressively lower volumes of glycerol 
(500 ml, 250 ml, and lastly 50 ml). Following the final wash, the cells were resuspended 
in 500 µl of cold, sterile 10% (w/v) glycerol, and frozen at -80°C as 50 µl aliquots.  
 Yeast cells (wild type and mutant strains) were inoculated in 10 ml of YPAD and 
grown at 30°C with overnight with constant agitation (200 rpm). Following overnight 
incubation, 100 ml of fresh media was inoculated from overnight cultures at a final 
concentration A580 nm of 0.2 and harvested by centrifugation at 500 x g for 5 min at RT 
when cultures reached an A580 nm of 0.5-0.7. Pelleted yeast cells were washed once with 
sterile H2O (12.5 ml), and then with 10 ml SORB buffer (1 M sorbitol, 100 mM LiOAc, 
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10 mM Tris-Cl pH 8.0, and 1 mM EDTA pH 8.0). Following washes, yeast cells were 
resuspended in 720 µl SORB buffer and treated with 80 µl salmon sperm DNA (10 
mg/ml, prepared by heating at 95°C for 10 min and cooled on ice) (Knop et al., 1999). 
Competent yeast cells were stored at -80°C as 50 µl aliquots.   
2.4.3 Maintenance of yeast and bacterial strains 
 Bacterial stocks were prepared by mixing 500 µl of bacterial culture grown in LB-
Amp medium overnight at 37°C with approximately 500 µl of 100% (w/v) glycerol 
sterilized in 2 ml cryogenic tubes and stored at -80°C. Yeast stocks were prepared by 
isolating a fresh yeast culture from a plate of appropriate medium (YPAD, YPG or 
selective media) by scraping, and resuspending yeast cells in 1 ml of 15% (w/v) glycerol 
sterilized in 2 ml cryogenic tubes. Following mixing of the cell suspension by vortexing, 
yeast stocks were stored at -80°C. 
2.4.4 Primer design and Sequence analysis 
 Oligonucleotide primers for PCR mutagenesis were designed manually using 
Vector NTI (Thermo-Fisher Scientific) and ApE Plasmid Editor v2.0.45 (M. Wayne 
Davis) software, and manufactured by Eurofins. The GC content and melting temperature 
of the primers was calculated using OligoEvaluator™ (Sigma-Aldrich). DNA sequencing 
reactions (Sanger method) were performed by Functional Biosciences (Madison, WI) 
using Big Dye V3.1 and run on ABI 3730xl instruments. Verification of mutations was 
performed using Vector NTI and the ApE Plasmid Editor software. 
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2.4.5 Sequence Alignment  
 Rcf1 homologs were identified by performing a BLASTp (protein-protein 
BLAST) search using the NCBI protein database. Sequences were aligned using the 
Clustal Omega Multiple Sequence Alignment method.    
2.4.6 Structure Modeling 
 Saccharomyces cerevisiae Rcf1 was modeled by protein structure homology 
modeling using SWISS-MODEL (Arnold et al., 2006; Bordoli et al., 2009). Structural 
representation of complex IV was created in The PyMOL Molecular Graphics System, 
Version 1.8 (Schrödinger, LLC) using the X-ray structure of bovine cytochrome c 
oxidase (PDB 2DYR). 
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CHAPTER 3: MUTATIONAL ANALYSIS OF THE HIG1-TYPE 2 
QRRQ MOTIF IN S. CEREVISIAE RCF1 
3.1 Introduction 
 The Hig1 protein family is conserved throughout evolution, with members found 
in α-proteobacteria and a wide variety of diverse eukaryotic taxa, including plants, fungi 
and mammals. Hig1 proteins can be divided into two similar, but distinct groups, type 1 
and type 2, based on their sequences. Hig1 proteins, including yeast Rcf1, contain a 
highly conserved sequence motif that is located adjacent to TM2, and is referred to herein 
as the QRRQ motif. The QRRQ motif in Rcf1 corresponds to (yeast Rcf1 numbering) 
[Q61]-(X)3-[R65]-(X)-[R67]-(X)3-[Q71]. Sequence alignments indicate that the residues that 
correspond to R67 and Q71 are absolutely conserved throughout Hig1 proteins (FIGURE 
8A). However, residues that correspond to Q61 and R65 represent a point of sequence 
divergence between Hig1-type1 and type2 proteins, where the QRRQ motif is a 
conserved feature among bacterial and mitochondrial type 2 proteins, and type 1 proteins 
contain a modified QRRQ motif sequence, [I/V]-HLIHM-R-(X)3-[Q], that differentiates 
them from type 2 proteins. Sequence alignment of the S. cerevisiae Hig1 homologs Rcf1 
and Rcf2 indicates that their similarity is mostly limited to the QRRQ motif, thereby 
raising the possibility that the QRRQ motif might represent a critical region for the 
interaction between Hig1 proteins, including Rcf1 and Rcf2, and the III-IV 
supercomplex/complex IV and underlie their overlapping function in supporting 
respiratory growth. 
 Hig1 proteins have been shown to be important for the correct assembly of 
complex IV and for respiration-based growth in yeast, and a close physical relationship 
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has been established between Hig1 family members, including Rcf1, and the complex IV 
subunits Cox3 and Cox12 (Strogolova et al., 2012). However, the functional significance 
of the relationship between Rcf1 and Cox3/complex IV, and the molecular basis of the 
respiratory growth defect in the absence of yeast Hig1 proteins Rcf1 and Rcf2, remains 
unknown. 
 Rcf1 physically associates with newly-synthesized Cox3 prior to its assembly into 
complex IV and, together with Rcf2, influences the assembly of the peripheral complex 
IV subunits Cox12 and Cox13 (Strogolova et al., 2012). The relationship with Cox12 
appears to be a conserved feature among Hig1 proteins. When expressed in Hig1-
deficient yeast (Δrcf1;Δrcf2) the C. elegans Hig1-type2 homolog (M05D6.5His) co-
purifies a greater amount of Cox12, relative to other complex IV subunits, than the 
authentic yeast Hig1 homolog Rcf1His (Strogolova et al., 2012). These results suggest that 
in addition to (or possibly via) Cox3, a close relationship may exist between Hig1 
proteins and Cox12, whereby the interaction between Rcf1 and Cox12 might be flexible, 
and the C.  M05D6.5His interaction with Cox12 is less dynamic, or possibly “locked in”. 
Thus, the respiratory growth deficiency and reduced complex IV activity observed in the 
absence of Hig1 proteins in S. cerevisiae might be attributed to changes in the Cox3 
protein, or the relationship between Cox3 and its associated protein partners within 
complex IV, including Cox12 and Cox4. Interestingly, Cox12, Cox4 and Hig1 proteins 
each interact with Cox3, and also represent the only nuclear-encoded complex IV 
subunits that are shared between diverse eukaryotic taxa, suggesting that a potential 
shared function may underlie their co-evolution. 
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 The Cox3 protein is one of three mitochondrial-encoded protein subunits (Cox1, 
Cox2 and Cox3) that form the central core of the enzyme, with the heme- and Cu-
containing Cox1 and Cox2 protein subunits forming the catalytically active core. While 
the Cox3 subunit does not directly contribute to electron transfer and O2 reduction, it 
represents an evolutionarily conserved component of prokaryotic and eukaryotic forms of 
the enzyme and has been proposed to play a regulatory role in enzyme function.  
 Cox3, through its position within the enzyme, maintains the potential to exert 
regulatory control over complex IV activity through a number of possible mechanisms. 
Cox3 interacts with Cox13, a non-essential subunit that has been shown to allosterically 
regulate the activity of complex IV through the binding of ATP. Together with Cox2 and 
Cox12, Cox3 forms the complex IV cytochrome c binding site. Additionally, Cox12 is a 
peripheral (IMS)-located complex IV subunit that, while not essential, supports complex 
IV activity. The presence of mammalian Cox12 (mCox6b) is required for optimal 
complex IV activity, and a mutation in the mCox6b1 isoform causes complex IV 
deficiency and is the underlying cause of a mitochondrial encephalomyopathy. Cox3 has 
also been postulated to play an important role in modulating the access of O2 to the active 
site of the enzyme. According to the crystal structure of bovine complex IV, Cox3 
interacts with 2 phosphatidylglycerol (PG1 and PG2) lipids that, together with Cox3, 
form a regulatory feature of the O2 uptake pathway. The F1FO ATP synthase inhibitor 
DCCD has been shown to inhibit complex IV through binding to the Cox3 subunit. The 
binding of DCCD to a highly conserved residue of Cox3 (bovine Glu90, yeast Glu98) 
leads to the formation of a DCU derivative that causes the subsequent migration of 
palmitate tails from the two proximal Cox3-associated PG molecules, inhibiting the O2 
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uptake pathway of complex IV (Shinzawa-Itoh et al., 2007). It has therefore been 
proposed that Cox3 regulates the enzymatic activity of complex IV through 
conformational changes that affect the position of associated PG lipid molecules, thereby 
modulating the access of O2 to the active site. Thus, Cox3 is positioned to exert 
significant regulatory control over complex IV enzyme activity; either through its 
modulation of peripherally bound complex IV subunits Cox12, Cox13 and Cox4, or 
through the modulation of the O2 uptake pathway via associated PG lipid molecules.  
 The primary focus of this chapter is to characterize the role of the Hig1/Rcf1 
QRRQ motif in the interaction between Rcf1 and Cox3/complex IV, and the importance 
of this motif in Rcf1’s role in supporting complex IV assembly and III-IV supercomplex 
organization. Preliminary characterization of the ability of Rcf1 and Rcf2 to 
cooperatively support the correct assembly of complex IV and its optimal activity 
demonstrated that the expression of a his-tagged Rcf1 derivative (Rcf1His) in Δrcf1;Δrcf2 
mitochondria restores the steady state protein levels of complex IV protein subunits 
(reduced in Δrcf1;Δrcf2 mutant mitochondria) to those of wild type mitochondria. The 
expression of Rcf1His in the Δrcf1;Δrcf2 mutant was also shown to restore the levels of 
assembled complex IV to those of wild type mitochondria, determined by blue native gel 
analysis. Furthermore, Δrcf1;Δrcf2 mutant mitochondria display a decrease in complex 
IV O2 consumption activity that is rescued by the expression of Rcf1His. The ability of the 
his-tagged Rcf1 derivative to complement the reduced complex IV levels and activity of 
the Δrcf1;Δrcf2 double mutant, provides a model by which the importance of the QRRQ 
motif for Rcf1 function can be characterized. Therefore, Rcf1 mutant derivatives 
harboring mutations in conserved residues in the QRRQ motif were created and 
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expressed in Δrcf1;Δrcf2 mutant mitochondria, and the ability of these mutants to 
complement the defects of the Δrcf1;Δrcf2 double mutant were directly compared to the 
double mutant harboring wild type Rcf1His.  
 A secondary aim of this chapter is to investigate potential functional differences 
between Hig1-type1 and Hig1-type2 proteins. While Hig1-type2 proteins are found in α-
protoeobactria, plants, fungi and animals, Hig1-type1 proteins are found exclusively in 
higher eukaryotes, and represent the predominant Hig1 type that have been detected in 
screens designed to identify genes that are expressed in response to hypoxic and 
oxidative stress. However, it remains unknown whether there exist functional differences 
between the two sub-types of Hig1 proteins. Initial experiments using the C. elegans 
Hig1-type2 isoform, suggested that homologous Hig1 proteins expressed in yeast 
maintain the capacity to interact with complex IV and can support respiratory growth. 
Therefore, human type1 and type2 Hig1 proteins expressed in the yeast Hig1-deficient 
strain (Δrcf1;Δrcf2) will be comparatively analyzed in their ability to complement the 
respiratory growth deficiency of Δrcf1;Δrcf2 mitochondria and interact with complex IV.  
 Finally, the molecular environment of the Rcf1 QRRQ motif was analyzed by 
using a cysteine (Cys)-based scanning strategy to identify Rcf1 partner proteins that may 
interact with the QRRQ motif, thereby providing further insight into the molecular 
interaction of Rcf1.  
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3.2 Chapter 3 Results 
3.2.1 Expression of Rcf1 QRRQ mutant derivatives 
 The functional significance of the conserved QRRQ motif in the yeast Rcf1 
protein was investigated by adopting a strategy of alanine site-directed mutagenesis. 
Three distinct Rcf1 mutant derivatives were initially created. In the first mutant, 
glutamines (Gln, Q) 61 and 71 were simultaneously mutated to alanine (Ala, A), to create 
the rcf1Q61A,Q71A derivative. In the second and third mutant derivatives arginines (Arg, R) 
65 and 67 were individually mutated to Ala, to create rcf1R65A and rcf1R67A, respectively.  
The mutated residues are predicted to reside within, or directly adjacent to the matrix 
loop of Rcf1, with residue R67 predicted to be near the matrix interface (FIGURE 8B). 
Rcf1 mutant derivatives were expressed as C-terminal His-tagged derivatives in the 
Δrcf1;Δrcf2 double null yeast strain. Expression was verified by western blot analysis of 
purified mitochondria fractions isolated from wild type and mutant derivative strains 
(FIGURE 8C). The steady state levels of the rcf1HisQ61A,Q71A and rcf1HisR67A derivatives 
appeared to be similar to that of wild-type Rcf1His control, indicating that mutation of the 
QRRQ motif in this manner did not appear to adversely affect the stability of the Rcf1 
protein. The expression of rcf1HisQ61A,Q71A and rcf1HisR67A derivatives appeared to 
complement the Δrcf1;Δrcf2 respiratory growth defect (growth on the non-fermentable 
carbon source, glycerol) to a similar extent as the wild type Rcf1His derivative (FIGURE 
8D). This finding indicates that an intact QRRQ motif is not essential for Rcf1's ability to 
support OXPHOS-based yeast growth. 
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Figure 8. Rcf1 is an inner mitochondrial membrane protein and a member of the 
Hig1-type 2 protein family that contain a conserved QRRQ motif. (A) Limited 
sequence alignment (amino acid residue numbers indicated) of the QRRQ motif region 
from a selection of Hig1-type 2 family members. Hs, Homo sapiens (NP_620175); Bt, 
Bos taurus (NP_001071329); Ce, Caenorhabditis elegans (NP_001254152) and Bj, 
Bradyrhizobium japonicum (WP_014491643). (B) Depiction of the predicted orientation 
of Rcf1 within the inner mitochondrial membrane, where N- and C-tails are predicted to 
be exposed to the intermembrane space. The location of the QRRQ (Q61, R65, R67, 
Q71) motif relative to the two predicted transmembrane segments (TM1 and TM2 
respectively) is indicated. (C) Mitochondria were isolated from the wild type or the 
ǻrcf1ǻrcf2FRQWUROVDQGWKHǻrcfǻrcf2 strain harboring either His-tagged Rcf1 
(Rcf1His), rcf1His
Q61A,Q71A (Q61,Q71) or rcf1His
R67A (R67A) derivatives. Rcf1 and Tim44 
(control) levels were analyzed by Western blotting. (D) Serial 10-fold dilutions of wild 
W\SH:7DQGǻrcf1ǻrcf2 strains expressing Rcf1His, rcf1HisQ61A,Q71A (Q61,Q71), 
rcf1His
R67A (R67A) derivatives or not (-), as indicated, were spotted on YP plates contain-
ing glucose (YPAD) or glycerol supplemented with 0.1 % galactose (YPG+0.1% Gal) 
and grown at 30oC.
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3.2.2 Expression of rcf1HisR67A alters the complex IV assembly state 
  To gain more insight into the extent to which the mutated QRRQ derivatives can 
support the functions of Rcf1, mitochondria were isolated from the strains harboring the 
rcf1HisQ61A,Q71A and rcf1HisR67A derivatives and a more in-depth biochemical analysis was 
performed.  
 The steady state levels of individual complex IV subunits were analyzed in 
mitochondria harboring the mutant Rcf1 derivatives. As previously reported the 
Δrcf1;Δrcf2 mutant mitochondria contained reduced levels of complex IV subunits 
(FIGURE 9A) (Strogolova et al., 2012). In contrast, the mitochondria harboring his-
tagged wild type Rcf1 or the rcf1HisQ61A Q71A or rcf1HisR67A derivatives, appeared to have 
normal levels of the complex IV subunits examined (FIGURE 9A). It can therefore be 
concluded that an intact QRRQ motif does not appear to be required by Rcf1 to support 
the stable accumulation complex IV subunits. 
 The assembly of complex IV and its association with complex III into the III-IV 
supercomplex is altered in the absence of Rcf1 and Rcf2 (Strogolova et al., 2012).  
Therefore, the ability of the QRRQ mutated derivatives of Rcf1 to support the assembly 
of complex IV and the III-IV supercomplex was analyzed. Mitochondria harboring the 
rcf1HisQ61A,Q71A or rcf1HisR67A derivatives were solubilized with the mild detergent 
digitonin, which preserves the III-IV assembly state, and the protein complexes were 
analyzed by blue native gel electrophoresis (BN-PAGE), followed by western blotting 
and immunedecoration, with antisera against a complex III subunit, cytochrome c1 
(FIGURE 9B). As previously reported, in the Δrcf1;Δrcf2 mitochondria there is a 
pronounced shift from the III2-IV2 form (observed in the wild type control mitochondria)  
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Figure 9. Mutation of the Rcf1 QRRQ motif affects the stability but not 
the assembly of complex IV. (A) Steady state protein levels of the OXPHOS 
VXEXQLWVLQPLWRFKRQGULDȝJLVRODWHGIURPLQGLFDWHGVWUDLQVDQGDV
detailed in Fig. 3.1C. Tim44 was used as a loading control. (B) Mitochondria 
LVRODWHGIURP:7DQGLQGLFDWHGǻrcf1ǻrcf2 strains were solubilized in 
digitonin (1%) and subjected to BN-PAGE analysis, Western blotting and 
immunedecoration with antibodies against complex III subunit, cytochrome c1 
Į Cytc1). (C), same as in (B), with the exception that mitochondria were 
solubilized with DDM (0.6%) prior to BN-PAGE and decoration was performed 
ZLWKDQWLERGLHVDJDLQVWWKHFRPSOH[,9VXEXQLW&R[Į&R[
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to a predominately III2-IV form and also to free III2 complexes (Fig. 9B) (Strogolova et 
al., 2012).  Normal III2-IV(1-2) supercomplex organizational state was largely restored in 
the Δrcf1;Δrcf2 mitochondria harboring the wild type Rcf1His. The rcf1HisQ61A,Q71A or 
rcf1HisR67A mutants, analyzed in parallel, appeared to display a similar capacity as the 
wild type Rcf1His derivative to support the organization of the III-IV supercomplex in the 
Δrcf1;Δrcf2 mitochondria.   
 These results would indicate that an intact QRRQ motif is not required for the 
ability of Rcf1 to support the assembly of complex IV and its ability to co-assemble with 
complex III. While this conclusion is consistent with the observed steady state levels of 
complex IV subunits, which appeared normal in the rcf1 mutant mitochondria, a 
noticeable difference was observed in the behavior of the complex IV from the rcf1His 
R67A mitochondria when solubilized with the detergent, dodecylmaltoside (DDM), prior to 
the BN-PAGE analysis (Fig 9C). Solubilization of wild type mitochondria with DDM 
causes complex IV to become physically separated from the supercomplex assembly state 
with complex III and complex IV migrates on the BN-PAGE with an apparent mass that 
is consistent with the complex IV monomer (Strecker et al., 2016; Vukotic et al., 2012). 
A small fraction of a slightly larger form of complex IV, termed IV* was also detected, 
as previously reported and may represent the population of complex IV where peripheral 
subunits Cox12 and Cox13 remain associated under the DDM conditions (FIGURE C) 
(Vukotic et al., 2012). The level of the DDM solubilized complex IV from the wild type 
or Δrcf1;Δrcf2+Rcf1His mitochondria (and also from the rcf1HisQ61A Q71A) were similar to 
each other, and all were significantly greater than that observed from the Δrcf1;Δrcf2 
mitochondria, where complex IV levels were reduced by approximately 50% as 
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previously reported (Strogolova et al., 2012). In contrast however, the rcf1HisR67A 
containing mitochondria analyzed in parallel, displayed strongly reduced levels of 
assembled complex IV following DDM solubilization (FIGURE 9C). Furthermore, in 
addition to the monomeric complex IV population, the rcf1His R67A mitochondria 
contained a novel complex IV sub-population, termed IV**, that migrated slower on the 
BN-PAGE gel. The sum of the levels of both complex IV populations observed in the 
rcf1HisR67A mutant mitochondria following DDM solubilization was approximately equal 
to the complex IV levels in the Δrcf1;Δrcf2 mutant, and thus were significantly lower 
than those from the mitochondria harboring the Rcf1His or rcf1HisQ61A,Q71A derivatives.  
 The reduced levels of the complex IV species observed in the DDM extracts of 
the rcf1HisR67A is inconsistent with the apparently normal steady state levels of complex 
IV subunits and the regular appearance of the digitonin-solubilized III-IV supercomplex 
in these mitochondria. Together with the observed presence of the novel complex IV** 
species, these results suggest that the assembly state of the complex IV is somewhat 
altered and more DDM detergent labile in the rcf1His R67A mitochondria, as compared to 
the wild type control.  
 The appearance of a novel, larger IV** species in the Δrcf1;Δrcf2 mutant 
harboring the rcf1HisR67A mutant derivative was unexpected. To directly compare the 
composition of the complex IV (IV and IV**) species from rcf1HisR67A mitochondria to 
that of complex IV from the Δrcf1;Δrcf2 mutant in the presence or absence of the his-
tagged wild type Rcf1, mass spectrometry analysis was performed by a collaborator, Dr. 
Ilka Wittig (Goethe-Universität Frankfurt, Germany). Mitochondria were initially 
solubilized in DDM-containing buffer and complexes were separated by first-dimension 
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(1-D) BN-PAGE. Following 1-D BN-PAGE, lanes of the Δrcf1;Δrcf2 mutant and 
Δrcf1;Δrcf2 harboring his-tagged wild-type or rcf1HisR67A derivatives were analyzed by 
mass spectrometry (FIGURE 10). The protein abundance profiles of subunits showed that 
in the Δrcf;Δrcf2 mutant mitochondria, the complex IV subunits largely co-migrated 
together in the region that corresponded to the monomeric IV complex. In the presence of 
Rcf1His the majority of the complex IV subunits detected were also present as IV/IV* 
species, however, the presence of a low level of complex IV subunits was also co-
detected in a larger molecular weight complex, whose migration corresponded to that of 
the IV** form in the rcf1HisR67A mitochondria and where a low level of Rcf1His protein 
co-migrated too. This finding indicates that the majority of the complex IV was not 
associated with Rcf1 and the minor subpopulation of complex IV+Rcf1 co-migrated as a 
larger IV** species. Consistent with the 1D-BN-PAGE (FIGURE 9C), the ratio of the 
IV** to the IV subpopulations was significantly increased in the rcf1HisR67A sample, with 
comparable levels of IV** and IV populations detected and, with the exception of the 
rcf1HisR67A protein, exhibited similar subunit profiles and abundance distributions. The 
rcf1HisR67A protein was detected co-migrating with the IV** species (and also in fractions 
larger than the IV** complex) and the total amount of rcf1HisR67A present in these 
fractions was significantly higher than that observed for corresponding fractions with the 
mitochondria harboring wild type Rcf1His (FIGURE 10).  
 Since the relative stoichiometric abundance of the complex IV subunits in the 
complex IV** species appeared to be relatively similar to that in the IV subpopulation, it 
can be concluded that the novel complex IV** subpopulation is, at least in part, 
characterized by the stable association of the Rcf1 protein. This association is more  
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Figure 10. Compositional analysis of the complex IV** subpopulation. 1-D 
%13$*(DQDO\VLVRISURWHLQFRPSOH[HVLQZLOGW\SHǻrcf1ǻrcf2 mitochondria and 
those harboring Rcf1His or rcf1His
R67A following solubilization with DDM (0.6%) was 
performed. The areas of the gel encompassing the complex IV and IV** species (as 
shown) were fractionated and proteins were identified and quantified by mass spec-
trometry. The abundance of identified proteins was quantified using intensity-based 
absolute quantification value (IBAQ), as described in Chapter 2. Heat maps and 
graphs show protein profiles normalized to the maximum abundance of a protein 
ZLWKLQ%1ODQHVRIWKHZLOGW\SHDQGǻrcf1ǻrcf2 mutants. 
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pronounced in the case of rcf1HisR67A mutant derivative and thus most likely accounts for 
the higher content of this subpopulation in the rcf1HisR67A mitochondria (relative to the 
null mutant or null mutant plus wild type Rcf1His controls). Therefore, the size difference 
between the IV** and the IV species, may solely be attributed the presence of the Rcf1 
protein. 
 When a second dimension SDS-PAGE (2D-SDS-PAGE) was performed 
following the 1D-BN-PAGE, the presence of rcf1HisR67A with the complex IV** species 
was confirmed by Western blotting followed by immunedecoration (FIGURE 11), where 
rcf1HisR67A was detected co-migrating with Cox2 and Cox3 proteins in the IV** 
subpopulation. In addition, a fraction of the rcf1HisR67A was also observed to be present in 
a higher molecular mass range, which also contained some Cox2 species (but not Cox3), 
which may represent a Cox2-containing assembly intermediate of complex IV. The level 
of Rcf1 co-migrating with complex IV species/subpopulations was significantly greater 
in the case of the rcf1HisR67A mitochondria, when compared to the wild type Rcf1His-
containing control, and indicates that the majority of complex IV is not normally present 
in association with Rcf1 (FIGURE 11). These results are consistent with the mass 
spectrometry analysis and suggest that the rcf1HisR67A may have a tighter association 
(possibly a higher affinity or less dynamic of an interaction) with complex IV than its 
wild type Rcf1 counterpart.  
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Figure 11. 2 Dimension (1D BN-PAGE/2D SDS-PAGE) analysis of the 
complex IV** subpopulation. Mitochondria isolated from the 
ǻrcf1ǻrcf2 mutant strain harboring Rcf1His or rcf1HisR67A were solubilized 
in digitonin (1%) and subjected to BN-PAGE analysis, 1D gel fragments 
from indicated mitochondria were subjected to SDS-PAGE analysis (2D), 
Western blotting and immunedecoration with antibodies against complex 
IV subunits and the Rcf1 protein. 
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3.2.3 The QRRQ motif influences the association of Rcf1 with complex IV, in 
 particular with the Cox12 and Cox3 subunits 
  
 The levels of complex IV associated with the His-tagged Rcf1 derivatives was 
also investigated through affinity purification via Ni-NTA chromatography, following 
solubilization from mitochondria with Triton X-100 (FIGURE 12A). A significantly 
higher level of complex IV subunits co-purified with the rcf1HisR67A derivative, as 
compared to the control Rcf1His protein, which was analyzed in parallel (FIGURE 12A). 
Consistent with the Triton X-100 lysis/purification results, an enhanced association of 
complex IV subunits with the rcf1HisR67A derivative, relative to the wild type Rcf1His 
control, was also observed under the digitonin conditions (where the III-IV association is 
preserved). Of particular note was the Cox12 subunit, which was found to co-purify with 
rcf1HisR67A, but not with the Rcf1His (or rcf1HisQ61A,Q71A) derivative (FIGURE 12A). Cox12 
is a non-essential subunit of complex IV, which is peripherally associated with the 
complex on the intermembrane space-side of the inner membrane and Rcf1 has been 
previously proposed to modulate its association with the complex IV. The co-purification 
of Cox12 with rcf1HisR67A may indicate that mutation of R67 residue in this manner may 
enhance the complex IV-Cox12 association. 
 Complex IV subunits did not co-purify with the rcf1HisQ61A,Q71A derivative under 
the Triton X-100 solubilization conditions, suggesting that mutation of the Q61/Q71 
residue pair in the QRRQ motif disturbs the integrity of the Rcf1-complex IV interaction 
(FIGURE 12A). However, when affinity purification of the his-tagged Rcf1 derivatives 
was performed under milder digitonin solubilization conditions, co-purification of the 
complex IV (and complex III) subunits with rcf1HisQ61A,Q71A was observed, and the  
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Figure 12. Mutation of the QRRQ motif affects the association of Rcf1 
with Cox3 and complex IV. (A) Affinity purification of Rcf1His, 
rcf1His
Q61A,Q71A, rcf1His
R67A derivatives following solubilization with Triton X-100 
detergent was performed, followed by SDS-PAGE, Western blotting and 
immunedecoration, as indicated. Total, 5% of solubilized material; Bound, 
affinity purified material on the Ni-NTA beads. (B) Same as (A), except solubili-
zation was performed with 1 % digitonin. 
	 84	
amounts of associated complex III and IV subunits were similar to the wild type Rcf1His 
control  (FIGURE 12B). Together, these observations would suggest that mutation of the 
Q61/Q71 pair within the QRRQ motif compromises the association of Rcf1 with the 
complex IV, such that it does not remain stable in the presence of Triton X-100, but can 
be preserved when the milder detergent (digitonin) solubilization conditions are applied.  
 Association of the Rcf1 protein with the complex IV, at least in part, involves the 
mitochondrially-encoded subunit 3, Cox3, of complex IV, which can physically associate 
with Rcf1 prior to its assembly into the complex IV. Therefore, the consequence of 
mutation of the QRRQ motif on its ability to interact with newly synthesized Cox3 was 
analyzed (FIGURE 13A). In organello translation in the presence of [35S]methionine was 
performed in isolated mitochondria and the His-tagged Rcf1 derivatives were purified by 
Ni-NTA chromatography following detergent solubilization with Triton X-100. 
Radiolabeled Cox3 co-purified with both the wild type Rcf1His and the rcf1HisR67A 
derivatives. Association of radiolabeled Cox3 with the rcf1HisQ61A,Q71A derivative under 
these detergent conditions was, however, not observed (FIGURE 13A). Furthermore, a 
pulse-chase kinetic analysis indicated that the association of radiolabeled Cox3 with the 
rcf1HisR67A derivative appeared to be more stable/prolonged than with the wild type 
Rcf1His control, suggesting that mutation of the R67 residue to alanine causes an 
enhanced association with Cox3, which may protect Cox3 from subsequent proteolytic 
turnover (FIGURE 13B).  
 Taken together these results indicate that mutation of the QRRQ motif has the 
potential to impact the nature of the Rcf1-complex IV interaction, through an altered 
interaction with the Cox3 and Cox12 subunits. Mutation of R67 to alanine, causes an  
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Figure 13. Mutation of the QRRQ motif affects the association of Rcf1 
with Newly-synthesized Cox3 . (A) In organello labeling in the presence of 
[35S]methionine was performed for 20 min in the isolated mitochondria, prior to 
solubilization with Triton X-100. Affinity purification of the his-tagged Rcf1 
derivatives was performed as described in (Figure 3.5), except following 
SDS-PAGE, the gels were subjected to autoradiography. (B) As described in 
(A), except, following the pulse of translation (20 min), translation was stopped 
through the addition of puromycin and cold methionine and further chased for 
the time periods indicated, prior to solubilization of the mitochondria with Triton 
X-100 and affinity purification of the Rcf1-deriviatives. 
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enhanced complex IV interaction, as evidenced by the presence of the complex IV** 
species, and the increased association of complex IV subunits, Cox12 and radiolabeled 
Cox3 with the rcf1HisR67A derivative. On the other hand, mutation of the Q61/Q71 pair 
compromises the interaction of Rcf1 with Cox3 and thus with the complex IV, as it was 
not observed under Triton X-100 purification conditions, and could only be observed 
under milder detergent conditions, digitonin.  
  
3.2.4 The complex IV in mitochondria harboring the rcf1His R67A derivative 
 displays altered enzymatic properties. 
 
 
 To further explore the properties of the complex IV in the rcf1HisR67A 
mitochondria, experiments were performed to assess its enzymatic activity properties. 
The complex IV enzyme solubilized in DDM retains its enzymatic activity, as evidenced 
by ‘in-gel’ activity assays performed following BN-PAGE analysis (FIGURE 14A). The 
level of complex IV activity was strongly reduced in the Δrcf1;Δrcf2 mutant compared 
both to the wild type control and the null mutant harboring the Rcf1His protein. This 
reduced complex IV enzyme activity can be attributed to the strong reduction in complex 
IV protein levels in the Δrcf1;Δrcf2 mutant (FIGURE 9A). Despite also being so reduced 
in protein content, the levels of DDM solubilized complex IV activity in both the IV and 
IV** subpopulations in the rcf1HisR67A sample appeared similar to, or even higher than, 
those obtained for the IV population in the Δrcf1;Δrcf2 +Rcf1His or the rcf1HisQ61A,Q71A 
mitochondria. These results suggest that the complex IV and complex IV** enzyme 
subpopulations solubilized from the rcf1HisR67A exhibit an increased level of enzyme 
specific activity, relative to those in the mitochondria harboring the wild type Rcf1His 
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control under these analysis conditions.  
 The O2-consuming capacity of the mitochondria harboring the rcf1HisR67A 
derivative was analyzed directly and under different bioenergetic states. Initially, the rate 
of O2 consumption was measured following the addition of substrate NADH, i.e. basal 
respiration, and known as “state 4” respiration (FIGURE 14 B). The state 4 O2 
consumption rates (OCR) in the Δrcf1;Δrcf2 mitochondria were approximately half of 
those in the mitochondria harboring the Rcf1His or rcf1HisQ61A,Q71A proteins. The 
mitochondria harboring the rcf1HisR67A derivative on the other hand contained slightly 
higher levels of state 4 respiration, relative to the Rcf1His control. The increase in state 4 
OCR in the rcf1HisR67A mitochondria did not appear to be due to an elevated basal OCR 
activity caused by a H+ leaky membrane. The respiratory control rate (state 3 respiration 
[NADH+ADP]/state 4) in the rcf1HisR67A mitochondria was similar to the other 
mitochondria measured, indicating the coupled state of these mitochondria (FIGURE 
14C).  
 The maximum oxygen consumption capacity of the complex IV was measured 
directly in the presence of ascorbate/TMPD and CCCP (FIGURE 14D). Compared to the 
double mutant harboring Rcf1His, the Δrcf1;Δrcf2 mutant contained approximately a 50% 
reduction in the maximal complex IV capacity (FIGURE 14D). The maximal complex IV 
OCR of mitochondria harboring the rcf1HisQ61A,Q71A or rcf1HisR67A mutant derivatives were 
similar or slightly higher than that of Δrcf1;Δrcf2+Rcf1His mitochondria. From these 
results it was concluded that both the rcf1HisQ61A,Q71A or rcf1HisR67A mutant derivatives 
displayed the capacity to fully support maximal complex IV activity when expressed in 
Δrcf1;Δrcf2 strain and when the complex IV is working to its maximum capacity. 
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Figure 14. Complex IV in rcf1HisR67A mitochondria displays altered catalytic proper-
ties. (A) 0LWRFKRQGULDLVRODWHGIURPZLOGW\SH:7RUWKHǻrcf1ǻrcf2 strain harboring 
the Rcf1His, rcf1His
Q61A,Q71A, rcf1His
R67A derivatives, as indicated, were solubilized with DDM 
(0.6%) and subjected to duplicate BN-PAGE analysis. The complex IV enzyme activity 
levels were analyzed in one set of samples by performing an in gel enzyme assay 
(middle panel) and in a parallel sample the complex IV protein levels were determining 
following Western blotting and decoration with Cox3 antibody (upper panel), as indicat-
ed. The levels of the Coomassie stained complex V (F1Fo-ATP synthase) are shown in 
lower panel, as a loading control. (B and C) The oxygen consumption rates (OCR) of the 
NADH driven state 4 and respiratory control ratio (RCR) - the ratio of state 3 
(NADH/ADP) to state 4 (NADH) OCR’s - were measured in the indicated isolated mito-
chondria, n = 3.  (D) The maximal capacity of complex IV was determined by measuring 
the OCR driven by ascorbate/TMPD in the presence of CCCP to dissipate the mem-
brane potential, n= 6. (E),VRODWHGǻrcf1ǻrcf2 mitochondria harboring the Rcf1His or 
rcf1His
R67A derivatives were incubated with DCCD at concentrations indicated for 30 min 
at room temperature, prior to measuring the maximal complex IV OCR in the presence 
of ascorbate/TMPD and CCCP. The percent inhibition caused by the DCCD treatment, 
relative to the control (no DCCD) is indicated, n =3
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Finally, the ‘in gel’ enzyme activity assay and the measurement of state 4 OCR’s 
would suggest that the complex IV enzyme in the rcf1HisR67A mitochondria may display 
differential enzymatic properties than when the wild type Rcf1 control protein is present. 
In support of this, it was observed that the complex IV enzyme displayed an increased 
sensitivity to DCCD (FIGURE 14E). DCCD binds to Cox3 (Glu90 residue in bovine 
Cox3, equivalent to Glu98 in yeast) and in doing so interferes with the oxygen uptake 
pathway of complex IV, which involves associated lipids (phosphatidylglycerol and 
cardiolipin molecules) with the enzyme (Ogunjimi et al., 2000; Shinzawa-Itoh et al., 
2007). The changes observed in complex IV caused by the enhanced association of 
rcf1His R67A, potentially alter the accessibility of DCCD to its target, possibly due to 
altered lipid association/arrangements and support the findings of altered structure and 
enzymatic function of the complex in the rcf1HisR67A mitochondria.  
 To further explore the possible role of the Rcf1 protein in the 
insertion/remodeling of cardiolipin associated with complex IV, the ability of Rcf1His and 
mutant derivatives to associate with Taz1, an enzyme involved in the remodeling of 
cardiolipin, was determined by Ni-NTA purification. While association between Taz1 
and wild type Rcf1His or the rcf1HisQ61A,Q71A derivative was not observed, the rcf1HisR67A 
derivative co-purified a low level of Taz1, suggesting that the Rcf1 protein might be 
involved in the insertion or remodeling of cardiolipin (FIGURE 15). The inability of wild 
type Rcf1His (and the rcf1HisQ61A,Q71A derivative) to co-purify Taz1, together with the 
altered interaction kinetics observed between newly synthesized Cox3 and the rcf1HisR67A 
derivative (FIGURE 13B), suggests that the mutation of the R67 residue in Rcf1 may 
affect an otherwise dynamic association of Taz1 with Rcf1-containing populations.  
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Figure 15. The rcf1HisR67A mutant derivative associates with the cardi-
olipin remodeling enzyme, Taz1. Affinity purification of Rcf1His, rcf1His-
Q61A,Q71A, rcf1His
R67A derivatives following solubilization with Triton X-100 
detergent was performed, followed by SDS-PAGE, Western blotting and 
immunedecoration, as indicated. Total, 5% of solubilized material; Bound, 
affinity purified material on the Ni-NTA beads.
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3.2.5 Rcf1 may be involved in post-translational modification of complex IV 
 
 
 Analysis of the amino acid sequence region encompassing the QRRQ motif in an 
alpha-helical plot indicated that the R67 residue co-aligned with the Q71 residue, where 
the Q61 residue neighbored the R65 residue, suggesting they may form Q/R pairs 
(FIGURE 16A). The QRRQ motif in the Rcf1 protein was further explored by making 
double mutants of the Q/R pairs independently, i.e. rcf1HisQ61A,R65A and rcf1HisR67A,Q71A 
and expressing them in the Δrcf1;Δrcf2 null mutant.  Steady state analysis of proteins 
isolated from the resulting strains indicated that the levels of both mutant Rcf1 
derivatives were strongly reduced, in particular the rcf1HisQ61A,R65A derivative, as 
compared to the wild type Rcf1His control (FIGURE 16B). Therefore, mutation of either 
of the Q/R pairs strongly impacts the stability and thus the steady state levels of the Rcf1 
protein.  
 Despite the strongly reduced levels of the rcf1HisQ61A,R65A protein, analysis of the 
complex IV subunit levels in the mutant mitochondria demonstrated that they were 
similar to that of the Rcf1His control and significantly higher than those observed in the 
Δrcf1;Δrcf2 null mitochondria (FIGURE 16B). BN-PAGE analysis of the III-IV 
supercomplex demonstrated that the levels of III2-IV(1-2) in Δrcf1;Δrcf2 harboring the 
rcf1HisQ61A,R65A protein were similar to the wild type levels of III2-IV(1-2) (FIGURE 16C, 
left panel).  The levels of DDM-solubilized complex IV in the rcf1HisQ61A,R65A 
mitochondria were also similar to those of the wild type Rcf1His control (FIGURE 16C, 
right panel). 
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Figure 16. Mutation of the QR pairs in the QRRQ motif in Rcf1 affects the 
stability of Rcf1, but complex IV assembles. (A) $QĮKHOLFDOSORWRI
UHVLGXHV/HX/WKURXJK*OQ4RI5FIGHSLFWLQJWKHFRORFDOL]DWLRQRIWKH
45UHVLGXHSDLUDQGWKH54UHVLGXHSDLURQWKHKHOL[(B)6WHDG\
VWDWHSURWHLQOHYHOVRIWKH2;3+26VXEXQLWVLQWKHPLWRFKRQGULDȝJ
SURWHLQLVRODWHGIURPLQGLFDWHGVWUDLQV7LPZDVXVHGDVDORDGLQJFRQWURO
(C)0LWRFKRQGULDLVRODWHGIURP:7DQGLQGLFDWHGǻrcf1ǻrcf2VWUDLQVZHUH
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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RU''0ULJKWSDQHODQG
VXEMHFWHGWR%13$*(DQDO\VLV:HVWHUQEORWWLQJDQGLPPXQHGHFRUDWLRQZLWK
DQWLERGLHVDJDLQVWFRPSOH[,,,VXEXQLWF\WRFKURPHc1Į&\WFOHIWSDQHODQG
FRPSOH[,9VXEXQLW&R[ULJKWSDQHO
	 93	
Although the steady state levels of the rcf1HisR67A,Q71A derivative were marginally 
higher than that of  rcf1HisQ61A,R65A protein, the presence of the rcf1HisR67A,Q71A protein 
only partially restored the complex IV subunits to wild type levels, indicating that 
mutation of the R67/Q71 pair  compromised the ability of this Rcf1 derivative to support 
complex IV assembly (FIGURE 16B).  Consistently, a partial restoration of the III2-IV1-2 
species was observed in the BN-PAGE analysis of the digitonin solubilized 
rcf1HisR67A,Q71A mitochondria, paralleling the observation that the levels of the complex 
IV subunits in the rcf1HisR67A,Q71A mitochondria are greater than those in the Δrcf1;Δrcf2 
control, but not equivalent to those of the wild type control (FIGURE 16C, left panel). 
However, when solubilized with DDM and analyzed by BN-PAGE, the levels of free 
complex IV from the rcf1HisR67A,Q71A mitochondria appeared similar to those of the 
Δrcf1;Δrcf2 null mitochondria, and in contrast to those from the rcf1HisQ61A,R65A 
mitochondria, where the levels of complex IV were similar to the wild type Rcf1His 
control (FIGURE 16 C, right panel). These results together suggest that complex IV from 
the rcf1HisR67A,Q71A mitochondria may exhibit some detergent instability to DDM, in a 
similar manner as was previously observed in the rcf1HisR67A mitochondria (FIGURE 9C). 
In contrast to the rcf1HisR67A mitochondria, the presence of a complex IV** form was not 
detected in the rcf1HisR67A,Q71A mitochondrial sample. This may be attributed to the 
strongly reduced levels of rcf1HisR67A,Q71A derivative in these mitochondria and thus 
would be limiting to form detectable levels of the complex IV** species. Alternatively, 
(or additionally) the introduction of the additional Q71A mutation, may have 
compromised the stability of the Rcf1-complex IV association. 
 Measurement of the maximal O2 consumption rates of complex IV in the 
	 94	
rcf1HisQ61A,R65A mitochondria demonstrated them to be fully restored to the levels in the 
wild type Rcf1His control mitochondria, whereas in the rcf1HisR67A,Q71A mitochondria, 
although they were significantly higher than those measured in the Δrcf1;Δrcf2 null 
mitochondria, they were not equivalent to the rcf1HisQ61A,R65A or wild type Rcf1His 
mitochondria (FIGURE 17A). The increased level of complex IV activity in these 
mutants was sufficient to restore aerobic growth, as expression of both rcf1HisQ61A,R65A 
and rcf1HisR67A,Q71A derivatives, ensured complementation of the growth defect phenotype 
of the Δrcf1;Δrcf2 strain (FIGURE 17B). 
 In summary, the Q61/R65 and R67/Q71 residue pairs within the QRRQ motif of 
Rcf1 are independently critical for the stability of the Rcf1 protein. However, despite 
being strongly reduced in levels, the Q/R pair mutated Rcf1 derivatives could support 
(fully for the Q61/R65 mutant and partially for the R67/Q71 mutant) the assembly and 
activity of complex IV. Importantly these findings indicate that Rcf1 does not need to be 
present at its wild type levels to support the activity of complex IV. Thus, these findings 
argue against Rcf1 exerting its influence on complex IV activity as a stoichiometrically 
equivalent component or subunit of the assembled complex IV enzyme. 
 
3.2.6 Rcf1 associates with a cardiolipin binding protein of complex III  
 The altered complex IV enzymatic activity in rcf1HisR67A mitochondria, together 
with the interaction between rcf1HisR67A and the cardiolipin-remodeling enzyme Taz1, 
suggested that Rcf1 might be involved in the arrangement or modification of lipids 
(specifically cardiolipin) within complex IV. Initial analysis of the nature of Rcf1’s 
interaction with the III-IV supercomplex revealed that Rcf1 could interact with complex  
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Figure 17. Mutation of the QR pairs in the QRRQ motif in Rcf1 does not 
negatively affect the catalytic activity of complex IV. (A) Maximal OCR of 
bioenergetically isolated complex IV was measured in mitochondria isolated from 
WKHǻrcf1ǻrcf2VWUDLQDQGWKHǻrcf1ǻrcf2 strain harboring the rcf1HisQ61A,R65A or 
rcf1His
R67A,Q71A derivatives, following addition of ascorbate/TMPD and CCCP.  (B) 
6HULDOIROGGLOXWLRQVRIZLOGW\SH:7DQGǻrcf1ǻrcf2 expressing Rcf1His, 
rcf1His
Q61A,R65A or rcf1His
R67A,Q71A derivatives or not, as indicated, were spotted on YP 
plates containing glucose (YPAD) or glycerol supplemented with 0.1 % galactose 
(YPG+0.1% Gal) and grown at 30 oC.
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III in the absence of a completely assembled complex IV (Strogolova et al., 2012). This 
finding raised the possibility that Rcf1 might independently bind to components of both 
complex III and complex IV through, or due to a functional relationship with, a feature 
common to both complexes (e.g. the modification of cardiolipin).  
 To determine the interaction partner(s) of Rcf1 within complex III, Rcf1His was 
purified from a mutant deficient in the assembly of both complex III and complex IV 
(e.g. a strain of yeast in which the mitochondrial DNA has been lost, i.e. ρ° yeast), and 
the association of specific complex III subunits was determined using antibodies directed 
against individual complex III subunits (FIGURE 18). In testing all but one of the 
complex III subunits (an effective Qcr8 antibody has yet to be acquired), only 
cytochrome c1, and to a lesser extent Qcr6, co-purified with Rcf1His. According to the 
crystal structure of the yeast complex III, Qcr6 interacts with cytochrome c1 within the 
fully assembled complex III enzyme (Hunte et al., 2000). Similar to other proteins within 
the Rcf1 interactome (e.g. Cox3, Cox12) cytochrome c1 interacts with cardiolipin (Lange 
et al., 2001). This result identifies cytochrome c1 as an interaction partner of Rcf1, and 
further supports a role of Rcf1 in the arrangement or modification of cardiolipin within 
respiratory enzyme complexes.  
 
3.2.7 Comparative analysis of Hig1-type1 and Hig1-type2 proteins and their 
 association with complex IV  
 
 
 Characterization of the Rcf1/Hig1 QRRQ motif suggested that conserved residues 
of the QRRQ motif influence the dynamic interaction between Rcf1 and complex IV, and 
may potentially influence the lipid assembly or modification that ultimately affects  
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Figure 18. Rcf1 associates with the Complex III cardiolipin-
associated subunit, cytochrome c1. Affinity purification of Rcf1His, from 
ȡ+DQGȡ0ǻrcf1 mitochondria   following solubilization with digitonin 
(1%) detergent was performed, followed by SDS-PAGE, Western blotting 
and immunedecoration, as indicated. Total, 5% of solubilized material; 
Bound, affinity purified material on the Ni-NTA beads
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complex IV enzymatic activity. The QRRQ motif represents a differentiating feature 
between Hig1-type1 and -type2 proteins. However, it is unknown whether the altered 
[I/V]-HLIHM-R-(X)3-[Q] motif of Hig1-type1 proteins affects the ability to support 
respiration-based growth or associate with complex IV.   
 To determine whether functional differences exist between Hig1-type 1 and type2 
proteins, both human isoforms were expressed as C-terminal His-tagged derivatives in 
the Hig1-deficient yeast strain Δrcf1;Δrcf2. Expression was verified by western blot 
analysis of purified mitochondria fractions isolated from wild type and mutant derivative 
strains (FIGURE 19A). The steady state levels of the Hig1-1AHis and Hig1-2AHis 
derivatives appeared to be slightly reduced when compared to the wild-type Rcf1His 
control, and may suggest that heterologous human Hig1 proteins are not entirely stable 
when expressed in Hig1-deficient yeast.  
 The ability of human Hig1 proteins to support respiratory-based growth in yeast 
was tested by growth on the non-fermentable carbon source glycerol (FIGURE 19B). The 
expression of Hig1-2A partially complemented the respiration-based growth defect of the 
Δrcf1;Δrcf2 yeast strain, while the expression of Hig1-1A did not restore growth. When 
the level of phenotype complementation was compared between human Hig1-2AHis and 
the his-tagged C. elegans Hig1 derivative M05D6.5His (a type 2 Hig1 derivative) 
expressed in the same background, respiration-based growth was similar between 
Δrcf1;Δrcf2 yeast strains harboring the human (Hig1-2AHis) or nematode (M05D6.5His) 
Hig1 proteins, where both partially restored the Δrcf1;Δrcf2 growth deficiency (FIGURE 
19B).  
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Figure 19. Hig1-type 1 and -type 2 proteins display contrasting levels of 
association with Complex IV. (A) Steady state protein levels of OXPHOS 
VXEXQLWVLQWKHPLWRFKRQGULDȝJSURWHLQLVRODWHGIURPWKHǻrcf1ǻrcf2 strain 
KDUERULQJKLVWDJJHG\HDVW5FIRUKXPDQ+LJW\SH+LJ$RUW\SH
+LJ$LVRIRUPVRUQRW0LWRFKRQGULDZHUHDQDO\]HGE\6'63$*(
:HVWHUQEORWWLQJDQGLPPXQHGHFRUDWLRQZLWKDQWLERGLHVDJDLQVWFRPSOH[,9
VXEXQLWV&R[DQG&R[ZLWK7LPDQGWKH)1)O ATP-synthase subunit, Su e, 
OHYHOVDVORDGLQJFRQWUROV%6HULDOIROGGLOXWLRQVRIZLOGW\SH:7DQG
ǻrcf1ǻrcf2\HDVWVWUDLQVH[SUHVVLQJ5FI+LVKXPDQ+V+LJ$+V+LJ$
RU&HOHJDQV&H0'+LJW\SHSURWHLQGHULYDWLYHVRUQRWDVLQGLFDWHG
ZHUHVSRWWHGRQ<3SODWHVFRQWDLQLQJJOXFRVH<3$'RUJO\FHUROVXSSOHPHQWHG
ZLWKJDODFWRVH<3**DODQGJURZQDWo&&$IILQLW\SXULILFD-
WLRQRI5FI+LV5FI+V+LJ$+LJ$RU+V+LJ$+LJ$GHULYD-
WLYHVIROORZLQJVROXELOL]DWLRQZLWK7ULWRQ;GHWHUJHQWZDVSHUIRUPHGIROORZHG
E\6'63$*(:HVWHUQEORWWLQJDQGLPPXQHGHFRUDWLRQDVLQGLFDWHG7RWDO
RIVROXELOL]HGPDWHULDO%RXQGDIILQLW\SXULILHGPDWHULDORQWKH1L17$EHDGV
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The capacity of the his-tagged human Hig1 derivatives to associate with complex 
IV was investigated through affinity purification via Ni-NTA chromatography, following 
solubilization from mitochondria with Triton X-100 (FIGURE 19C). The relative amount 
of human Hig1-1AHis and Hig1-2AHis protein that was purified on the beads, as 
determined by western blot using His antiserum, was significantly reduced (~70% 
reduction), compared to the levels of Rcf1His. A similar pattern of reduction was observed 
in the total mitochondrial fraction (total), and thus, suggests that human Hig1 proteins 
might be less stable in yeast mitochondria.  
 First, heterologous Hig1-type2 proteins (Rcf1 and Hig1-2A) were compared in 
their ability to associate with complex IV, the level of complex IV subunit co-purification 
was similar between the human Hig1-2AHis derivative and the Rcf1His control (FIGURE 
19C). However, when the level of complex IV co-purification was compared to the level 
of Rcf1His/Hig1-2AHis bound to the Ni-NTA beads, a greater amount of Rcf1His was 
bound to the beads, suggesting that Hig1-2AHis associates with a greater amount of 
complex IV, relative to Rcf1His. When the association with complex IV was compared 
between Hig1-1AHis and Rcf1His, a reduced association of complex IV subunits with the 
Hig1-1AHis derivative, relative to the wild type Rcf1His control, was observed. When the 
level of complex IV association was compared between Hig1-1AHis and Hig1-2AHis, 
where the amount of His-tagged protein bound to the beads was similar, Hig1-2AHis co-
purified a significantly greater amount of complex IV protein than Hig1-1AHis.  
 Together, these results indicate that Hig1-type1 proteins, which contain a 
modified [I/V]-HLIHM-R-(X)3-[Q] motif display a weaker interaction with complex IV, 
relative to Hig1-type 2 proteins, and cannot complement the respiration-based growth 
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defect of the Δrcf1;Δrcf2 yeast strain. These results highlight the importance of the 
QRRQ motif as a potential basis of functional differences between Hig1-type 1 and -type 
2 proteins, and further support the conserved role of the QRRQ motif of Hig1-type 2 
proteins in influencing association with complex IV and supporting respiratory growth.  
 
3.2.8 Analysis of the molecular environment of the Rcf1 QRRQ motif  
 The preceding results suggested an important role for the QRRQ motif in the 
function of the Rcf1 protein. Yet the molecular environment surrounding the QRRQ 
motif was unknown. In particular, it was important to identify potential protein partners 
that may interact with the QRRQ region of Rcf1.   
 To analyze the molecular environment of the conserved QRRQ motif region and 
identify potential protein partners, a Cysteine (Cys)-based scanning strategy via a Cys-
based crosslinking was adopted. Cysteine site-directed mutagenesis was used to introduce 
unique Cys residues into the Rcf1 QRRQ motif region in the context of a Cys-less 
Rcf1His derivative (rcf1HisC28A,C38A) where the sole Rcf1 cysteines, C28 and C38, have 
been mutated to Ala. Four distinct Rcf1 mutant derivatives were created, with the 
location of the “inserted” Cys residues selected on the basis of their position relative to 
the conserved QRRQ residues (FIGURE 20A). In the first mutant, tryptophan (Trp, W) 
58 was mutated to Cys, to create the rcf1HisC28A,C38A,W58C (W58C) derivative. In the 
second mutant derivative Alanine (Ala, A) 60 was mutated to Cys, to create 
rcf1HisC28A,C38A,A60C (A60C). The third and fourth mutants were created by individually 
mutating Valine (Val,V) 68 and Glycine (Gly, G) 69 to Cys, to create rcf1HisC28A,C38A,V68C 
(V68C) and rcf1HisC28A,C38A,G69C (G69C) derivatives, respectively. Rcf1 mutant  
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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+LVWDJJHG5FI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rcf1HisC28A,C38A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&&:&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&&*&GHULYDWLYHV5FIOHYHOVZHUH
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PLWRFKRQGULDZHUHLQFXEDWHGLQ6+%XIIHUFRQWDLQLQJ
'062SULRUWR6'63$*((C) 6HULDOIROGGLOXWLRQVRIZLOGW\SH:7DQG
ǻrcf1ǻrcf2\HDVWVWUDLQVH[SUHVVLQJWKH5FIHisGHULYDWLYHRUF\VWHLQHPXWDQWGHULYD-
WLYHVRUQRWDVLQGLFDWHGZHUHVSRWWHGRQ<3SODWHVFRQWDLQLQJJOXFRVH<3$'RU
JO\FHUROVXSSOHPHQWHGZLWKJDODFWRVH<3**DODQGJURZQDWRC.
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derivatives were expressed as C-terminal His-tagged derivatives in the Rcf1/Rcf2 double 
null yeast strain (Δrcf1;Δrcf2). Expression was verified by western blot analysis of 
purified mitochondria fractions isolated from wild type and mutant derivative strains 
(FIGURE 20B). The Δrcf1;Δrcf2 yeast strain displays a respiration-based growth defect 
(Strogolova et al., 2012). The expression of rcf1HisC28A,C38A,W58C, rcf1HisC28A,C38A,A60C, 
rcf1HisC28A,C38A,V68C and rcf1HisC28A,C38A,G69C derivatives complemented the Δrcf1;Δrcf2 
respiratory growth defect (growth on the non-fermentable carbon source, glycerol) to a 
similar extent as the wild type Rcf1His derivative (FIGURE 20C). From this result it was 
concluded that these yeast strains were viable and that the loss of C28 and C38, or the 
Cys insertion mutations do not affect the ability of the resulting Rcf1 derivatives to 
complement the respiratory growth defect of the Δrcf1;Δrcf2 yeast strain.  
The molecular environment of the QRRQ motif region was analyzed via 
sulfhydryl (SH) –specific cross-linking by the SH-specific homobifunctional reagent 
bismaleimidoethane (BMOE), and subsequently analyzed by SDS-PAGE and 
immunedecoration with Rcf1 antisera. Following BMOE crosslinking, wild type Rcf1His 
formed a number of adducts with partner proteins, the most prominent of which was a 40 
kDa adduct (Rcf1+ a 20 kDa partner protein)(FIGURE 21). None of the Rcf1His BMOE 
crosslinking adducts were detectable in the rcf1HisC28A,C38A derivative, indicating  that the 
BMOE (SH-SH) crosslinking observed in the wild type Rcf1His involved the C28 and 
C38 residues. When the crosslinking patterns of the Cys insertion Rcf1 mutant 
derivatives were directly compared to those of wild type Rcf1His and the rcf1HisC28A,C38A 
derivative, a number of novel crosslinking adducts containing Rcf1 and partner proteins 
were identified (FIGURE 21A). Of particular interest was a significant increase  
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Figure 21. Cysteine -based scanning analysis of the molecular environ-
ment of the Rcf1 QRRQ motif. Chemical cross-linking (BMOE) was performed 
RQPLWRFKRQGULDLVRODWHGIURPWKHǻrcf1ǻrcf2FRQWURODQGǻrcf1ǻrcf2 strains 
harboring the Rcf1His derivative or cysteine mutant derivatives, as indicated. 
)ROORZLQJ6'63$*(DQG:HVWHUQEORWWLQJGHFRUDWLRQZLWK+LVWDJHSLWRSHĮ
His12) antiserum was performed. The positions of the dominant 40 kDa (Rcf1+ 
20 kDa protein) Rcf1-containing adduct, and the monomeric Rcf1 (Rcf1His) are 
indicated.
Į+LV
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(approximately twice the level observed in wild type Rcf1His mitochondria) in the 40 kDa 
adduct in the rcf1HisC28A,C38A,V68C and rcf1HisC28A,C38A,G69C derivatives. Interestingly, in the 
rcf1HisC28A,C38A,V68C derivative the 40 kDa adduct was observed even in the absence of 
cross-linking reagent, albeit at a significantly lower level compared to the presence of 
cross-linking reagent. These results suggested that the C68 within the Rcf1 QRRQ motif 
potentially forms a disulfide bond with an Rcf1 partner protein.  
 To determine the identity of the protein partner that forms a 40 kDa adduct with 
Rcf1, BMOE cross-linking was combined with affinity chromatography to affinity purify 
the Rcf1 crosslinking adduct, and liquid chromatography –tandem mass spectrometry 
(LC-MS/MS) analysis to identify the partner protein. Cross-linking was performed in 
rcf1C28A,C38A,V68C mitochondria, and in parallel with a rcf1C28A,C38A mutant control. 
Following crosslinking, mitochondria were solubilized first in SDS-containing buffer, 
followed by Triton–X100 solubilization. Rcf1His –containing adducts were purified by 
Ni-NTA affinity chromatography, and separated by SDS-PAGE. The purified 40 kDa 
adduct that contained rcf1C28A,C38A,V68C and the 20 kDa partner protein was visualized by 
silver staining (FIGURE 22), excised and subjected to LC-MS/MS in collaboration with  
Dr. Kate Noon at the Medical College of Wisconsin Mass Spectrometry Facility. 
Common contaminants were excluded from the final results and false positives were 
eliminated from the resulting data set by comparing the LC-MS/MS spectra of 
rcf1C28A,C38A,V68C to that of the rcf1C28A,C38A derivative. Rcf1was the only protein detected 
within the excised 40 kDa cross-linking adduct. These results suggest that Rcf1 may form 
a homodimer, and that the insertion of a Cys at V68 enhances the formation of the Rcf1 
homodimer.  
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Figure 22. Liquid chromatography- (tandem) mass spectrometry identi-
fication of an Rcf1-Rcf1 dimer. Chemical cross-linking (BMOE) was 
SHUIRUPHGRQPLWRFKRQGULDLVRODWHGIURPWKHǻrcf1ǻrcf2 strain harboring 
rcf1His
C28A,C38A (C28,C38) or rcf1His
C28A,C38A ,V68C (C28,C38,V68C) and the affinity 
purification of Rcf1-containing adducts following solubilization with Triton 
X-100 detergent was performed. Following SDS-PAGE, affinity purified 
Rcf1-containing adducts were visualized by silver stain and the 40 kDa 
rcf1His
C28A,C38A ,V68C - containing adduct was analyzed by liquid 
chromatography- (tandem) mass spectrometry (LC-MS/MS).  
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3.2.9 Investigation of the protonation state of R67 in influencing the molecular 
 interactions of the Rcf1 protein 
 
 
 The mutation of R67 within the QRRQ motif of Rcf1 resulted in a distinct pattern 
of biochemical and bioenergetic changes within the mitochondria that appeared to be, at 
the very least, tangentially related to lipid synthesis and/or remodeling within respiratory 
enzymes. Transmembrane helical prediction algorithms predict that Rcf1 R67 resides at 
the matrix loop-transmembrane interface of the Rcf1 protein. While R67 is predicted to 
be protonated at the reported physiological pH of the mitochondrial matrix (pH7.7), the 
pH within the inner mitochondrial membrane micro-environment may vary (Santo-
Domingo and Demaurex, 2012). The mutation of Arg 67 to Ala simultaneously changed 
the size and protonation state of the amino acid, and introduced a de-protonated residue 
to the Rcf1 QRRQ motif. Thus, the functional consequences of mutating R67 could be 
related to the protonation state of Rcf1 R67, an amino acid that is exceptionally 
conserved among both type1 and type2 Hig1 proteins.  
 To characterize the Rcf1 R67 protonation state and its potential influence on 
complex IV and the molecular environment of Rcf1, mutations were introduced that were 
predicted to change the charge of the residue; R67Q (uncharged), R67H (pH-sensitive), 
R67K (charged, [+]), R67E (charged, [-]). The resulting Rcf1 R67 mutant derivatives, i.e. 
rcf1HisR67Q,  rcf1HisR67H , rcf1HisR67K and rcf1HisR67E , were expressed in the Δrcf1;Δrcf2 
null mutant. Steady state analysis of proteins isolated from the resulting strains indicated 
that the levels of mutant Rcf1 R67 derivatives were equal to the wild type Rcf1His control 
(FIGURE 23A). Therefore, mutation of R67 in this manner did not appear to adversely 
affect the stability of the Rcf1 protein.  
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Figure 23. Charge-altering mutations in Rcf1 R67 do not negatively affect the 
assembly state of complex IV or the assembly of complex IV with complex 
III, in contrast to the size-altering R67A mutation. (A) Steady state protein 
OHYHOVRI2;3+26VXEXQLWVLQPLWRFKRQGULDȝJSURWHLQLVRODWHGIURPWKHZLOG
W\SHDQGWKHǻrcf1ǻrcf2 strain harboring his-tagged Rcf1(Rcf1His), rcf1HisR67Q 
(R67Q), rcf1His
R67H (R67H) , rcf1His
R67K (R67K), and rcf1His
R67E (R67E) derivatives, or 
QRW0LWRFKRQGULDZHUHDQDO\]HGE\6'63$*(:HVWHUQEORWWLQJDQGLPPXQH-
GHFRUDWLRQZLWKDQWLERGLHVDJDLQVWLQGLFDWHG2;3+26SURWHLQV7LPOHYHOVZHUH
used as loading controls. (B) Mitochondria isolated from WT and indicated 
ǻrcf1ǻrcf2 VWUDLQVZHUHVROXELOL]HGLQGLJLWRQLQOHIWSDQHORU''0
ULJKWSDQHODQGVXEMHFWHGWR%13$*(DQDO\VLV:HVWHUQEORWWLQJDQG
LPPXQHGHFRUDWLRQZLWKDQWLERGLHVDJDLQVWFRPSOH[,,,VXEXQLWF\WRFKURPHc1 
Į&\Wc1OHIWSDQHORUFRPSOH[,9VXEXQLW&R[Į&R[ULJKWSDQHO
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Analysis of the complex IV subunit levels in mutant mitochondria demonstrated 
that they were similar to that of the Rcf1His control and significantly higher than those 
observed in the Δrcf1;Δrcf2 null mitochondria (FIGURE 23A). BN-PAGE analysis of the 
III-IV supercomplex indicated that the levels of III2-IV(1-2) in Δrcf1;Δrcf2 harboring the 
Rcf1 R67 mutant proteins were similar to the III2-IV(1-2)  levels in double mutant 
harboring the wild type Rcf1His derivative, or rcf1HisR67A mutant derivative, which were 
both analyzed in parallel (FIGURE 23B, left panel).  The levels of DDM-solubilized 
complex IV in the R67Q, R67H, R67K and R67E mitochondria were also similar to those 
of the wild type Rcf1His control, and in contrast to the strongly reduced levels of 
assembled complex IV and appearance of the novel IV** form that was observed in the 
rcf1HisR67A, which were both analyzed in parallel (FIGURE 23B right panel). 
Together, these results suggest that charge-altering mutations in R67 that do not 
alter the size of the amino acid (in contrast to the R67A mutation), likewise do not 
negatively affect the assembly state of complex IV or the assembly of complex IV with 
complex III.  
 The levels of complex IV that associated with the His-tagged Rcf1 R67 
derivatives was also investigated through affinity purification via Ni-NTA 
chromatography, following solubilization from mitochondria with digitonin (FIGURE 
24A). The level of complex IV (and complex III, Cytc1) subunits that co-purified with the 
rcf1HisR67Q, rcf1HisR67K and rcf1HisR67E derivatives were similar to the control Rcf1His 
protein, which was analyzed in parallel (FIGURE 24A). Notably, a slight increase in 
level of association with complex IV (and Complex III) was observed in the rcf1HisR67H 
derivative. In contrast, when complex IV association was analyzed under stronger  
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Figure 24. Charge-altering mutations in Rcf1 R67 affect the association of 
Rcf1  with complex IV. (A) Affinity purification of Rcf1His, rcf1HisR67Q, rcf1HisR67H , 
rcf1His
R67K, rcf1His
R67E derivatives following solubilization with 1 % digitonin deter-
gent was performed, followed by SDS-PAGE, Western blotting and immunedec-
oration, as indicated. Total, 5% of solubilized material; Bound, affinity purified 
material on the Ni-NTA beads. (B) Same as (A), except solubilization was 
performed with Triton X100.
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(Triton-X100) solubilization conditions, the ostensibly similar levels of association with 
complex IV that were observed under milder detergent solubilization conditions 
disappeared, and gave way to nuanced changes in complex IV association (as determined 
by Cox2 immunedecoration) between respective R67 mutant derivatives. Specifically, the 
level of Cox2 that co-purified with the rcf1HisR67H and rcf1HisR67K derivatives was reduced 
by approximately 50%, compared to wild type Rcf1His, which was evaluated in parallel 
(FIGURE 24B). On the other hand, the rcf1HisR67Q and rcf1HisR67E derivatives did not 
appear to co-purify complex IV under Triton-X100 solubilization conditions.  
 These results are consistent with initial analysis of the QRRQ motif using the 
rcf1HisQ61A Q71A and rcf1HisR67A derivatives, in that they support the conclusion that Rcf1 
likely displays a dynamic interaction with complex IV that is influenced, or possibly 
governed, by the QRRQ motif.  
 Measurement of the state 4 OCR in Δrcf1;Δrcf2 mitochondria harboring Rcf1 
R67 mutants indicated that rcf1HisR67Q and rcf1HisR67H fully restored state 4 OCR to the 
levels in the wild type Rcf1His control mitochondria, whereas the rates in the rcf1HisR67K  
and rcf1HisR67E  mitochondria were slightly higher, compared to the wild type Rcf1His 
control mitochondria (FIGURE 25A). The respiratory control ratio was similar across all 
R67 mutant derivatives and closely matched that of the wild type Rcf1His control 
(FIGURE 25B). The coupled state of these mitochondria suggests that the elevated state 4 
OCR of the R67K and R67E mitochondria is not due to an elevated basal OCR activity 
caused by a H+ leaky membrane. Measurement of the complex IV OCR directly in the 
presence of ascorbate/TMPD in the rcf1HisR67Q and rcf1HisR67H mitochondria demonstrated 
them to be slightly elevated, as compared to the levels in the wild type Rcf1His control  
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Figure 25. A charged Rcf1 R67 residue affects the catalytic properties 
of complex IV. (A and B) The oxygen consumption rates (OCR) of the 
NADH driven state 4 and respiratory control ratio (RCR) - the ratio of state 
3 (NADH/ADP) to state 4 (NADH) OCR’s - were measured in mitochondria 
LVRODWHGIURPZLOGW\SH:7RUWKHǻrcf1ǻrcf2 strain harboring the Rcf1His, 
rcf1His
R67A , rcf1His
R67Q, rcf1His
R67H , rcf1His
R67K, rcf1His
R67E derivatives, or not (-), n = 
3.  (C) The bioenergetically isolated activity of complex IV was determined 
by measuring the OCR driven by ascorbate/TMPD, n= 3. (D) Serial 10-fold 
dilutions of indicated strains were spotted on YP plates containing glucose 
(YPAD) or glycerol supplemented with 0.1 % galactose (YPG+0.1% Gal) 
and grown at 30 oC.
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mitochondria, whereas in the rcf1HisR67E and, to a greater extent, the rcf1HisR67E 
mitochondria the complex IV OCR was significantly higher than the wild type Rcf1His 
control mitochondria (FIGURE 25C). The increased level of complex IV activity in the 
R67 mutants was sufficient to restore aerobic growth, as expression of each R67 mutant 
derivative (rcf1HisR67Q,  rcf1HisR67H , rcf1HisR67K and rcf1HisR67E), complemented the growth 
defect phenotype of the Δrcf1;Δrcf2 strain (FIGURE 25D).  
 Together, these results suggest that rcf1HisR67Q,  rcf1HisR67H , rcf1HisR67K and 
rcf1HisR67E mutant derivatives display the capacity to fully support complex IV activity 
when expressed in Δrcf1;Δrcf2 strain. Furthermore, the state 4 OCR measurements 
would suggest that the complex IV enzyme in the rcf1HisR67K and rcf1HisR67E mitochondria 
may display differential enzymatic properties than when the wild type Rcf1 control (or 
rcf1HisR67Q and rcf1HisR67H) protein is present.  
 To determine whether charge-altering mutations in R67 (R67Q, R67H, R67K, 
R67E), effect the molecular environment of Rcf1 a chemical cross-linking approach was 
adopted, using m-maleimidobenzoyl-N-hydroxysuccinimide ester (MBS), an amine-
sulfhydryl cross-linker with a 7.3 Å spacer length. Cross-linking was performed in 
isolated mitochondria harboring the Rcf1 derivatives and subsequently analyzed by SDS-
PAGE and immunedecoration with Rcf1 antisera (FIGURE 26, left panel). Previous 
analysis demonstrated that the mutation R67A influences the proximity between Rcf1-
and Cox2 subunit, seen in the gained crosslink between rcf1HisR67A and Cox2 (not shown). 
Therefore, the affect of charge–related mutations in R67 on the ability of Rcf1 to be 
cross-linked to Cox2 was determined by immunedecoration of a parallel MBS 
crosslinking experiment with Cox2-specific-antisera (FIGURE 26, right panel).  
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Figure 26. Mutation of R67 Affects the molecular environment of Rcf1 and 
Cox2. Chemical cross-linking (MBS) was performed on mitochondria isolated 
IURPWKHǻrcf1ǻrcf2FRQWURODQGǻrcf1ǻrcf2 strains harboring the Rcf1His, 
rcf1His
R67A , rcf1His
R67Q, rcf1His
R67H , rcf1His
R67K, rcf1His
R67E derivatives, as indicated. 
Following SDS-PAGE, and Western blotting, immunedecoration with the 
+LVWDJHSLWRSHĮ+LVOHIWSDQHORUFRPSOH[,9VXEXQLWĮ&R[ULJKW
panel) antiserum was performed. The positions of the Rcf1-Cox2 adduct, and 
monomeric Rcf1 and Cox2 are indicated.
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Consistent with previous results and observed in parallel with the Rcf1-antibody 
decoration, no Cox2-containing adduct was detected in Δrcf1;Δrcf2 mitochondria 
harboring His-tagged wild type Rcf1. Additionally, no Cox2 adduct was observed in the 
Cox2-deficient control strain, Δcox18. The ability of Rcf1 to be cross-linked to Cox2 
varied across R67 mutant derivatives expressed in Δrcf1;Δrcf2 mitochondria. Similar to 
the R67A control, which was analyzed in parallel, R67Q and R67H mutant derivatives 
gained the ability to be cross-linked to Cox2. In contrast, no crosslinking to Cox2 was 
observed in Δrcf1;Δrcf2 mitochondria harboring either the R67K or R67E mutant 
derivatives. It was therefore concluded that, similar to the R67A mutant, the arrangement 
of Rcf1 with complex IV is altered in the R67Q and R67H mutants, such that a close 
proximity between Rcf1-and Cox2 subunit is gained.  
 These results suggest that the protonation state of R67 may influence the 
molecular environment of Rcf1 and Cox2/complex IV.  
3.3 Chapter 3 Summary 
 In summary, these results demonstrate the importance of the QRRQ motif in 
influencing a dynamic interaction between Cox3 and complex IV. It was found that the 
QRRQ motif impacts the ability of Rcf1 to associate with the assembled complex IV, and 
the Cox3 and Cox12 protein subunits. In addition, these data reveal that Rcf1 exists in 
close proximity to Cox2, a catalytically important subunit of complex IV. The mutation 
of conserved residues within the QRRQ motif lead to the assembly of a novel Rcf1-
complex IV subpopulation that displays altered enzymatic properties. The conserved 
QRRQ motif may further influence the molecular environment of Rcf1 and its potential 
relationship with the cardiolipin-remodeling enzyme Taz. 
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 Comparative analysis of Hig1-type 1 and type 2 proteins revealed differences in 
their ability to interact with complex IV. Given the importance of the QRRQ motif for the 
interactions of Rcf1 stated above, it is tempting to speculate that the differences observed 
in the association between type 1 and type 2 proteins and complex IV could potentially 
be related to differences in the amino acid composition of their respective QRRQ motifs.    
Finally, it was found that Rcf1 may form a homodimer and that the QRRQ motif 
might influence the formation, or stability of the Rcf1-Rcf1 dimer.  
Based on these findings, a model is proposed where Rcf1 transiently associates 
with complex IV to modify it, possibly its lipid composition, and by doing so, alters its 
enzymatic properties. 
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CHAPTER 4: CHARACTERIZATION OF THE MOLECULAR 
ENVIRONMENT OF RCF1 AND AAC 
 
4.1 Introduction 
 Mitochondria are dynamic eukaryotic organelles that operate within and respond 
to the metabolic context of the cell. Each of the mitochondrial processes, including the 
regulation of cellular Ca2+ flux, ROS homeostasis, the assembly of iron-sulfur clusters, 
and OXPHOS require a level of interconnectedness between mitochondria and the rest of 
the cell. Mitochondrial carriers are a family of proteins that connect the biochemical 
pathways of the mitochondrial matrix to those of the cytoplasm through the transport of 
amino acids, cofactors, fatty acids, keto acids, inorganic ions, and nucleotides across the 
mitochondrial membrane (Palmieri, 2013). 
 In the final steps of OXPHOS, the F1FO ATP-synthase utilizes the proton gradient 
generated by electron transport complexes to synthesize ATP from inorganic phosphate 
and ADP. This metabolically critical process relies on a sufficient ADP/ATP exchange 
carried out by the adenine nucleotide translocase, commonly referred to in yeast as the 
ADP/ATP carrier (AAC) (Gawaz et al., 1990; Klingenberg, 1989; Nury et al., 2006; 
Pebay-Peyroula and Brandolin, 2004). Under normal respiratory conditions the AAC 
protein imports ADP3- into the mitochondrial matrix and exports ATP4- into the cytosol 
for use in cellular functions. Under severe mitochondrial damage the reversal of the 
translocase facilitates the export of mitochondrial ADP and import of cytosolic ATP into 
the mitochondria, thereby maintaining the mitochondrial membrane potential and 
biosynthesis processes that are critical for cell viability (Chen, 1995; Chen and Clarke-
Walker, 1996; Giraud and Velours, 1997). The importance of AAC proteins in cellular 
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metabolism is underscored by the fact that the AAC protein accounts for nearly 10% of 
the total mitochondrial protein content, and is therefore considered the most abundant 
protein within the mitochondria (Brand, 2005).  
 A number of isoforms of AAC proteins have been identified in different 
organisms. The yeast Saccharomyces cerevisiae contains the ADP/ATP carrier (AAC), a 
homolog of AAC proteins and a classic member of the mitochondrial carrier family with 
an essential role in the translocation of adenine nucleotides across the mitochondrial 
membrane system (Klingenberg, 2008). Yeast contain 3 distinct AAC isoforms: Aac1, 
Aac2 and Aac3 (Kolarov et al., 1990; Lawson and Douglas, 1988; O'Malley et al., 1982). 
Aac2 is the primary isoform expressed in aerobically growing yeast, Aac3 is expressed 
largely in anaerobically growing yeast, and Aac1 is expressed at low levels regardless of 
oxygen availability (Gawaz et al., 1990; Kolarov et al., 1990; Lawson et al., 1990).  
 Encoded by nuclear DNA, AAC proteins are synthesized in the cytosol prior to 
being imported into the mitochondria and inserted in the inner membrane (Endres et al., 
1999; Pfanner et al., 1987; Ryan et al., 1999). AAC proteins have six transmembrane α 
helical domains (H1-H6) that span the inner mitochondrial membrane and form alpha 
helices, with short hydrophobic N- and C- terminal tails located in the intermembrane 
space (Pebay-Peyroula et al., 2003). Two specific inhibitors, carboxyatractyloside 
(CATR,AT) and bongkrekic acid (BA), have significantly aided functional analysis of 
AAC. AT binds to the IMS side of AAC locking the translocase in a cytosol-open state 
referred to as “c-state”, and BA binds to the matrix side locking AAC in a matrix-open 
state referred to as “m-state” (FIGURE 27) (Aquila et al., 1978; Brandolin et al., 1993; 
Riccio et al., 1975). The crystal structure of the yeast Aac2 protein bound to AT has been  
	 119	
 
	 120	
solved and structural and functional analyses support a domain-based alternating-access 
transport mechanism that underlies mitochondrial AAC function (Pebay-Peyroula et al., 
2003; Ruprecht et al., 2014). In short, AAC contains three domains that surround a 
central substrate-binding site. The rotation of these domains mediates the dynamic 
formation and disruption of interdomain salt bridge networks that regulate access to 
either side of the membrane, and allow equimolar nucleotide exchange between the 
cytosol and mitochondrial matrix (Ruprecht et al., 2014). The matrix salt bridge 
interactions are braced by highly conserved glutamine (Q) residues, that are located in a 
[K/R]-(X)3-[Q] motif, and serve as charged, integral components of the salt bridge. 
Specifically, the Q residues function to stabilize an otherwise dynamic region of AAC by 
increasing the magnitude of the energy barrier, thereby preventing conversion to the 
matrix-open conformation in the absence of substrate binding (Ruprecht et al., 2014). A 
similar salt bridge network, found in the IMS region of AAC, stabilizes the IMS-closed 
conformation state during the dynamic ADP/ATP translocation cycle. The formation and 
disruption of IMS-localized salt bridge networks result in dynamic conformational 
changes within the IMS-exposed, H2-L-H3 (helix2-loop-helix3) region of AAC, and 
result in the subsequent opening and closing of the channel (FIGURE 28). While the 
importance of salt bridge networks and Q braces (in the matrix) for supporting AAC in its 
“closed” conformational states has been shown, it is unclear how the respective “open” 
states of AAC are stabilized. 
 Yeast Aac2 has been shown to physically interact with the translocase of the inner 
mitochondrial membrane complex (TIM23), and the complex III-complex IV  
 
	 121	
 
Figure 28. The yeast ADP/ATP carrier, Aac2.  The Aac2 protein contains 
6 transmembrane helices (H1-H6) that comprise 3 domains. The rotation of 
the Aac2 domains mediates the dynamic formation and disruprion of cyto-
plasmic salt-bridge networks that support equimolar nucleotide transport 
across the inner mitochondrial membrane, and matrix-localized salt-bridges 
are stabilized by highly conserved Q residues. Image from Ruprecht et al,. 
2014. 
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supercomplex and associated TIM23 (Dienhart and Stuart, 2008). Additionally, it was 
shown that the loss of Aac2 results in changes in the supercomplex assembly state, with a 
shift from the III2-IV2 form to the III2-IV form. These changes were hypothesized to be 
due to limiting levels of complex IV, which were also reduced in the absence of Aac2. 
These results suggest that AAC does not exist in isolation in the mitochondrial inner 
membrane, but is rather physically and, possibly functionally, associated with other 
respiratory proteins and complexes to facilitate the transport of ADP and ATP. The 
current model of AAC function is heavily dependent upon dynamic structural flexibility. 
Therefore, molecular interactions between AAC and nearby proteins might influence the 
activity of the carrier. Furthermore, it can be inferred that any such changes could have 
consequences for mitochondrial energy production and cellular metabolic activity. 
 Rcf1 has previously been shown to physically associate with respiratory 
supercomplexes, including the complex III- complex IV – AAC supercomplex, (III-IV-
AAC). 2-dimension BN/SDS-PAGE analysis of mitochondrial respiratory 
supercomplexes showed that AAC and Rcf1 are components of III-IV respiratory 
supercomplexes (Dienhart and Stuart, 2008; Strogolova et al., 2012). Affinity purification 
of III-IV-AAC using histidine (His)-tagged complex III and AAC derivatives, 
cytochrome c1His or HisAAC, both resulted in the co-purification of Rcf1 (Strogolova et 
al., 2012). In an independent study, the two-step purification of Rcf1-His6 /HA3 resulted 
in the co-purification of AAC (Chen et al., 2012). Additionally, Rcf1 and AAC proteins 
have been shown to exist in close physical proximity within the inner mitochondrial 
membrane. MBS can facilitate the conjugation of wild type and his-tagged derivatives of 
Rcf1 and AAC (Strogolova et al., 2012). This partnership was enhanced in [rho0] 
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(mtDNA-deficient) mitochondria where the co-assembly of Rcf1 with the complex III-
complex IV supercomplex is abolished, as neither complex III or complex IV assemble in 
the absence of mtDNA. It was subsequently demonstrated that the ability of Rcf1 to form 
the 45 kDa crosslinking adduct was lost in a mutant where the most prominent isoform of 
AAC (Aac2) had been genetically deleted (Δaac2 mutant). The Rcf1-AAC interaction 
was restored when HisAac2 was expressed in the Δaac2 mutant, and again enhanced in a 
[rho0] Δaac2 mutant expressing HisAac2. Likewise, in a Δaac1 Δaac2 double mutant Rcf1 
lost the ability to form the 45 kDa adduct and the expression of Aac1His or Aac3His under 
the control of a galactose-inducible promoter (GAL10) restored the adduct and changed 
the size; to a slightly larger form when Aac1His was expressed and to a slightly smaller 
form when Aac3His was expressed (Strogolova et al., 2012). It was therefore concluded 
that the 45 kDa Rcf1 –containing adduct was Rcf1 cross-linked to AAC. However, the 
formation of the purported Rcf1His-AAC cross-linked adducts could be detected by 
western blotting and immunedecoration using either Rcf1 or His antisera, but was not 
detected by immunedecoration using an AAC-specific antibody (Stuart lab unpublished 
results). Thus, the validity of the Rcf1-AAC crosslink, i.e. that AAC is truly a partner to 
Rcf1, requires further characterization, ideally by an alternative methodology. This 
independent validation of the Rcf1-AAC adduct was an initial goal of this study. 
 In the previous chapter of this dissertation, results were presented that support a 
hypothesized role of Rcf1/Hig1 in regulating complex IV activity in response to 
metabolic changes. However, the relationship between Rcf1 and AAC is much less 
understood, and a number of fundamental aspects of the Rcf1-AAC interaction remain 
uncharacterized. Therefore, the 2 main aims of this chapter were to (1) characterize Hig1 
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family conserved regions of the Rcf1 protein in their ability affect the interaction between 
Rcf1 and AAC, and (2) determine whether dynamic conformational changes and/or 
structural characteristics of the AAC protein influence the relationship between AAC and 
Rcf1. 
 In characterizing the Rcf1-AAC interaction using a C-terminal deletion mutant of 
Rcf1, it was shown that the Hig1 domain of Rcf1 and not the fungal-specific C-terminal 
domain is important for the ability of Rcf1 to associate with AAC proteins (Strogolova et 
al., 2012). Furthermore, in mitochondria harboring an Aac2 derivative, aac2A113C (where 
A113, located in the IMS-localized H2-L-H3 domain of Aac2, has been exchanged for 
Cys), disulfide bond formation between Rcf1 and aac2A113C could be promoted by 5,5-
dithio-bis-(2-nitrobenzoic acid (DTNB, Ellman’s reagent). Rcf1 contains just 2 Cys 
residues, C28 and C38, that are located in the IMS and TM1 region of the Rcf1 protein 
(Figure 4), and wild type Aac2 contains 4 Cys residues that are located in matrix or TM 
regions of the AAC protein. Therefore, the DNTB-facilitated disulfide bond formation 
between the aac2A113C derivative and Rcf1 demonstrates that the N-terminal IMS region 
of Rcf1 exists in close physical proximity to the H2-L-H3 domain of the AAC protein. 
Mitochondrial Rcf1/Hig1 proteins contain a [P32]-X-[V34]-[P35]-X-[G37] (S.c. Rcf1 
numbering) motif located at the N-terminal tail region near the IMS/TM1 interface that is 
conserved specifically among mitochondrial Hig1 proteins, i.e. the [P]-X-[V]-[P]-X-[G] 
motif is not a feature of prokaryotic Hig1 proteins, where AAC is also absent. In the Rcf1 
protein, the [P]-X-[V]-[P]-X-[G] motif is flanked by 2 cysteines, C28 (Rcf1-specific) and 
C38 (conserved among mammalian Hig1-type2), and at least one of these cysteines can 
be cross-linked to AAC proteins. A recently published NMR structure of the human 
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Hig1-type1 protein indicates that the N-terminal tail of Hig1 proteins contain a short 
amphiphilic helix that is oriented parallel to the surface of the membrane (Lindert et al., 
2014). The analogous region in the yeast Rcf1 protein would be comprised of amino acid 
residues F20-Y26, encompassing a region that is in close proximity to the cysteines of 
Rcf1 that have been shown to interact with the H2-L-H3 domain of AAC. Thus, the 
proline and glycine residues within the [P]-X-[V]-[P]-X-[G]  motif potentially provide a 
level of conformational flexibility that might affect the association of the putative N-tail 
amphiphilic helix of Rcf1 with the H2-L-H3 domain of AAC. Therefore, the potential 
influence of the Rcf1/Hig1 [P]-X-[V]-[P]-X-[G]  motif and flanking cysteine residues on 
the interaction between Rcf1 and AAC was explored here.  
 The Hig1/Rcf1 conserved QRRQ motif, by its putative location within the matrix 
loop of the Rcf1 protein, represents a potential point of interaction between Rcf1 and 
AAC. Moreover, Rcf1 Q61 and Q71 each form Q/R pairs, seen in a helical wheel plot of 
the Rcf1 amino acids that comprise the matrix loop of the Rcf1 protein (FIGURE 16A), 
that are separated by 3 residues i.e. [Q61]-(X)3-[R65] and [R67]-(X)3-[Q71], and closely 
resemble the salt-bridge bracing Q residues of the AAC [K/R]-(X)3-[Q] motif. However, 
the ability of the Rcf1 QRRQ motif to directly interact with AAC, or possibly influence 
the interaction between Rcf1 and AAC, has not been characterized. Of particular interest 
is the possible role of conserved Q residues (Q61 and/or Q71) of the Hig1/Rcf1 QRRQ 
motif in supporting the m-state conformation of AAC by bracing the matrix-localized 
residues of AAC that participate in salt bridge formation. The molecular environment of 
the Rcf1 QRRQ motif and its relationship to the functional state of the AAC protein will 
be explored in this chapter.   
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 The H2-L-H3 domain forms a structurally dynamic gating region within AAC, 
and the conformational flexibility of this region is critical for transport activity of the 
carrier. Additionally, the H2-L-H3 region has been shown to affect the transport of H+ 
across the inner mitochondrial membrane by AAC, i.e. the H2-L-H3 domain of AAC 
could significantly contribute to H+ leak across the membrane, thereby demonstrating that 
this domain can influence the mitochondrial membrane potential, and thus, membrane 
potential dependent mitochondrial functions. In agreement with its importance for AAC 
function, the H2-L-H3 region of AAC is the site of a number of pathogenic mutations 
that have been proposed to dominantly uncouple respiration. Therefore, the interaction 
between Rcf1 and a functionally critical, pathogenically relevant region of AAC could 
potentially influence the activity of the carrier under different mitochondrial energetic 
states. In support of this prediction, preliminary results from the Stuart lab suggest that 
the interaction between Rcf1 and AAC may be dependent upon the conformational state 
of the carrier. When disulfide bond formation was tested in the presence of specific 
inhibitors of AAC, it was found that AT (which locks AAC into c-state with the substrate 
binding site accessible to the IMS), but not BA (locks AAC into m-state with the 
substrate binding site accessible to the matrix), adversely affected disulfide bond 
formation between the aac2A113C derivative and Rcf1. It is unknown whether the 
conformational state -dependent interaction between Rcf1 and the aac2A113C derivative 
exists between Rcf1 and wild-type AAC, i.e. via MBS chemical cross-linking. Therefore, 
specific inhibitors of AAC were utilized to determine whether the conformation of AAC 
influences formation of the Rcf1-AAC cross-link adduct. Determining whether the 
formation of the Rcf1-AAC cross-linked adduct occurs preferentially in one AAC 
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conformational state over the other, i.e. the c-state (substrate binding site accessible to the 
IMS) or m-state (substrate binding site accessible to the mitochondrial matrix), could 
shed light on the functional significance of the Rcf1-AAC interaction, and may provide 
insight into whether Rcf1 could stabilize AAC in a particular state (matrix open or IMS 
open).  
 The proposed Rcf1-AAC interaction can occur independent of assembled 
complex IV (or complex III), seen in the enhanced level of Rcf1-AAC crosslinking in the 
absence of mitochondrial DNA in rho0 mitochondria (Strogolova et al., 2012). The 
observed cross-linking of Rcf1 to AAC in rho0 mitochondria indicates that these two 
proteins may interact independently of their association with the III-IV supercomplex. 
Given the interactions between Rcf1 and both complex IV and AAC, Rcf1 might be 
centrally positioned to function in the communication between AAC and IV/III-IV, 
thereby providing a level of regulation to coordinate the activity of these two critical 
OXPHOS enzymes in response to the metabolic need of the cell. However, it is not 
known whether the dynamic conformational changes in AAC that are associated with an 
increase in its activity level, i.e. during state 3 respiration where the presence of 
exogenously supplied ADP in the presence of substrate (NADH) increases the level of 
adenine nucleotide transport, affects the ability of Rcf1 to be cross-linked to AAC. It was 
therefore addressed in this study whether the Rcf1-AAC interaction could be modulated 
through alterations in the bioenergetic status of the mitochondria. 
 AAC contains 3 bound cardiolipin molecules that have been shown to be required 
for transport in reconstituted vesicles (Klingenberg, 2009). It is unknown however, 
whether the presence of cardiolipin, a proposed structural and functional component of 
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AAC, influences the interaction between Rcf1 and AAC. It was therefore addressed in 
this chapter whether the absence of cardiolipin affects the ability of Rcf1 and AAC to be 
cross-linked.  
 In wild-type mitochondria, AAC has been reported to form a digitonin-stable 
dimer that migrates to approximately 80 kDa on a blue native gel (Ryan et al., 1999). In 
contrast, in mitochondria that are deficient in cardiolipin synthesis (i.e. the Δcrd1 
mutant), AAC BN-PAGE mobility is altered, and migrates to a position below 80 kDa 
(Jiang et al., 2000). The authors of the latter study attribute the AAC mobility shift in the 
Δcrd1 mutant to the absence of bound cardiolipin, and propose that AAC in the Δcrd1 
mutant exists in a sub-optimally folded conformation, thereby resulting in altered BN-
PAGE mobility. It is not known whether the presence of Rcf1 (or Rcf2) affects the native 
gel mobility of AAC and this will be explored in this chapter.  
 This chapter details the characterization of the Rcf1-AAC interaction. The 
primary focus of the experiments herein was to answer specific questions underlying the 
basis of the Rcf1 -AAC interaction. The aim of these experiments was to analyze the 
functional relationship between Rcf1 and AAC by characterizing the role of conserved 
regions of the Rcf1 protein in the Rcf1-AAC interaction, and also by examining whether 
conformational dynamics or structural characteristics of AAC influence the molecular 
environment of Rcf1 and AAC.     
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4.2 Chapter 4 Results 
4.2.1 Independent Verification of the Rcf1His-AAC MBS Cross-link Via  
 LC-MS/MS 
 
  
 The relationship between Rcf1 and AAC is not fully understood; therefore one of 
the aims of this dissertation was to characterize the molecular interaction and potential 
functional relationship between Rcf1 and AAC.  
 The close proximity between Rcf1 and AAC was initially discovered through 
chemical cross-linking analysis, where MBS appeared to facilitate the conjugation of 
wild type and his-tagged derivatives of Rcf1 and all three isoforms of AAC (Strogolova 
et al., 2012). While the 45 kDa adduct could be detected using Rcf1 or His antisera, it 
was not detected when the AAC antibody was used. Thus, theoretically it remained a 
possibility that the 45 kDa adduct does not actually represent Rcf1 cross-linked to AAC, 
but rather, that the ability of Rcf1 to be cross-linked to a different (unidentified) protein 
and form the 45 kDa adduct, is contingent upon the presence of AAC. An initial goal 
therefore was to verify that the MBS adduct truly represented a partnership between Rcf1 
and AAC.  
 To determine the composition of the MBS-dependent 45 kDa adduct containing 
Rcf1, crosslinking was performed in mitochondria isolated from the Δrcf1,Δrcf2 double 
mutant harboring His-tagged Rcf1 in parallel with a Δrcf1,Δrcf2 double mutant control. 
Following cross-linking, mitochondria were solubilized using buffer containing Triton X-
100 and Rcf1His –containing adducts were purified by Ni-NTA affinity chromatography, 
and separated on a gel by SDS-PAGE. The purified 45 kDa adduct that contained Rcf1His 
	 130	
was visualized by silver staining, excised and subjected to LC-MS/MS by our 
collaborator Dr. Kate Noon at the Medical College of Wisconsin Mass Spectrometry 
Facility. False positives were eliminated from the resulting data set by comparing the LC-
MS/MS spectra of the Δrcf1,Δrcf2 + Rcf1His to that of the Δrcf1,Δrcf2 double mutant. The 
two most abundant proteins within the excised 45 kDa crosslinking adduct were Aac2 
and Rcf1.  
 It can therefore be concluded that Rcf1 is cross-linked to Aac2 via MBS, 
independently verifying that Rcf1 and Aac2 exist in close proximity within the inner 
mitochondrial membrane. 
4.2.2 Characterization of N-terminal amino acid residues of Rcf1 and their 
 influence on the molecular environment of Rcf1 and AAC       
 
 The highly conserved Rcf1/Hig1 PXVPXG motif represents a potential point of 
interaction between Rcf1 and AAC. At least one of two cysteine residues (C28 and C38) 
that flank this region can be crosslinked to AAC, and the proline residues (and possibly 
the glycine) that comprise the PXVPXG motif may be a conformational feature that 
would allow a dynamic interaction between Rcf1 and AAC that may be dependent upon 
the bioenergetic state of the mitochondria. 
 Mutational analysis of the PXVPXG motif of Rcf1 was performed in part, 
through a collaboration with students in the upper level Experimental Molecular Biology 
course at Marquette University, taught by Dr. Ben Kemp. Students created and analyzed 
Rcf1 PXVPXG mutants, where conserved residues of the PXVPXG motif were 
individually mutated to alanine. One student, Hanting Tsai, subsequently joined the 
Stuart lab and continued the project under the joint supervision of Dr. Rosemary Stuart 
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and myself. Thus, the growth analysis and MBS cross-linking results of the rcf1HisP32A 
and rcf1HisP35A mutant derivatives represent experiments completed by Hanting Tsai. 
 To determine whether the conserved prolines P32 and P35 of the PXVPXG motif 
of Rcf1 support the Rcf1-AAC interaction, MBS crosslinking was performed in isolated 
Δrcf1;Δrcf2 mitochondria harboring rcf1HisP32A or rcf1HisP35A mutant derivatives, and 
analyzed by SDS-PAGE and immunedecoration with Rcf1 antisera (FIGURE 29A). Both 
the rcf1HisP32A and rcf1HisP35A derivatives maintained the ability to be cross-linked to AAC 
as evidenced by the presence of the 45 kDa Rcf1 adduct which was detected in the 
mutant mitochondria at a similar level to that in the wild type Rcf1His control. Thus, it 
was concluded that P32 and P35 of the conserved Rcf1 PXVPXG motif, are not required 
for the interaction between Rcf1 and AAC 
 Rcf1 cysteines C28 and C38 flank the PXVPXG motif and have been shown to 
participate in DTNB-facilitated disulfide bond formation between Rcf1 and the aac2A113C 
derivative. As the only cysteine residues within the Rcf1 polypeptide, C28 and C38 
represent the only residues of Rcf1 that could participate in the observed SH-SH disulfide 
bond with AAC. It was therefore concluded that Rcf1 C28 and C38 and thus, the N-tail of 
the Rcf1 protein, is in close proximity to the functionally relevant H2-L-H3 domain of 
AAC. Here, the importance of the Rcf1 N-tail cysteines in supporting the Rcf1-AAC 
interaction was further analyzed.  
 Rcf1 C28 and C38 were simultaneously mutated to alanine, and the resulting 
rcf1HisC28A C38A mutant derivative was expressed in Δrcf1;Δrcf2 mitochondria. First, it was 
tested whether Rcf1 C28 and C38 were required for the cross-linking of Rcf1 and AAC 
through the heterobifunctional (SH-NH3) cross-linking reagent MBS, i.e. whether C28  
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Figure 29. Rcf1 cysteine residues influence the molecular environment 
of Rcf1 and AAC. (A) Chemical cross-linking (MBS) was performed on mito-
chondria isolated from the ǻrcf1ǻrcf2 control (-) and 
ǻrcf1ǻrcf2 strains harboring the Rcf1His, rcf1HisP32A (P32A), or rcf1HisP35A (P35A) 
derivatives, as indicated. Following SDS-PAGE, and Western blotting, 
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positions of the Rcf1-AAC adduct, and monomeric Rcf1 are indicated. (B) 
Chemical cross-linking (MBS) was performed on mitochondria isolated from 
the ǻrcf1ǻrcf2 (-) and ǻaac2 controls and the ǻrcf1ǻrcf2 strain harboring the 
Rcf1His or rcf1His
C28A C38A (C28A C38A) derivatives, as indicated. SDS-PAGE, 
Western blotting and immunedecoration was performed as in (A). (C) Chemi-
cal cross-linking (DFDNB) was performed as in (B) in the indicated strains, 
and analyzed as in (B).  
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and/or C38 represent the sole sulfhydryl components of the MBS-facilitated Rcf1-AAC 
cross-link. MBS crosslinking was performed in isolated Δrcf1;Δrcf2 mitochondria 
harboring the rcf1HisC28A,C38A mutant derivative, and analyzed by SDS-PAGE and 
immunedecoration with Rcf1 antisera (FIGURE 29B). A 45 kDa Rcf1 adduct, i.e. Rcf1 
cross-linked to AAC, was observed in the wild type control, but was not detected in 
rcf1HisC28A,C38A mitochondria. Therefore it was concluded that Rcf1 C28 and C38 are 
required for the crosslinking of Rcf1 to AAC by the SH-NH3 cross-linking reagent MBS, 
and thus, that C28 and/or C38 represent the sulfhydryl component of the MBS-facilitated 
Rcf1-AAC cross-link. 
 Next, to determine whether Rcf1 C28 and C38 influence the molecular 
environment of Rcf1 and AAC, crosslinking was performed using the amine-amine 
homobifunctional crosslinking reagent, 1,5-difluro-2-4 dinitrobenzene (DFDNB). 
DFDNB facilitates the cross-linking of two proteins through amine groups on either 
protein partner, and thus does not rely on the direct participation of cysteines to cross-link 
two proteins. Therefore, the use of DFDNB as a cross-linking reagent provides a means 
to determine whether Rcf1 C28 and C38 influence the amine-amine crosslinking between 
Rcf1 and AAC, and thus the molecular environment of Rcf1 and AAC. Crosslinking was 
performed using DFDNB and analyzed by SDS-PAGE and immunedecoration with Rcf1 
antisera (FIGURE 29C). A DFDNB-specific 45 kDa adduct, i.e. Rcf1 cross-linked to 
AAC, was observed in wild type Rcf1His mitochondria and was absent in mitochondria 
deficient in Aac2 (Δaac2). In contrast to wild type Rcf1His, a strong reduction of the 45 
kDa Rcf1-AAC adduct was observed in rcf1HisC28A C38A mitochondria.  
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These results demonstrate that Rcf1 C28 and/or C38 directly participate in an 
MBS facilitated SH-NH3 cross-link between Rcf1 and AAC, and additionally influence 
the ability of Rcf1 to be cross-linked to AAC via DFDNB facilitated NH3-NH3 
conjugation. Thus, it can be concluded that C28 and C38, located in the N-tail of Rcf1 
and predicted to reside adjacent to the IMS-membrane interface near the functionally 
relevant H2-L-H3 domain of AAC, impact the molecular environment of Rcf1 and AAC.   
4.2.3 The integrity of the Rcf1 QRRQ motif alters the molecular interaction 
 between Rcf1 and AAC 
 
  
 To probe the consequence of mutation of the QRRQ motif on the molecular 
environment of Rcf1 and AAC, an MBS chemical cross-linking approach was adopted. 
Cross-linking was performed in isolated mitochondria harboring the Rcf1 derivatives and 
subsequently analyzed by SDS-PAGE and immunedecoration with Rcf1 antisera and the 
ability of Rcf1 derivatives to form the AAC 45 kDa adduct was analyzed (FIGURE 30A). 
Formation of the 45 kDa Rcf1-AAC adduct was observed in rcf1HisQ61A,Q71A mitochondria 
to a similar level as the 45 kDa Rcf1-AAC adduct in wild type Rcf1His mitochondria, 
indicating the rcf1HisQ61A,Q71A mutant derivative maintained the ability to be cross-linked 
to AAC. On the other hand, cross-linking between rcf1HisR67A and AAC was markedly 
reduced, despite normal levels of Rcf1 and AAC in these mitochondria (FIGURE 9A). 
This observation suggests that the mutation of R67 to alanine interfered with Rcf1’s 
association with the AAC protein.  
 Given that the mutation of Rcf1 R67 to alanine affected the molecular 
environment of Rcf1 and AAC, charge-altering Rcf1 R67 mutant derivatives (R67Q,  
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Figure 30. Rcf1 R67 influences the molecular environment of Rcf1 and 
AAC. (A) Chemical cross-linking (MBS) was performed on mitochondria 
isolated from the ǻrcf1ǻrcf2 control (-) and ǻrcf1ǻrcf2 strains harboring the 
Rcf1His, rcf1His
Q61A,Q71A (Q61A Q71A), or rcf1His
R67A (R67A) derivatives, as indicat-
ed. Following SDS-PAGE, and Western blotting, immunedecoration with the 
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was performed on mitochondria isolated from the ǻrcf1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R67H, R67K, R67E) were next examined in their ability to associate with AAC. Charge-
altering Rcf1 R67 mutant derivatives were examined in their ability to form the 45 kDa 
Rcf1-AAC adduct by MBS cross-linking, and analyzed by SDS-PAGE and 
immunedecoration with Rcf1 (anti-His) antiserum (FIGURE 30B). The 45 kDa Rcf1-
AAC adduct was observed in wild type Rcf1His mitochondria and in each of the charge-
altering Rcf1 R67 mutant mitochondria, in contrast to R67A, where a reduction in 
crosslinking to AAC was consistently observed (FIGURE 30B).   
 These results suggest that Rcf1 R67, a signature QRRQ motif residue that is 
highly conserved among Hig1 proteins, influences the association between Rcf1 and 
AAC, and in a manner that appears to be independent of the protonation state of R67.  
4.2.4 The Bio-Energetic State of the Mitochondria Influences the Ability of Rcf1 
 and AAC Proteins to be Cross-linked 
 
 
 In isolated mitochondria, in the absence of substrate for the electron transport 
chain and exogenously added nucleotides (ADP/ATP), it is presumed that the structure of 
AAC is static, and under these conditions Rcf1 can be cross-linked to AAC by MBS. 
However, it is not known whether a conformationally dynamic AAC, as predicted to exist 
under different mitochondrial bioenergetic states, affects the interaction between Rcf1 
and AAC, as judged by its ability to form an MBS facilitated adduct with Rcf1. 
 To determine whether the mitochondrial bioenergetic state influences the ability 
of Rcf1 to be chemically cross-linked to AAC, cross-linking was performed in 
Δrcf1;Δrcf2 mitochondria harboring Rcf1His during state 4 and state 3 respiration. 
Isolated mitochondria were incubated in the presence of NADH alone (state 4), or with 
NADH and ADP (state 3) and crosslinking was subsequently performed with MBS. 
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Mitochondria were re-isolated and analyzed by SDS-PAGE and western blotting using 
Rcf1 antisera (FIGURE 31). Formation of the Rcf1-AAC adduct was observed in state 4 
respiration, and at a level that was similar to crosslinking in the absence of substrate. In 
contrast, crosslinking between Rcf1 and AAC was lost when state 3 respiration was 
induced. From these results it can be concluded that the bioenergetic state of the 
mitochondria affects the ability of Rcf1 to be cross-linked to AAC, whereby a higher 
bioenergetic state that confers AAC that is dynamic in conformation, results in the loss of 
interaction between Rcf1 and AAC. Furthermore, these results suggest that the Rcf1-
AAC interaction captured by MBS cross-linking might be influenced by the 
conformation of AAC.  
4.2.5 The ability of Rcf1 to be cross-linked to AAC is dependent upon the 
 conformational state of AAC 
 
 
 Determining that the bioenergetic state of the mitochondria influences the ability 
of Rcf1 to be cross-linked to AAC was an important step towards characterizing a 
potential dynamic relationship between Rcf1 and AAC. However, it remained unclear 
whether a specific conformational state of AAC confers the ability to form the Rcf1-AAC 
cross-linked adduct.  
 To determine whether the ability of Rcf1 to be cross-linked to AAC is dependent 
upon the conformation of AAC, MBS cross-linking was performed in isolated wild type 
mitochondria during state 4 respiration in the presence of the specific inhibitors AT 
(which locks AAC in the cytosol open ‘c-state’) or B.A., (which locks AAC in the matrix 
open ‘m-state’)(FIGURE 27). Mitochondria were re-isolated and analyzed by SDS-
PAGE and western blotting using Rcf1 antisera (FIGURE 32). When inhibitor was added  
	 138	
 
_His
Figure 31. The bio-energetic state of the mitochondria influences the 
ability of Rcf1 AAC proteins to be cross-linked. Chemical cross-linking 
(MBS) was performed on mitochondria isolated from the ǻrcf1ǻrcf2 strain 
harboring the Rcf1His derivative. Prior to the addition of MBS, mitochondria 
were incubated in NADH (state 4), NADH followed by ADP (state 3) , or not, 
as indicated. Following SDS-PAGE, and Western blotting, immunedecoration 
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Figure 32. The ability to cross-link Rcf1 and AAC is dependent upon 
the  structural conformation of the AAC protein. Chemical cross-linking 
(MBS) was performed on mitochondria isolated from the ǻUFIǻUFI strain 
harboring the Rcf1His derivative. Prior to the addition of MBS, mitochondria 
were incubated in ADP, ATP, or  NADH and atractyloside (AT), or bongkrekic 
acid (B.A.) as indicated. Following SDS-PAGE, and Western blotting, immune-
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the Rcf1-AAC adduct, and monomeric Rcf1 are indicated. 
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to mitochondria in state 4 respiration, formation of the 45 kDa Rcf1-AAC adduct was 
observed when AAC was locked in the m-state i.e. in the presence of BA, but was 
abolished when AAC was locked in the c-state by AT. In contrast, the ability of Rcf1 to 
form a 40 kDa Rcf1-Rcf1 homodimer was unaffected by the conformation of AAC, as 
evidenced by detection of equal levels of the Rcf1-Rcf1 homodimer in the presence and 
absence of AAC inhibitors AT and B.A., and supports that the altered molecular 
environment of Rcf1 in the presence of AT is specific for the Rcf1-AAC interaction.  
 These results suggest that the ability of Rcf1 to be cross-linked to AAC via MBS 
is dependent upon the structural conformation of AAC, whereby AAC with its channel 
open to the mitochondrial matrix can be cross-linked to Rcf1, and AAC with its channel 
open to the IMS (cytosol) cannot be cross-linked to Rcf1. The IMS exposed H2-L-H3 
region of AAC has been shown to undergo significant conformational changes in 
response to the dynamic remodeling of the transport-regulating cytosolic salt-bridge 
network of AAC during the ADP/ATP transport cycle (Ruprecht et al., 2014). The H2-L-
H3 region of AAC has been shown to interact with C28 and/or C38 of the N-tail of Rcf1, 
a region of Hig1 proteins that has been modeled to be oriented parallel to the surface of 
the membrane (Lindert et al., 2014). Thus, the conformation-dependent ability to cross-
link Rcf1 and AAC via MBS, might reflect a functional role for Rcf1 in its interaction 
with AAC. 
4.2.6 The molecular environment of Rcf1 and AAC is altered in the absence of 
 cardiolipin 
 
  
 Cardiolipin has been shown to bind tightly to AAC where it is important, but not 
essential for AAC function (Beyer and Klingenberg, 1985; Brandolin et al., 1980; Jiang 
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et al., 1997; Kramer and Klingenberg, 1980; Ruprecht et al., 2014). A possible role for 
the Rcf1 protein in the insertion/remodeling of cardiolipin associated with complex IV 
proteins was supported by results from the characterization of the Rcf1 QRRQ motif, and 
in particular, the Rcf1 R67A mutant (reported in Chapter 3 of this dissertation). 
Consistent with the important role of R67 in the molecular interactions of Rcf1, as 
previously shown between Rcf1 and Cox3/complex IV, R67 was found to influence the 
association of Rcf1 with AAC (FIGURE 30A,B). Therefore, the relationship between 
Rcf1 and AAC was analyzed in the absence of cardiolipin. 
 To determine whether the association between Rcf1 and AAC is affected by the 
absence of cardiolipin, MBS cross-linking of the Rcf1 protein was performed in 
mitochondria isolated from mutants displaying defective cardiolipin biosynthesis, such as 
the cardiolipin synthase mutant, Δcrd1, and the Tam41 null mutant, Δtam41 (FIGURE 
33). Tam41 is a CDP-diacylglycerol synthase required for cardiolipin biosynthesis in 
mitochondria and thus like Δcrd1, Δtam41 mitochondria are deficient in cardiolipin 
(Tamura et al., 2013). When analyzed in parallel to wild type mitochondria, a complete 
loss of Rcf1-AAC formation was observed in Δtam41 mitochondria, and a partial loss of 
Rcf1-AAC formation was observed in Δcrd1 mitochondria. The level of Rcf1-AAC 
reduction in Δcrd1 and Δtam41 mitochondria was similar to that observed in Rcf1 R67A 
mutant mitochondria, which was analyzed in parallel (not shown).  
 The altered environment of Rcf1 with respect to AAC proteins in cardiolipin-
deficient mitochondria mirrors that of the rcf1HisR67A protein, and further supports a role 
of Rcf1 in the lipid modification of partner proteins, including AAC. 
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Figure 33. The molecular environment of Rcf1 and AAC is altered in 
the absence of cardiolipin. Chemical cross-linking (MBS) was performed on 
mitochondria isolated from the wild type (WT) and ǻaac1ǻaac2 controls and 
the ǻcrd1 and ǻtam41 mutant strains, as indicated. Following SDS-PAGE, and 
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4.2.7 The native gel mobility of AAC is influenced by the presence of Rcf1 and 
 Rcf2  
 
 
 The absence of cardiolipin synthase (CRD1) has been shown to result in the 
altered native gel migration of AAC, and the authors of this study speculate that the AAC 
mobility shift in Δcrd1 mitochondria is the result of a conformational change in AAC that 
is attributed to the absence of bound cardiolipin (Jiang et al., 2000). Evidence has been 
presented in chapter 3 of this dissertation that supports a role of Rcf1/Hig1 proteins in 
modifying complex IV, possibly its lipid composition, in a manner that alters the 
structure of the enzyme.   
 To determine whether Rcf1 (and/or Rcf2) influence the native gel mobility of 
AAC similar to the reported gel mobility shift in Δcrd1 mitochondria, mitochondria were 
subjected to BN-PAGE following solubilization in digitonin-containing buffer, and AAC 
was detected by western blot analysis using AAC antisera (FIGURE 34). The mobility of 
AAC in Rcf1, Rcf2 and double null Δrcf1;Δrcf2 mitochondria was directly compared to 
AAC from wild-type mitochondria, which was calculated to migrate to approximately 80 
kDa. Compared to AAC from wild type mitochondria, AAC from the Δcrd1 mutant 
displayed an increased mobility, similar to the results published by Jiang and colleagues, 
while no AAC band was detected at or below 80 kDa in Δaac2 mitochondria (analyzed 
separately, not shown) (Jiang et al., 2000).  In the Δrcf1,Δrcf2 double mutant the 
detection of AAC was greatly diminished. The levels of AAC are not reduced in 
Δrcf1,Δrcf2 or Δcrd1 mitochondria compared to wild type, as evidenced by SDS-PAGE 
analysis (FIGURE 9A, Δcrd1 not shown). However, the ability to detect AAC by the 
antibody following BN-PAGE in Δrcf1,Δrcf2 and Δcrd1 mitochondria is significantly  
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Figure 34. The native gel mobility of AAC is altered in the 
absence of Rcf1 and Rcf2. Mitochondria isolated from wild type (WT) 
and ǻcrd1 controls, and the ǻrcf1, ǻrcf2, or ǻrcf1ǻrcf2 mutant strains 
were solubilized in digitonin (1%) and subjected to BN-PAGE analysis, 
Western blotting and immunedecoration with antibodies against AAC 
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reduced. Thus, it could be speculated that the altered detection of AAC in the absence of 
Rcf1 (and Rcf2) or cardiolipin may be due to an altered AAC native structure that 
reduces accessibility to the epitope by the AAC antibody. The very small amount of AAC 
that was detected in the Δrcf1;Δrcf2 double mutant displayed an increase in mobility, 
however the extent of the mobility shift was not as large as observed in the Δcrd1 mutant. 
AAC in the single Δrcf2 mutant displayed a mobility shift equal to that of the double 
mutant. In contrast, AAC from Δrcf1 mutant mitochondria did not display a significant 
shift in mobility compared to wild-type AAC.  
 From these results it can be concluded that the absence of Rcf2, and not Rcf1, 
results in a BN-PAGE mobility shift in AAC. However, the BN-PAGE mobility shift in 
the Δrcf1;Δrcf2 double mutant and single Δrcf2 mutant, was not equal to the shift 
observed in the Δcrd1 mitochondria, and therefore is not likely to represent a complete 
absence of cardiolipin assembled with AAC, as in the Δcrd1 mitochondria.   
4.3 Chapter 4 Summary 
In summary, these results provide further characterization of the molecular 
environment of Rcf1 and AAC and in particular, the molecular, bioenergetic and 
conformational factors that influence the Rcf1-AAC relationship. The identity of the 
previously identified Rcf1-AAC cross-link adduct was independently verified by 
combining MBS cross-linking and Ni-NTA chromatography with LC-MS/MS. 
 Two regions of the Rcf1 protein that are highly conserved among the Hig1 family 
were analyzed in their ability to influence the molecular environment of Rcf1 and AAC. 
First the N-tail region of Rcf1 was analyzed and it was concluded that the mutation of 
prolines P32 and P35 in the conserved Rcf1 PXVPXG motif do not adversely affect cross-
	 146	
linking between Rcf1 and AAC. However, in addition to being required for the ability of 
Rcf1 to cross-link to the functionally relevant H2-L-H3 domain of AAC via MBS, Rcf1 
Cys residues C28 and C38 were found to influence the NH3-NH3 cross-linking between 
Rcf1 and AAC by DFDNB. Analysis of the Hig1 QRRQ motif of Rcf1 indicates that 
arginine residues, R65 and R67 support the ability of Rcf1 to be cross-linked to AAC via 
MBS, whereas the mutation of glutamine residues Q61 and Q71 to alanine appear to be 
dispensable in influencing the molecular environment between Rcf1 and AAC.  
 Together, these results suggest that two different regions of the Rcf1 protein, one 
predicted to be located on the IMS side of the IMM and the other on the matrix side of 
the IMM, each can influence the molecular environment between Rcf1 and AAC. Given 
the difference in the predicted location of R67 (mitochondrial matrix) relative to C28 and 
C38 (IMS), it is possible that the relationship between Rcf1 and AAC may involve long-
range structural changes in the Rcf1 protein. Such long-range structural changes in Rcf1 
could be predicted to affect potential roles of Rcf1 in stabilizing AAC salt bridge 
networks in the matrix, via Q/R pairs of the Rcf1 QRRQ motif, or influencing dynamic 
structural changes within the IMS H2-L-H3 region of AAC via Rcf1 C28 and/or C38. 
 Following the analysis of conserved Rcf1 regions, a number of conformational 
and structural characteristics of the AAC protein were analyzed in their ability to 
influence the molecular environment of Rcf1 and AAC. The ability of Rcf1 to be cross-
linked to AAC via MBS was shown to be dependent upon the bioenergetic state of the 
mitochondria, where Rcf1 and AAC can be cross-linked during bioenergetically inactive 
conditions, in the presence of ADP or ATP alone, and during state 4 (basal) respiration, 
but the Rcf1-AAC interaction is abolished during state 3 respiration where AAC is active. 
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The ability of Rcf1 to be cross-linked to AAC was found to be affected by structural 
conformation changes in the AAC protein, seen in the cross-linking between Rcf1 and 
AAC that is open to the matrix, and the loss of cross-linking between Rcf1 and AAC that 
is open to the IMS.  
 Finally, it was demonstrated that the ability to cross-link Rcf1 and AAC is 
influenced by the presence of cardiolipin, as evidenced by the loss of MBS crosslinking 
between Rcf1 and AAC in cardiolipin deficient mitochondria (Δcrd1 and Δtam41). 
Native gel mobility analysis suggested that in the absence of Rcf2, and possibly the 
absence of both Rcf1 and Rcf2, the native gel mobility of AAC is altered, a result that 
further suggests a potential cooperative role of the two yeast Hig1 proteins Rcf1 and Rcf2 
in their relationship with AAC. However, the native gel mobility shift of AAC in the 
absence of Rcf2 (and both Rcf1 and Rcf2) did not appear to be equal to the shift seen in a 
cardiolipin deficient mutant, and thus may indicate that the arrangement or number of 
cardiolipin molecules bound to AAC, rather than the complete absence of bound 
cardiolipin, is altered in the absence of Rcf1 and Rcf2. 
 Taken together, these results suggest that a functional relationship may exist 
between Rcf1 and AAC, where their molecular environment is dynamic and the Rcf1 –
AAC relationship is influenced by conserved regions of Rcf1/Hig1 protein, the structural 
conformation of AAC, the bioenergetic state of the mitochondria.  
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CHAPTER 5: DISCUSSION 
5.1 Introduction  
 Hig1 proteins have emerged as important factors regulating complex IV assembly 
and respiratory supercomplex organization (Chen et al., 2012; Fischer et al., 2016; 
Strogolova et al., 2012; Vukotic et al., 2012). Members of the Hig1 family of proteins 
have also been linked to a number of mitochondrial processes including apoptosis, 
mitochondrial fusion and fission, mediation of oxidative damage, hypoxic growth, tumor 
growth and viability and aging (Ameri et al., 2015; An et al., 2013; 2011; Chen et al., 
2012; Fischer et al., 2016; Vukotic et al., 2012). The reported interactions between Hig1 
proteins and critical regulatory components of OXPHOS, including independent 
association with separate components of complex III and complex IV respiratory 
supercomplexes, and their close physical proximity to the ADP/ATP carrier protein 
(AAC), place Hig1 proteins at a pivotal regulatory position with the potential to modulate 
OXPHOS activity. While it is clear that this evolutionarily conserved family of proteins 
is important for mitochondrial function, a common mechanism underlying their function 
is currently unknown. Furthermore, the possible physiological significance of the two 
groups of isoforms, the Hig1-type 2 and Hig1 type 1 subgroups, is not known.  
 In this dissertation study the yeast Hig1 protein Rcf1, a member of the Hig1-type 
2 subgroup has been studied. The functional importance of conserved motifs within the 
Hig1 domain of Rcf1, including the QRRQ motif and residues within, and adjacent to, 
the N-terminal PXVPXG motif, have been probed in their ability to support the 
association of Rcf1 with partner proteins and influence Rcf1’s potential to modulate 
OXPHOS activity.  
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5.2 The role of Rcf1 in supporting complex IV activity 
 The Rcf1 protein supports the assembly of complex IV, and the abundance and 
functional capacity of the complex IV enzyme are reduced in the absence of Rcf1. Yet 
the mechanistic underpinnings of the role that Rcf1/Hig1 family proteins play in 
supporting complex IV assembly and activity have not been thoroughly characterized 
prior to this study. Therefore, a major focus of this dissertation study was to identify the 
potential molecular mechanism by which Rcf1 (and Hig1 proteins) influence the 
assembly and activity of the complex IV enzyme.  
 A number of recent studies have suggested that Hig1 proteins (including Rcf1) 
may function to secure the correct assembly of a subpopulation of complex IV, thereby 
regulating the activity of the enzyme and its level of organization into supercomplexes 
(Chen et al., 2012; Fischer et al., 2016; Strogolova et al., 2012; Vukotic et al., 2012). 
Furthermore, it was shown that the binding of the Hig1-type 1 protein, Higd1a, to 
complex IV enhances the activity of the enzyme (Hayashi et al., 2015). The authors of the 
latter study speculated that the enhanced complex IV activity occurs through structural 
changes near the catalytic center of the enzyme caused by the direct binding of the 
Higd1a protein to the complex IV enzyme (Hayashi et al., 2015). Therefore, one 
hypothesized role of Rcf1 (and Hig1 proteins) was that Rcf1 potentially functions as 
stoichiometric subunit of complex IV where it functions to regulate the activity of the 
enzyme either as structural component, or through securing the correct assembly of 
peripheral subunits of the complex IV enzyme and its organization into supercomplexes.  
 In agreement with previous studies, several lines of evidence presented here 
support a role of the Rcf1 protein in regulating the assembly or maturation of complex IV 
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in a manner that influences the catalytic activity of the enzyme. However, a distinctive 
feature of the evidence presented in this dissertation study is that it supports a speculative 
role of Rcf1 in exerting regulatory control on a subpopulation of complex IV in a 
transient and dynamic relationship with the enzyme, rather than acting as a stoichiometric 
or structural component of complex IV. 
 First, the affinity purification results presented here suggest that only a small 
fraction of complex IV is found in association with Rcf1, and these results were 
supported by the 1D BN-PAGE /2D-SDS-PAGE (LC-MS/MS) analysis of complex IV. 
Similarly, it has been reported that only a small percentage of complex IV is found in 
association with Rcf1 (Strogolova et al., 2012; Vukotic et al., 2012). These results are in 
agreement with previously reported purification of sub-stoichiometric amounts of Rcf1 
with complex IV (i.e. Rcf1 that co-purifies with the III2-IV2), which led the authors of the 
study to speculate that Rcf1 may function as a non-stoichiometric factor in securing the 
proper late-stage assembly of individual respiratory complexes (Mileykovskaya and 
Dowhan, 2014). Additionally, these results are in agreement with a recent study that 
presents a speculative role of Rcf1 in the modulation of cytochrome c binding in the III-
IV supercomplex, where the absence of Rcf1 is reported to affect only a fraction of 
complex IV in the mitochondria (Rydström Lundin et al., 2016). Second, it is reported 
here that in rcf1HisR67A mitochondria both the IV and IV** populations display enhanced 
catalytic activity, as evidenced by the in-gel activity of the IV and IV** sub-populations. 
However, the 1D-BN-PAGE/2D SDS-PAGE (LC-MS/MS and immunodecoration) 
experiments indicate that rcf1HisR67A is only found in association with IV**, indicating 
that the enhanced activity of the IV population is not due to the direct association of 
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Rcf1, but rather, Rcf1’s molecular “imprint” on the enzyme. Finally, it was shown here 
that, despite a strong reduction in the steady state levels of the Rcf1 Q/R pair mutant 
derivatives (i.e. rcf1HisQ61A,R65A and rcf1HisR67A,Q71A), the O2 consumption rate of complex 
IV was comparable between the Δrcf1,Δrcf2 double mutant harboring Rcf1 Q/R pair 
mutant derivatives and wild type Rcf1, (all of which contained O2 consumption rates that 
were significantly greater than in the double null), and suggests that Rcf1 does not act as 
a stoichiometric subunit to influence the activity of complex IV.  
 The results presented here support a role of the Rcf1 protein in regulating the 
assembly or maturation of complex IV in a manner that influences the catalytic activity of 
the enzyme. Moreover, these results suggest that Rcf1 may exert regulatory control on a 
subpopulation of complex IV through a transient and dynamic relationship with the 
enzyme, rather than acting as a stoichiometric or structural component of the complex IV 
enzyme. 
5.3 The role of Rcf1 in supporting AAC 
 The Rcf1 and AAC proteins are components of III-IV supercomplexes that have 
been shown to exist in close physical proximity within the inner mitochondrial membrane 
(Strogolova et al., 2012). Yet the molecular environment between Rcf1 and AAC was 
largely uncharacterized prior to this study. Specifically, it was unknown whether the 
structural characteristics and dynamic conformational changes that underlie the adenine 
nucleotide transport function of AAC influence the molecular environment of AAC and 
Rcf1. Likewise, the role of conserved regions of the Rcf1 protein in affecting the Rcf1-
AAC environment was unknown.  
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 Evidence presented here suggests the molecular environment of Rcf1 and AAC is 
dynamic, and is influenced by physical aspects of both partners, including conserved 
regions of Rcf1/Hig1 protein and the structural conformation of AAC. First, it was shown 
that two different regions of the Rcf1 protein that are predicted to be physically separated 
by the lipid bilayer influence the molecular environment between Rcf1 and AAC. It was 
shown that the alanine mutation of Rcf1 cysteine residues, C28 and C38, abolishes MBS 
(SH-NH3) cross-linking between Rcf1 and AAC, and strongly reduced the NH3-NH3 
cross-linking between Rcf1 and AAC by DFDNB. Additionally, the alanine mutation of 
conserved arginines within the Rcf1 QRRQ motif negatively impacts the ability to cross-
link Rcf1 and AAC by MBS. The regions of the Rcf1 protein that contain C28/C38 and 
the QRRQ motif are predicted to be physically separated by the lipid bilayer. Thus, taken 
together these results suggest that the Rcf1 QRRQ motif may contain the ability to 
influence the structural conformation of the Rcf1 protein, and thereby affect the 
molecular environment between Rcf1 and the AAC protein. Second, the structural 
conformation of the AAC protein was shown to influence the molecular environment 
between Rcf1 and AAC. Two specific inhibitors of AAC, AT and B.A. lock the 
translocase in opposing structural conformations. When AAC was locked in a matrix 
open state (m-state) by B.A., it could be cross-linked to Rcf1 via MBS. However, when 
AAC was locked in a cytosol open state (c-state) by AT, it was shown that cross-linking 
between Rcf1 and AAC was inhibited. These results suggest that the molecular 
environment between Rcf1 and AAC may be dynamic, and is possibly influenced by both 
the Rcf1 QRRQ motif and the activity of the AAC protein. In support of this speculation, 
evidence is presented here that demonstrates the Rcf1 and AAC molecular environment is 
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influenced by the bioenergetic state of the mitochondria, as shown in the ability to cross-
link AAC and Rcf1 under bioenergetically inactive conditions, (i.e. in the presence of 
ADP or ATP alone, and during state 4 (basal) respiration), and the strong reduction in 
Rcf1-AAC cross-linking that was detected during state 3 respiration where AAC is 
active. 
 Together, these results support the speculation that a functional relationship may 
exist between Rcf1 and AAC, where Rcf1 may function to stabilize the AAC protein in a 
specific structural conformation, possibly by bracing residues of the AAC protein that 
participate in conformation stabilizing salt-bridges, such as the salt-bridge residues of the 
H2-L-H3 region of AAC (located in the IMS-side of the inner membrane). Studies 
currently ongoing in the lab are aimed at determining if the catalytic properties of the 
AAC protein are altered in mitochondria deficient in the Rcf1/Rcf2 proteins or in those 
harboring Rcf1 mutant derivatives (Vera Strogolova, PhD dissertation). Furthermore, it is 
possible that the speculated functional relationship between Rcf1 and AAC may be 
dependent upon the ability of Rcf1 to form a homo-dimer. Mutations in the Rcf1 protein 
that negatively impact the formation of the Rcf1-Rcf1 homo-dimer (i.e. C28A/C38A, 
R65A, and R67A) were the same mutations that resulted in a strong reduction in the 
amount of cross-linking between Rcf1 and AAC. Therefore, it will be important to 
determine whether the Rcf1 dimer represents a functional form of the Rcf1 protein.  
 Finally, evidence was presented here that suggests the relationship between Rcf1 
and AAC may be influenced by cardiolipin. It was shown that the ability to cross-link 
Rcf1 and AAC was strongly reduced in cardiolipin deficient mitochondria (Δcrd1 and 
Δtam41). Furthermore, a shift was observed in the native gel mobility of AAC in the 
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absence of Rcf1 and Rcf2 (and Rcf2 alone). However, the AAC native gel mobility shift 
in Δrcf1Δrcf2 mitochondria did not appear to be equal to the shift seen in a cardiolipin-
deficient mutant, and suggests that in the absence of Rcf1 and Rcf2 (Δrcf1 Δrcf2), the 
arrangement or number of cardiolipin molecules bound to AAC might be altered, rather 
than the complete absence of cardiolipin bound to AAC. It will be important for future 
studies to compare the lipid composition of AAC between wild type and Δrcf1 Δrcf2 
mitochondria to determine whether there are differences in the composition of cardiolipin 
species bound to AAC. Additionally, it will be important to determine whether potential 
differences in the lipid composition of AAC in Δrcf1 Δrcf2 mitochondria has functional 
consequences for the nucleotide transport of AAC, and whether any altered AAC 
function might contribute to the apparent complex IV-independent growth phenotype of 
the Δrcf1 Δrcf2 mutant yeast strain.  
5.4 Rcf1 and the Lipids associated with Complex IV and AAC  
 Evidence presented here suggests that Rcf1 may play a role in modifying the lipid 
content of OXPHOS enzymes. The majority of this evidence supports a role of Rcf1 in 
securing the correct integration or modification of the signature mitochondrial 
phospholipid cardiolipin into complex IV. However, results presented here also suggest 
that Rcf1 may play a more general role in facilitating the assembly or modification of 
lipids (i.e. cardiolipin and/or other lipid species) that are associated with multiple 
OXPHOS enzymes.  
 Each of the proteins that comprise the Rcf1 interactome have been proposed to 
associate with cardiolipin. Complex IV contains two distinct types of cardiolipin binding 
sites, two high affinity binding sites that have been implicated in the electron transfer 
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process and two lower affinity sites that have been proposed to contribute to the structural 
integrity or possible dimerization of the complex (Arnarez et al., 2013; Sedlák and 
Robinson, 2015; Sedlák et al., 2006; Shinzawa-Itoh et al., 2007; Yoshikawa et al., 2012). 
The cardiolipin binding sites within the complex IV enzyme have been mapped to the 
Cox3 protein and to the Cox12 and Cox13 proteins, and these specific proteins have been 
shown to be intimately connected to Rcf1 and its functional relationship with complex IV 
(Strogolova et al., 2012; Vukotic et al., 2012). 
 Several lines of evidence presented in this dissertation study support a speculative 
role of Rcf1 in facilitating the integration or remodeling of cardiolipin that is associated 
with complex IV. First, it has been shown that the stability of complex IV is altered in 
mitochondria harboring rcf1HisR67A, as evidenced by an increased susceptibility to 
detergent. Additionally, it was previously shown that the steady state levels of complex 
IV are reduced in the absence of Rcf1 (Strogolova et al., 2012). Second, evidence is 
presented here that suggests the catalytic properties of complex IV are altered in 
rcf1HisR67A mitochondria, and include the enhanced ‘in-gel’ activity of complex IV and 
increased sensitivity to the inhibitor DCCD. Third, it is shown here that the cardiolipin 
remodeling enzyme, Taz1, co-purifies with the rcf1HisR67A mutant derivative. 
 Together, these results support the speculation that Rcf1 may function to facilitate 
the correct species, or arrangement of cardiolipin into the complex IV enzyme. 
Furthermore, evidence obtained from this dissertation study supports the possibility that 
Rcf1 may play a more generalized role in securing the correct lipid composition of 
multiple OXPHOS enzymes.  
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 In addition to the close physical relationship between Rcf1 and the cardiolipin-
associated proteins of complex IV, results presented here suggest that Rcf1 displays an 
intimate interaction with the cardiolipin-associated complex III protein, cytochrome c1, as 
evidenced by the co-purification of cytochrome c1 with Rcf1 in the absence of assembled 
complexes III and IV (i.e. ρ0 mitochondria). This result supports the previously published 
association between Rcf1 and cytochrome c1 when the assembly of a single complex (III 
or IV) is inhibited or strongly defective (Chen et al., 2012; Strogolova et al., 2012). 
Similar to proteins of complex IV that interact with Rcf1, an interaction between 
cytochrome c1 and cardiolipin has been demonstrated, and the cytochrome c1 –associated 
cardiolipin has been implicated in the stability and functional integrity of the complex III 
enzyme (Lange et al., 2001). Further evidence to suggest a role of Rcf1 in the 
incorporation or remodeling of cardiolipin that is associated with OXPHOS enzymes was 
observed in the reduced capacity of Rcf1 to be cross-linked to AAC in the absence of 
cardiolipin, as shown by the strong reduction in the cross-linking of Rcf1 to AAC in the 
cardiolipin-deficient mutants, Δcrd1 and Δtam41. Finally, the speculated role of Rcf1 in 
facilitating the correct integration or remodeling of cardiolipin that is associated with 
OXPHOS enzymes presented here, is consistent with the speculation that the Rcf1 and 
the cardiolipin synthase protein, Crd1, may act in the same pathway to promote 
respiration (Chen et al., 2012).   
 The proposed role of Rcf1 in the integration or modification of lipids that are 
associated with OXPHOS enzymes is based, in part, by the observation that the Rcf1 
interactome is almost exclusively comprised of proteins that specifically associate with 
cardiolipin molecules (i.e. Cox3, Cox12, Cytc1, AAC, and Taz1). Therefore, it is possible 
	 157	
that Rcf1 functions to facilitate the correct assembly or remodeling of cardiolipin within 
OXPHOS complexes, and may represent an underlying function of Hig1 proteins.   
 On the other hand, it is possible that Rcf1 may play an even more general role in 
the incorporation of lipids (i.e. not exclusively cardiolipin) into respiratory complexes. In 
support of this speculation is the evidence presented here that indicates the DCCD 
inhibition of complex IV is elevated in rcf1HisR67A mitochondria. While DCCD is 
predominantly known as an inhibitor of the F1FO ATP-synthase (complex V), it has been 
shown that at high concentrations DCCD can negatively impact the activity of complex 
IV (Shinzawa-Itoh et al., 2007). Structural characterization of DCCD bound to complex 
IV indicates that DCCD interacts with a conserved glutamate of the Cox3 protein (Glu90 
in bovine Cox3, equivalent to Glu98 of yeast Cox3), where the binding of DCCD to 
Cox3 Glu90 induces the migration of the palmitate tails of Cox3-associated 
phosphatidylglycerol lipids, PG1 and PG2, into the proposed O2 uptake channel of 
complex IV, blocking the access of O2 to the heme a3-CuB catalytic center of the complex 
IV enzyme. Therefore, the altered DCCD inhibition of complex IV OCR that was 
observed in rcf1HisR67A mitochondria may reflect a function of Rcf1 in the incorporation 
of Cox3-associated PG molecules, in addition to, or together with, the Cox3- associated 
cardiolipin. Furthermore, the speculated altered lipid composition of Cox3/complex IV 
may underlie the detergent instability of complex IV that is observed in rcf1HisR67A 
mitochondria.  
 In summary, several lines of evidence presented here support a role of Rcf1 in the 
lipid integration or remodeling of respiratory enzymes. Due to the largely speculative 
nature of this proposed role of Rcf1, future studies are needed to more fully characterize 
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the relationship between Rcf1 and the lipids associated with respiratory enzymes. In 
particular, it will be import to analyze whether Rcf1 is capable of binding lipids, and to 
further characterize the relationship between Rcf1 and the Glu98 residue of Cox3. The 
lipid profile of wild type, single mutant (Δrcf1 and Δrcf2) and double mutant (Δrcf1; 
Δrcf2) mitochondria was analyzed by Dr. Steven Claypool (Johns Hopkins University 
School of Medicine) (results not shown), and no significant differences in the total 
mitochondrial lipid profile were observed between either of the two single mutants (Δrcf1 
and Δrcf2) or the double mutant (Δrcf1; Δrcf2), compared to the wild type. However, 
Rcf1 appears to associate with only a fraction of complex IV, and it will be important to 
characterize the lipid composition of Rcf1-associated enzyme complexes to determine 
whether there are characteristic hallmarks in the lipid composition of Rcf1-associated 
respiratory enzyme complexes.  
5.5 The role of the Rcf1/Hig1 QRRQ motif 
 The current Rcf1 model predicts that Rcf1 contains 2 transmembrane domains 
that are oriented with both N and C tails exposed to the IMS, and connected by a short, 
matrix localized-loop. However, the latest unpublished data from Peter Brzezinski and 
Pia Ädelroth (Stockholm University) indicate that Rcf1 may contain 5 transmembrane 
domains and, contrary to the currently understood Rcf1 model, places the QRRQ motif in 
the IMS, with C28 and C38 near the matrix. Therefore, when appropriate, consideration 
of the proposed 5-transmembrane model of the Rcf1 protein will be discussed.  
 The results presented here highlight the importance of the QRRQ motif of Rcf1 
for its interaction with complex IV and molecular environment with AAC. How does the 
QRRQ motif influence the molecular interactions of the Rcf1 protein? The results from 
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this dissertation study present a number of interesting possibilities that could explain the 
role of the QRRQ motif. 
 First, several lines of evidence support a role of the QRRQ motif in influencing 
the structural conformation of the Rcf1 protein. The mutation of R67 (and R65, results 
not shown) of the QRRQ motif to alanine result in a strong decrease in the ability of Rcf1 
to form the MBS-facilitated cross-linking adduct with AAC. Mutational analysis of C28 
and C38, residues that were predicted to be located in the IMS/TM1 region of Rcf1 but 
recently have been shown to be located in the TM1/matrix region (FIGURE 35), 
demonstrated that MBS cross-linking between Rcf1 and AAC is dependent upon these 
cysteines. In the 2 transmembrane helices model of Rcf1, the predicted matrix/TM2-
localized R65 and R67 residues of Rcf1 are located a substantial distance from the critical 
AAC cross-linking region of Rcf1 (i.e. R65 and R76 are located on the opposite side of 
the membrane bilayer and in a different TM region of the Rcf1 protein from the C28 and 
C38 residues) (FIGURE 35). In the 5 transmembrane helices Rcf1 model, these domains 
are also located in opposite mitochondrial compartments, except that the QRRQ motif is 
predicted to be located in the IMS and C28/C38 near the matrix (Figure 35). Thus, in 
both models, the ability of QRRQ motif residues, R65 and R67, to influence the 
proximity of the Rcf1 C28 and C38 to AAC, suggests that residues of the QRRQ motif 
might contain the ability to influence the structural conformation of the Rcf1 protein. In 
support of this assertion are results demonstrating that the mutation of R67 (to alanine,  
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Figure 35. Predicted Model and NMR Structure of the S. cerevisiae Rcf1 Protein. 
(A).The predicted topology of Rcf1 in an Nout-Cout orientation within the inner 
mitochondrial membrane (IMM) and containing 2 transmembrane domains (TM1 and 
TM2). The predicted locations of C28 and C38 (cyan) and the QRRQ motif (red) are 
indicated. (B).The NMR structure of Rcf1 in an Nout-Cin orientation, and containing 5 
trasnmembrane domains (TM1-TM5). The locations of C28 and C38 (cyan) and the 
QRRQ motif (red) are indicated The solution NMR structure of Rcf1 was obtained by 
Dr. Peter Brzezinski and Dr. Pia Ädelroth (Stockholm University). Following expression 
in E.Coli, the yeast Rcf1 protein was denatured and re-folded from inclusion bodies. 
(unpublished results, personal communication between R. Stuart and P. Brzezinski).  
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glutamine or histidine, but not lysine or glutamic acid) confers a novel cross-link adduct 
between Rcf1 and the Cox2 protein. While the cross-linking between Rcf1 mutant 
derivatives and Cox2 requires further characterization, this result independently suggests 
that the molecular environment of Rcf1 is influenced by R67 of the QRRQ motif. 
Therefore, the QRRQ motif might function to influence the assembly or maturation of 
OXPHOS complexes, including complex IV and AAC, by controlling the structural 
conformation of the Rcf1 protein, thereby influencing the molecular environment of Rcf1 
and partner proteins, including AAC and the catalytically critical complex IV subunit, 
Cox2. Moreover, Rcf1 might potentially function as a wedge that regulates the assembly 
or modification of lipids within complex IV or AAC. In this regard, it is envisioned that 
the QRRQ motif might regulate the physical constraints of the matrix (or IMS) loop, 
resulting in a level of torsion that would be predicted to control the position of the Rcf1 
transmembrane regions relative to each other.  Thus, the position of the Rcf1 
transmembrane regions are speculated to confer an ‘open’ or ‘closed’ conformation of the 
Rcf1 wedge that serves to regulate the lipid composition of OXPHOS complexes by 
controlling the access of lipid synthases (or modifying enzymes) to lipid-associated 
proteins of the Rcf1 interactome (i.e. Cox3, Cytc1, AAC) (FIGURE 36). Furthermore, the 
possibility that structural changes in the Rcf1 protein may be dependent upon the 
protonation state of the R67 residue (suggested by the ability of glutamine and histidine, 
but not lysine or glutamic acid resides to promote the formation of the Rcf1-Cox2 adduct) 
suggest a potential mode of regulation, whereby the bioenergetic state of the 
mitochondria might influence the protonation state of Rcf1 R67 via changes in the pH of 
the mitochondrial matrix. The ability of wild-type Rcf1 to be cross-linked to AAC  
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progressively decreased as the bioenergetic status of the mitochondria changed (FIGURE 
31). The decrease in the ability of Rcf1 to be cross-liked to AAC during state 3 
respiration (i.e. when the AAC activity level is predicted to be elevated) suggests that 
either the activity of the translocase, or bioenergetic activity dependent changes in the pH 
of the mitochondrial compartments (matrix or IMS) influence the ability of Rcf1 to be 
cross-linked to AAC. Future experiments will be important for characterizing whether the 
bioenergetic status of the mitochondria affects the association of Rcf1 with partner 
proteins or enzyme complexes. 
 Second, evidence is presented here that suggests Rcf1 can form a homo-dimer. 
The mutational insertion of a cysteine in the QRRQ motif (V68C), results in the 
enhanced formation (or stability) of the observed Rcf1-Rcf1 homo-dimer. In contrast, 
Rcf1 mutant derivatives harboring mutations in conserved QRRQ residues displayed a 
strong reduction in the homo-dimer (R65A, R67A, Q61A/R65A, R67A/Q71A). It is 
important to note that the mutation of both Q residues (seen in the Q61A/Q71A Rcf1 
mutant derivative) did not negatively impact the formation of the Rcf1-Rcf1 homo-dimer, 
and suggests that the R65 and R67 residues of the QRRQ motif might be involved in the 
formation or stability of an Rcf1 homo-dimer. Whether Rcf1 functions as a dimer 
remains unknown. Evidence presented in chapter 3 indicates that Rcf1 can associate with 
complex III subunits (Cytc1 and Qcr6) in the absence of fully assembled complex III or 
complex IV (ρ0 mitochondria), and supports the findings that Rcf1 can associate with 
complex III independent of assembled complex IV (Strogolova et al., 2012), or the Cox3 
protein (Chen et al., 2012; Garlich and Stuart unpublished results). Thus, it could be 
speculated that individual Rcf1 proteins within an Rcf1-Rcf1 homo-dimer could 
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independently associate with complex III and complex IV, and thereby support the 
correct assembly (i.e. the lipid content) of individual enzyme complexes in a manner that 
influences their organization into supercomplexes. A number of recent findings support 
this speculation, and include the altered organization of III-IV supercomplexes in the 
absence of Rcf1 (and Rcf2), where there is a reduction in the III2-IV2 species and an 
increase in the III2-IV (Chen et al., 2012; Strogolova et al., 2012; Vukotic et al., 2012), 
and the reported role of Rcf1 in mediating electron transfer between complex III and IV 
by securing a tightly-bound cytochrome c (Rydström Lundin et al., 2016). Notably, the 
Cox12 protein, together with Cox2, defines the cytochrome c binding site within complex 
IV. It was previously shown that the correct assembly of Cox12 is negatively impacted 
by the absence of Rcf1 (and Rcf2) (Strogolova et al., 2012). Additionally, the Cox12 
protein has been shown to interact with cardiolipin (Arnarez et al., 2013; Sedlák and 
Robinson, 2015; Sedlák et al., 2006; Shinzawa-Itoh et al., 2007; Yoshikawa et al., 2012). 
Thus an Rcf1 dimer might support the assembly and structural organization of respiratory 
enzyme complexes by facilitating the correct lipid integration into individual complexes. 
Further characterization of the functional significance of Rcf1-Rcf1 homo-dimer, and the 
role of the QRRQ motif in its formation (or maintenance) should be addressed in future 
experiments.    
  Finally, a notable feature of the QRRQ motif that appears to be conserved among 
Hig1-type 2 proteins are Q/R pairs that co-align when the QRRQ motif is analyzed in an 
α-helical plot, i.e. the R67 residue co-aligns with the Q71 residue, and the R65 residue is 
adjacent to the Q61 residue (FIGURE 16A). Mutational analysis of the Q/R pairs 
suggests that either pair is independently critical for the stability of the Rcf1 protein, 
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where the stability of the Rcf1 protein is negatively impacted by the mutation of either 
pair, and observed to be marginally more detrimental in the Q71A/R65A mutant 
derivative (FIGURE 16B). Furthermore, the mutation of either Q/R pair resulted in a 
strong reduction in the Rcf1-Rcf1 homo-dimer. Therefore, the Q/R pairs might represent 
functional regions of the Rcf1 protein that could, in theory, interact with the same partner 
protein in a manner that is dependent on the conformation of the Rcf1 protein. As 
discussed above, the strong reduction in the ability of Rcf1 to be cross-linked to AAC in 
the R65A and R67A mutants could be interpreted as a role of the QRRQ motif, via R65 
and R67, in influencing the structural conformation of the Rcf1 protein. Thus, two Q/R 
pairs would allow Rcf1 to interact with the same protein partner by alternating the 
interaction between the respective Q/R pairs. Reciprocally, the two Q/R pairs might 
secure the ability of a relatively static Rcf1 protein to interact with a partner protein that 
undergoes dynamic structural rearrangement (potentially caused by catalytic activity), 
such as the transition between m- and c-states by AAC, the oxidation and reduction of 
cytochrome c, proton pumping and reduction of O2 by the III-IV supercomplex, or the 
assembly (or modification) of lipids that associate with OXPHOS enzymes.      
 Regardless of the specific mode of interaction, this dissertation study highlights 
the importance of the QRRQ motif as a determinant of the dynamics of Rcf1’s interaction 
with Cox3 and complex IV, and demonstrates that altering the QRRQ motif significantly 
influences the catalytic activity of the complex IV enzyme.   Moreover, the ability to 
form an Rcf1-AAC cross-linking adduct is also affected by mutations in the QRRQ 
motif, suggesting that the QRRQ motif plays an important role in influencing the 
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molecular environment of Rcf1 and partner proteins that are critical OXPHOS 
components.   
5.6 Comparison of Hig1-type 1 and type 2 isoforms  
 The Hig1 family of proteins is evolutionarily conserved from α-proteobacteria to 
diverse eukaryotic taxa, and can be separated into two distinct groups, -type 1 and -type 
2, based on their sequences. The expression of the Hig1-type 1 isoform is induced in 
response to various cellular stresses, where it has been shown to play a role in 
maintaining mitochondrial function and cell survival during hypoxia. In contrast, the -
type 2 isoform appears to be constitutively expressed and, importantly, is limited to α-
proteobacteria and lower eukaryotes (Strogolova et al., 2012). However, similar to -type 
1 proteins, several recent studies suggest that –type 2 proteins may also function to 
protect the functional integrity of mitochondria from oxidative damage during hypoxia.  
 What then, is the significance of the variations between –type1 and –type2 
isoforms, including: the divergent QRRQ motif sequences between type 1 and type 2 
isoforms, their differential expression patterns (hypoxia-induced vs. constitutive), and the 
differences in their taxonomic distribution (-type 2 isoforms found exclusively in α-
proteobacteria and lower eukaryotes? Furthermore, how are these differences reconciled 
with the apparent overlapping function of Hig1 proteins in the maintenance of 
mitochondrial function during cellular stress, and the proposed role of the Hig1-type 2 
protein Rcf1 in the modification of the complex IV enzyme?  
 The Hig1-type 2 [Q]-(X)3-R-X-R-(X)3-[Q] motif is noticeably different from the 
Hig1-type 1 stress-induced isoforms that contain a [I/V]-HLIHM-R-(X)3-[Q] motif. The 
results presented here suggest that differences in this motif between Hig1-type1 and 
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Hig1-type2 isoforms may influence a dynamic relationship between Hig1 proteins and 
complex IV, as evidenced by the reduced amount of complex IV that was found to co-
purify with Hig1-type1His as compared with Hig1-type2His (and compared to the yeast 
type 2 protein, Rcf1His). One possibility is that the differences in these motifs may reflect 
the need for differential modifications to complex IV that allow the enzyme to function 
optimally under stress conditions, such as during hypoxia. In this capacity, it is 
speculated that Rcf1 would function to secure a specific lipid composition within 
complex IV (i.e. the integration or remodeling of specific PG or CL species that associate 
with complex IV) that results in an altered (potentially enhanced) efficiency of O2 uptake 
to the heme a3-CuB center of the enzyme. Alternatively, it is possible that differences in 
these motifs underlie distinct dynamic interactions with complex IV that are divergent 
between type1 and type2 isoforms, where type 1 proteins display a “loose/rapid” 
interaction with complex IV and type 2 proteins display a relatively  “tight/slow” 
association. A “loose/rapid” interaction between the Hig1-type1 isoform and complex IV 
may be advantageous (over the “tight/slow” association of type2) during hypoxia, where 
the need for rapid modifications to complex IV is critical to minimizing ROS and 
promoting survival.  
 Another apparent difference between Hig1-type 1 and type 2 isoforms is that the 
expression of Hig1-type 1 proteins is induced by cellular stress, whereas type 2 proteins 
appear to be constitutively expressed. What accounts for the differences in the expression 
of Hig1 isoforms?  
 Under conditions of limiting O2 (hypoxia), the incomplete reduction of O2 can 
lead to the production of damaging superoxide radicals, resulting in mitochondrial 
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dysfunction. Thus, the ability of mitochondria to continue to function under low O2 
conditions is critical for efficient energy production and the survival of the organism. 
Hypoxic-induced isoforms of complex IV (Cox5b), cytochrome c (iso-2-cytochrome c) 
and AAC (Aac3) collectively represent components that alter the composition of 
respiratory enzyme complexes and associated proteins to enhance ATP production by 
OXPHOS and maintain mitochondrial function under low O2 conditions (Hodge et al., 
1989; Kwast et al., 1999; Sabová et al., 1993). Therefore, the hypoxia-induced Hig1-type 
1 isoform could represent a sub-group of Hig1 proteins that contain the unique ability (to 
that of the Hig1-type 2 isoform) to recognize or interact with hypoxia-induced OXPHOS 
isoforms (i.e. Cox5b, iso-2-cytochrome c, and Aac3), and thereby maintain the regulation 
of OXPHOS by Hig1 proteins under low O2 conditions.  
 It is possible that Hig-type 1 proteins confer a modification to complex IV that is 
different from that of Hig1-type 2 proteins, and that allows the enzyme to function 
optimally during hypoxia. Alternatively, type 1 proteins might enhance the activity of 
OXPHOS enzymes by the same function that is proposed for type 2 proteins (including 
Rcf1) (i.e. facilitating the assembly or modification of associated lipids). Thus, in 
addition to the presence of constitutively expressed Hig1-type 2 protein, the induction of 
the hypoxia-induced type 1 isoform would be predicted to increase the abundance of 
Hig1 proteins that are functionally identical, and thereby secure optimal OXPHOS 
function under low O2 conditions by significantly increasing the proportion of Hig1-
modified (catalytically enhanced) OXPHOS enzymes.   
 While Hig1-type 2 proteins are found in many bacteria and lower eukaryotes, the 
type 1 isoform appears to be exclusively present in higher eukaryotes. If Hig1 proteins 
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(type 1 and type 2) share a common underlying function, such as facilitating the 
modification of lipids that are associated with OXPHOS complexes, their divergent 
taxonomic distribution might reflect differences in the type of lipids that associate with 
OXPHOS enzymes between bacteria and higher eukaryotes. While the lipid binding sites 
of Cox3/subunit III have been shown to be extensively conserved from bacteria to 
mammals, the specific type of lipid that binds to the Cox3/subunit III are different 
between bacteria and mammals (Varanasi et al., 2006). It is also possible that the 
hypoxia-induced type 1 isoform may represent an additional level of regulation that has 
been acquired exclusively by higher eukaryotes, that provides an enhanced efficiency of 
O2 transfer under low O2 conditions, either by the increased abundance of Hig1 proteins 
or through a different function (i.e. different type of enzyme modification) than the type 2 
isoform.  
5.7 The Role of Hig1 proteins in hypoxia and stress conditions 
 What is the relationship between the speculated role of Rcf1 in the lipid 
integration or remodeling of OXPHOS complexes presented here and the reported 
involvement of Rcf1/Hig1 proteins in the mediation of hypoxic and oxidative damage? A 
number of recent independent studies have implicated Rcf1 (and Hig1 homologs from 
various eukaryotic taxa) in the mitigation of ROS production and oxidative damage 
(Ameri et al., 2015; Chen et al., 2012; Fischer et al., 2016; Vukotic et al., 2012). Two of 
these studies presented evidence that suggests Rcf1/Hig1 proteins are required for growth 
under hypoxic conditions (Vukotic et al., 2012) and maintenance of lifespan (Fischer et 
al., 2016). Furthermore, it was recently shown that the binding of a Hig1 family protein 
(Higd1a) to complex IV positively regulates complex IV activity through structural 
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changes in the enzyme, and the authors speculate that Higd1a –associated structural 
changes may be important for the reported Higd1a-dependent survival during hypoxia 
(Hayashi et al., 2015). Here, it has been proposed that Rcf1, in a dynamic manner that is 
influenced by the Hig1-type 2 QRRQ motif, associates with Cox3- containing complex 
IV, possibly during assembly, and affects the stability and catalytic properties of the 
enzyme by securing the correct maturation of the enzyme and its associated lipids. The 
altered level of complex IV inhibition by DCCD that was observed in rcf1HisR67A 
mitochondria suggests that Rcf1 may affect the stability and enzymatic activity of 
complex IV by influencing the assembly or modification of Cox3-associated lipids that 
are reported to regulate the O2 uptake pathway of the complex IV enzyme.  
 The reported regulation of the complex IV O2 path by Cox3-associated lipids was 
proposed by Shinzawa-Itoh et al., to occur through changes in the conformation of the PG 
tail ends that are induced by the introduction of O2 molecules into the pathway, or 
potentially through long-range interactions with the redox active center of the enzyme, 
and that are predicted to control the O2 supply to the a3-CuB oxygen reduction site 
(Shinzawa-Itoh et al., 2007). In support of this speculation are reports that subunit 3 of 
Rhodobacter sphaeroides aa3-type cytochrome c oxidase, homologous to the Cox3 
protein of mitochondrial complex IV, protects the structural integrity of the heme a3-CuB 
active center from suicide inactivation in a lipid-dependent manner through long range 
interactions with the active center (Bratton et al., 1999; Varanasi et al., 2006). The 
regulation of the complex IV O2 path by Cox3-associated lipids was found to be strongly 
dependent on the composition of the Cox3-associated PG molecules, suggesting that the 
specificity of the Cox3-associated PG species may be a critical determinant in the level of 
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regulation of the complex IV O2 path (Shinzawa-Itoh et al., 2007). Therefore, it is 
possible that the association between Rcf1 and newly-synthesized Cox3 may be 
important for securing the integration of specific lipid species into complex IV that 
confer a unique level of regulation.  
 Furthermore, the reported roles of Rcf1 in the mediation of oxidative damage and 
ROS production, and the required presence of Rcf1 for hypoxic growth and lifespan 
maintenance, suggest that Rcf1 –modified complex IV species may be critical for 
OXPHOS under sub-optimal conditions such as hypoxia. Thus, Rcf1-dependent 
modifications to complex IV are proposed to result in a complex IV species that is 
capable of optimal function under hypoxic conditions, resulting in decreased ROS 
production that minimizes oxidative damage (including lipid peroxidation) and supports 
OXPHOS, thereby maintaining normal lifespan under hypoxic conditions. In agreement, 
the results of this dissertation study support the speculation that Rcf1/Hig1-type 2 
proteins, through a transient and dynamic interaction with newly-synthesized Cox3 
protein that is dependent on the QRRQ motif, function to modulate the catalytic 
properties of the complex IV enzyme, potentially through Cox3-associated lipids that 
potentially result in long-range structural changes near heme a3-CuB. Furthermore, it is 
speculated here that the proposed Rcf1-dependent complex IV structural changes 
modulate the access of O2 to the redox-active heme a3-CuB center, thereby mitigating the 
production of, or damage from, reactive oxygen species during hypoxia (FIGURE 37).  
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Figure 37. Proposed Rcf1-Complex IV interface. It is speculated that Rcf1 
(depicted here in green), through a transient and dynamic interaction with 
newly-synthesized Cox3 (Blue) that is influenced by the Rcf1 QRRQ motif, 
functions to modulate the catalytic properties of the complex IV enzyme, 
potentially through Cox3 lipids that result in long-range structural changes that 
affect the heme a3-CuB center, thereby modulating access of the access of O2 
to the redox center. 
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5.8 Model of the proposed role of Rcf1/Hig1 proteins 
 Based on the results of this dissertation study, a model is proposed in which the 
Rcf1 protein, through its association with newly synthesized Cox3, functions to regulate 
the catalytic properties of the complex IV enzyme by facilitating the integration (or 
modification) of Cox3-associated lipids that modulate the O2 pathway to the heme a3-CuB 
catalytic center. Moreover, it is speculated that Rcf1 contributes to the heterogeneity of 
the complex IV enzyme population within the mitochondria by modifying the O2 uptake 
efficiency of a subpopulation of complex IV, thereby securing a subpopulation of 
complex IV that functions optimally during hypoxia, thereby mitigating the production 
of, or damage from, reactive oxygen species, the absence of this complex IV 
subpopulation in Δrcf1 mitochondria results in yeast that are more susceptible to 
hypoxia-induced mitochondrial dysfunction and oxidative damage (FIGURE 38).    
 In conclusion, the results presented in this dissertation study highlight the 
importance of Rcf1 in the regulation of aerobic cellular energy production via OXPHOS, 
and a common mechanism of Hig1 proteins is proposed here, where Rcf1/Hig1 proteins 
influence OXPHOS through the assembly of respiratory enzyme complexes that are 
adapted to function optimally under stress. 
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